‘
Saibal Kar, M.D, FAHA, FACC, FSCAI
Director of Interventional Cardiac Research
Program Director of Interventional Cardiology
Associate Professor of Medicine
Curriculum Vitae
PERSONAL HISTORY
Business Address:
8631 West Third Street, 415 E Towers
Los Angeles, CA 90048, USA
Email: karsk@cshs.org, saibalkar60@gmail.com.
Tel: (310) 423 3874 Fax: (310) 967 8323
Citizenship:
United Kingdom
Marital Status:
Single
EDUCATION
1977 –1979
1979 -1984
1984-1985
1987-1989
1990
1990
1991-1992
1993
1994-1996
1996
1996-1998
1998-2000
2000-2001
Premedical/Higher Secondary Education, St Xavier’s College, Calcutta, INDIA
M.B, B.S, (Medical School Diploma), Nilratan Sircar Medical
College, Calcutta University, Calcutta INDIA
Internship. Nilratan Sircar Medical College. Calcutta, INDIA
Residency in Internal Medicine. Post-Graduate Institute of Medical Education &
Research, Chandigarh, INDIA
Senior Resident in Internal Medicine, Post-graduate Institute of
Medical Education & Research, Chandigarh, INDIA
Senior Resident in Cardiology, Sanjay Gandhi Post-graduate
Institute, Lucknow, INDIA
Fellowship in Cardiology. Post-graduate Institute of Medical Education & Research,
Chandigarh, INDIA
Senior Resident (Post DM) in Cardiology, Post-graduate Institute of
Medical Education & Research, Chandigarh, INDIA
Fellowship in Interventional Cardiology. Epworth Hospital. Melbourne. Australia
Internship(in USA). Dept of Medicine. West Los Angeles VA
Medical Center, UCLA, Los Angeles. California
Resident in Internal Medicine. UCLA. West Los Angeles VA Medical Center, Los
Angeles, California
Fellowship in Cardiology. UCLA. Cedars-Sinai Medical Center. Los Angeles, California.
USA
Fellowship in Interventional Cardiology. UCLA.Cedars-Sinai Medical Center. Los
Angeles, California, USA
Page 1 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
LICENSURE
1.
2.
3.
West Bengal. INDIA. No 45013 since 1986
Medical Practitioners Board of Victoria. No MPS021710 March 24, 1994 to August 1, 1997
California, USA. No A063816 since October 1997
BOARD CERTIFICATION
1990
1990
1992
1995
1995
1996
1998
2000
2001
M.D.(Doctor of Medicine). Post-graduate Institute of Medical Education &
Research, Chandigarh, INDIA
Diplomate National Board of Medicine. New Delhi, INDIA
D.M.(Doctor of Medicine in Cardiology). Post-graduate Institute of Medical Education & Research,
Chandigarh, INDIA.
USMLE(Step 1 and Step 2)
ECFMG
USMLE(Step 3)
Diplomate in Internal Medicine. American Board of Internal Medicine
Diplomate in Cardiovascular Diseases. American Board of Internal Medicine
Diplomate in Interventional Cardiology. American Board of Internal Medicine
PROFESSIONAL EXPERIENCE
Present Position:
Staff Cardiologist
Director of Interventional Cardiac Research
Division of Cardiology/ Department of Medicine
Cedars Sinai Medical Center, Los Angeles, CA, USA
Associate Professor of Medicine at David Geffen School of
Medicine at UCLA, Los Angeles, CA.
Previous Positions:
1.
2.
3.
4.
1998-2003: Intensivist. Good Samaritan Hospital, Los Angeles, California
1995-1996: Intensivist. St Vincent’s Hospital. Melbourne, Australia
1994-1996: Part time Emergency Medicine Physician. Epworth Hospital, Melbourne Australia
1993-1994: Assistant Professor, Division of Cardiology, Dept of Medicine
Post-graduate Institute of Medical Education & Research, Chandigarh, INDIA
Page 2 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
PROFESSIONAL ACTIVITIES
Committee Service:
1.
2.
3.
4.
5.
6.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Cardiac Cath Laboratory Advisory Committee, Cedars-Sinai Medical Center, Los Angeles
Resident selection committee, Cedars Sinai Medical Center, Los Angeles. 2002, 2004
Scientific Advisory of Board. International Academy of Cardiology. 8th World Congress on Heart
Failure Mechanisms, and Management: July 2002
Scientific Advisory of Board. 3 World Congress on Heart Disease: New Trends in research,
diagnosis and treatment. 2003
Member of the Executive Committee for the CLOSURE I trial
Member of Institution Review Board at Cedars Sinai Medical Center, Los Angeles, CA. since May
2006
Member of the Performance Improvement Committee: Cardiology, since 2002
Member of the Cath Lab Advisory Committee: Division of Cardiology, Cedars Sinai Medical Center,
Los Angeles, CA
Abstract Grader for the Society of Cardiovascular Angiography & Interventions (SCAI-American
College of Cardiology Interventional Summit( SCAI-ACCI2 summit) since , 2008
Program Committee for the Annual Transcatheter Therapeutics Meeting
Program Committee : American College of Cardiology i2 summit 2010, 2011, 2012, 2013,2014
Program Committee: American College of Cardiology annual conference 2011, 2012, 2013, 2014
Program Committee : Society of Cardiovascular Angiography & Interventions 2010, 2011
Program Committee: Transcatheter Therapeutics, 2012, 2013
Abstract Grader for Transcatheter Therapeutics
Abstract Grader for American College of Cardiology 2010, 2011, 2012,2013
Abtract Grader for annual SCAI meeting 2010, 2011, 2012, 2013
PROFESSIONAL ASSOCIATIONS
1.
2.
3.
4.
5.
6.
7.
Cardiological Society of India (Life member)
Member of American College of Physicians: ACP # 01110339 Elected in 11/97
Fellow of American College of Cardiology, Sept 2002
Member of the American Medical Association since 1998
Fellow of the American Heart Association since 2001
Fellow of the Society of Cardiovascular Angiography and Interventions since 2004
Interventional Council of American College of Cardiology March 2012 to March 2015
MANUSCRIPT REVIEWER
1.
2.
3.
4.
5.
6.
Journal American College of Cardiology
American Journal of Cardiology
International Journal of Cardiovascular Imaging
Circulation: CardiovascularInterventions
Echocardiography
Journal American College of Cardiology: Interventions
CONSULTING SERVICES
1.
2.
.3.
4.
5.
Medtronic Inc
Gerson Lehrman Group
Boston Scientific
Abbott Vascular
Gore Medical
Page 3 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
HONORS AND AWARDS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
1981
1984
Gold Medal in Anatomy. Nilratan Sircar Medical College, Calcutta, INDIA.
First Certificate of Honors, Gynaecology and Obstretics, Nilratan Sircar Medical
College, Calcutta. INDIA
.1984 J.L. Poddar Gold Medal in Gynaecology and Obstetrics, Niltratan Sircar Medical College,
Calcutta. INDIA
1984 Debendra Nath Dawn Medal in Gynaecology and Obstetrics, Nilratan Sircar
Medical College, Calcutta. INDIA
1984 University Honors in General Surgery, Calcutta University, Calcutta, INDIA
1984 Highest Rank in University in the final MBBS examination, Nilratan Sircar
Medical College, Calcutta, INDIA
1989 Silver Medal in Medicine. For distinguished performance in the final MD
examination (board certification in medicine). Post-graduate Institute of Medical
Education & Research, Chandigarh, INDIA
1997-98
Best Resident of the year: Internal Medicine, West Los Angeles VA Medical
Center; UCLA
1997-98
Sherman Mellinkoff Best Resident Teacher Award of the Year: Internal
Medicine; West Los Angeles VA Medical Center; UCLA
1999-00
Elliot Corday Outstanding Cardiology Fellow of the year
2003
Honored Member of of America’s Registry of Outstanding Professionals
Ed 2003-2004
2007 Mentor Award 2006-2007: In recognition of Exceptional Mentorship in the
Academic and Clinical Practice of Cardiovascular Medicine: Presented by the
The Cardiology Fellows of Cedars Sinai Medical Center
’09 2007 Visiting Professor MC MEDICOR International Center for Cardiovascular
Diseases, Slovenia
May 2010. Second Prize for the Best of Best Abstract, Society of Cardiovascular
Angiography and Interventions.
March 25, 2012. Honored by the American Association of Cardiologist of Indian Origin
RESEARCH GRANTS AND FELLOWSHIPS
ACTIVE PRECLINICAL STUDIES
Kar (PI)
St Jude Medical
2/23/2011 to 3/31/2013
$700,000
1%
HeartPOD Implantable Left Atrial Pressure Monitoring Device in a Canine Model-Training Protocol
This is a animal model training protocol of training physicians to implant this device in humans for the
clinical trial
Role: Principal Investigator
Kar(PI)
Advanced Bifurcation Systems:
4/20/2009 to 11/30/2013
Preclinical evaluation of a novel bifurcation stent in porcine coronary arteries
Role: Principal Investigator
Page 4 of 65
1%
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Kar(PI)
St Jude Medical
4/2/2007 to 3/31/2013
$900,000
1%
Chronic evaluation of the HeartPod Implantable Left Atrial Pressure Monitoring Device in a Canine Model.
In this initial study all animals have been implantable. The study is continuing to follow some of the survival
animals
Role: Principal Investigator
Kar(PI)
Circulite
4/08/2009 to 3/31/2013
$200,000
1%
Acute evaluation of percutaneously delivered implantable assist device in a porcine model. This is the first
of its kind transseptal Left atrial to aorta implantable device that is in development. The percutaneous
delivery system is being evaluated for the fist time in our institution in preparation of a first in man study in
2013
Role: Principal Investigator
Kar(PI)
Valcare
9/26/2012 tp 09/30/2013
$100,000
1%
Acute evaluation of transcatheter mitral valve repair using a Valcare Annuloplasty Ring. The aim of the
study is develop and evaluate a method of transcatheter delivery and anchoring of this annuloplasty ring,
prior to planning first in man study. This is the first animal study being performed with this device
Role: Principal investigator
ACTIVE CLINICAL TRIALS
Kar (PI)
Evalve Inc/Abbott Vascular
3/1/05 - 1/31/14
1%
$95,000
EVEREST II clinical trial
The goal of this study is demonstrate of the role of percutaneously delivered clip
on the mitral valve for the treatment of mitral regurgitation.
In this landmark Phase II study, our group is the lead enroller in the nation, This study completed
enrollment in 2008. Patients will be followed till 2013.
Role: Principal Investigator
Kar(PI)
Evalve Inc/Abbott Vascular
2/25/2009 to continuing
$ 80,000
5%
REALISM
Prospective, multicenter continued access registry of the EVEREST II trial of the use of the MitraClip for the
treatment of mitral regurgitation. The study will provide additional safety and effectiveness data in a real
world condition to support premarket approval application(PMA). Lead enroller of this study. k
Role: Principal Investigator
Kar(PI)
Abbott Vascularj
ar(Principal Investigator)
Abbott Vascular
2/27/2013- continuing
Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy for Extremely High Surgical
Patients(The COAPT trial)
IDE: G120024
Page 5 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Prospective randomized study comparing the MitraClip along with best medical therapy to best medical
therapy alone for treatment severe functional mitral regurgitation patients who are not surgical candidates.
All patients will be followed for 5 years
5/27/05 – 3/31/2013
Kar (PI)
Atritech Inc/ Boston Scientific
1%
$15,000
Protect AF study
The goal of the study is to demonstrate the role of Percutaneous Atrial Appendage
Occlusion as an alternative to long term anticoagulation for patients with Atrial fibrillation.
(This clinical study is the first comparative study comparing medical treatment versus closure of Atrial
appendage for the prevention of stroke. In view of the large number of patients with Atrial fibrillations if this
study is positive it will create a large impact in the community. The study completed enrollment in 2008.
Patients are still being followed for 5 years.
Role: Principal Investigator
Kar(PI)
Atritech Inc/Boston Scientific
10/29/2008 to 3/31/2013
1%
Continued Access Protocol (CAP registry)
Prospective multicenter continued access registry of the use of the Watchman Device to provide additional
safety and efficacy data to support premarket approval application(PMA). This registry completed
enrollment in late 2009. This registry was stopped once the PREVAIL trial was conceived. We were the
second highest enroller of this study.
Role: Principal Investigator
Kar(PI)
Atritech Inc/Boston Scientific
01/28/2011 to Continuing
$ 78,000
2%
PREVAIL Trial
This is confirmatory study to demonstrate the role of Percutaneous closure of the left atrial appendage
occlusion using the Watchman device in the prevention of stroke in patients with non valvular atrial
fibrillation who are at significant risk for stroke. Enrollment was completed in June 2012. All patients are
being followed for 5 years. We were the second highest enroller of this study.
Role: Principal Investigator
Kar(Principal Investigator) (National Principal Investigator)
Boston Scientific
4/15/2013 - 3/31/2014
Continuous Access to PREVAIL(CAP2)
IDE: G020312
Prospective multicenter continued access registry of the use of the Watchman Device to provide additional
safety and efficacy data to support premarket approval application(PMA). The inclusion and exclusion
criteria are similar to that of the PREVAIL trial. In this study, Dr Kar serves as the national principal
investigator
Kar(PI)
AGA Medical a subsidiary of St Jude Medical
9/21/2010 – continuing
$60,000
1%
Amplatzer Cardiac Plug study
This is a pilot study to evaluate safety and efficacy percutaneous closure left atrial appendage using the
amplatzer cardiac plug. The pilot study will be followed by a large scale multicenter randomized pivotal
study. Pilot study has been completed and the randomized study has just started.
Role: Principal Investigator
Page 6 of 65
Curriculum Vitae
Kar(PI)
Gore Medical
Saibal Kar, M.D, FAHA, FACC, FSCAI
9/30/2011 to continuing
$20,000
1%
REDUCE Trial
Prospective, multicenter randomized study comparing closure of a patent foramen ovale using the GORE
HELEX Septal Occuder plus antiplatelet therapy versus antiplatelet therapy alone in the secondary
prevention of stroke in patients with a history of cryptogenic stroke and a patent foramen ovale.
Role: Principal Investigator.
Makkar(PI)
Edwards Lifesciences
3/25/2011 to continuing
1%
The PARTNER II trial
Prospective randomized study comparing Edwards Sapien XT transcatheter aortic valve to conventional
surgical valve replacement for the treatment of severe aortic valve stenosis in moderate surgical risk
patients.
Role: Co-investigator
Zahn(PI)
Edwards Lifesciences
04/09/2009 to continuing
1%
The COMPASSION Study
Prospective multicenter study evaluating the role of the Edwards Sapien transcatheter valve in the pulmonic
valve in patients with a history of failed surgical conduits in the right ventricular outflow tract.
Role: Co-investigator
C Noel Bairey Merz
NIH: National Institutes Of Health
5/14/2008 to continuing
5%
Women’s Ischemia Syndrome Evaluation(WISE) Coronary Vascular Dysfunction
In this study it planned to determine whether coronary vascular dysfunction predicts abnormalities in
cardiac MRI imagng. In addition to determine whether these abnormalities detected by MRI are actually
predictive of adverse outcomes in women with angina with angiographically normal coronaries with
abnormal function.
Role: Co-investigator
,Czer, L (PI)
St Jude Medical
3/19/2012 to 2/28/2013
1%
Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)
Prospective, multicenter, randomized controlled clinical trial comparing safety and effectiveness of
treatment of heart failure guided by left atrial pressure monitoring system versus standard of care. My role is
to implant the left atrial pressure system in patients who are randomized to receive the device
Role: Co-investigator
Makkar(PI)
Edwards Lifesciences
10/18/2007 to 8/31/2013
01%
THE PARTNER Trial
Prospective, multicenter, randomized trial comparing Edwards SAPIEN Transcatheter Heart Valve versus
surgical treatment or medical treatment for aortic stenosis in patients who very high risk or extreme risk for
conventional cardiac surgery. The trial has completed enrollment and at present patients enrolled in the
study are being followed for a total of 5 years.
Page 7 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Role: Co-investigator
Makkar(PI)
Medtronic
8/15/2012 to 7/31/2013
1%
Symplicity HNT 3, Renal Denervation in Patients with Uncontrolled Hypertension
10,000
Prospective, multicenter, randomized, controlled study comparing renal denervation versus conventional
medical treatment for resistant hypertension. This is novel study evaluating a new treatment for
hypertension.
Role: Co-investigator
Shah (PI)
St Judes Medical
10/31/2005 to 6/30/2013
$60,000
5%
HOMEOSTASIS TRIAL
The Phase I study in US is to demonstrate the safety and efficacy of chronic left atrial pressure monitoring
using the Heart POD device in patients with chronic heart failure patients. This novel device was invented in
Cedars Sinai Hospital. Dr Eigler, Dr Whiting and Dr Kar were involved in the preclinical development of this
product. The enrollment of this phase of this study has been completed, patients are being followed.
Role: Co-investigator in this study. Plays an important role in proctoring physicians
all over the world involved in this study in proper deployment of this device.
Role: Co-Investigator
4/23/2013 – continuing
Makkar(Principal Investigator)
Abbott Vascular
EXCEL: Evaluation of XIENCE PRIME™ or XIENCE V® versus Coronary Artery Bypass Surgery for
Effectiveness of Left Main Revascularization
This is a randomized study comparing surgical revascularization versus stenting of the left main coronary
artery. This will be a long term follow up study
Role: Co-investigator
LECTURES AND PRESENTATIONS
Cardiology Grand Rounds: West Los Angeles VA Medical Center. July 2001 Mitral valvuloplasty
“Current status of Mitral valvuloplasty”, Cardiology Grand Rounds: UCLA Harbor, Torrance, CA. Feb 2002
“Percutaneous Closure of Patent Foramen Ovale in pts with Neurological Events”, 8th World Congress of
Heart Failure, July 2002, Washington
“Treatment of Patent Foramen Ovale with Stroke: Coumadin vs. Closure “, Stroke Update, Dept of
Neurology, Cedars Sinai Medical Center, Los Angeles, June 2002
Page 8 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
“Heart Sounds” Clinical Medical Lecture Series, Dept of Medicine, Cedars Sinai Medical Center, Los
Angeles, June 2002
“Everolimus eluting stents prevents in-stent restenosis without toxicity in a porcine model” Research and
Progress, Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, July 2002.
“Catheter Based Closure of Patent Foramen Ovale with history of Neurological Events”. International
Academy of Cardiology: 8th World Congress on Heart Failure: Mechanisms and Management.
July 15, 2002
“Patent foramen Ovale and Neurological Events Neurological Grand Rounds”, Neurology Grand Rounds,
Cedars Sinai Medical Center, Los Angeles, August 23, 2002.
“Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defects”, Cardiology Grand Rounds,
Cedars Sinai Medical Center, Los Angeles, August 27, 2002
“Histological Analysis of Elution of Everolimus from a Biodegradable Polymer Coated Stent” Industry
Breakfast Symposium, Transcatheter Cardiovascular Therapeutics, Washington, September 2002.
“Efficacy of Elution of Everolimus from a Biodegradable Polymer Coated Biosensors Stent in prevention of
In stent Restenosis in a Porcine Model: one and three month data, The Drug-Eluting Stent Summit,
Transcatheter Cardiovascular Therapeutics, September 2002
Drug Coated Stents: “Promises and Reality”. CARDICOM 2003, Sanjay Gandhi Postgraduate
Institute, Lucknow, INDIA
“Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defects”, Lecture to the
Advanced Nurse Practice Committee. Cedars Sinai Medical Center, Los Angeles, CA. March 13, 2003.
“Primary Percutaneous Coronary Intervention- beyond Epicardial Patency”. Invited Lecture for symposium
of Acute Coronary Syndromes in Slovenia. Bled, Slovenia. April 12, 2003
“Drug Eluting Stents: Bench to Bedside. Invited Lecture for Division of Cardiology, University Medical
Center, Ljubljana, Slovenia. April 14, 2003
“Important Highlight of Inteventional Cardiology: ACC 2003”. Cardiology Grand Rounds, Cedars-Sinai
Medical Center, Los Angeles, CA. April 29, 2003
“Use of Intracardiac Echocardiography for Closure of ASDs and PFOs” . 3rd World Congress of
Heart Diseases- New Trends in Research, Diagnosis, and Treatment. Washington DC, July 13, 2003.
“Percutaneous Transluminal Septal Myocardial Ablation for Treatment of Symptomatic Hypertrophic
Cardiomyopathy.”.Japanese Association of Cardiovascular Catheterization Therapeutics (JACCT) , Sendia,
JAPAN. July 31 to Aug 2.
“Is Everolimus the next main contender Clinical DES Contender? Results from FUTURE I and II” .
Drug Eluting Stent Summit. Transcatheter Therapeutics(TCT) September 19, 2003
“Use of the Porcine Model for Cardiac Research”. Tri Branch Fall Symposium hosted by Southern
California Branch of AALAS. City of Hope September 10, 2003
“Closing Heart Defects” Does it Really help in Preventing strokes”. Cardiology Grand Rounds.
Cedars Sinai Medical Center, Los Angeles. October 7, 2003.
“Role of closing heart defects in the prevention of stroke”..
Page 9 of 65
Dallas, October 26, 2003.
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
“Intracardiac Echocardiography: A new tool to guide procedure in the Catheterization Laboratory.
Grand Rounds. Echo Society Meeting. Salt Lake City, Utah. January 22, 2003.
“Percutaneous Closure of Cardiac Defects: A true reality”. Cardiology Grand Rounds. Harbor- UCLA.
Torrance. California. February 2, 2004
“Pharmacoinvasive approach for Acute coronary syndrome: Transition to Percutaneous Coronary
Intervention. Noon Conference. UCLA Harbor, Torrance, California September 13, 2004.
Transcatheter Therapeutics: Immunomodulation and Vaccines for Atherosclerosis.
Washington DC, September 27, 2004
Transcatheter Therapeutics: HDL based Immune modulation for Atherosclerosis.
Washington DC, Sept 28, 2004.
Transcatheter Therapeutics, Washington DC. Featured Lecture: The Molecular Basis of Vulnerable Plaque.
September 30, 2004
Cardiology Grand rounds. Indications of closure of atrial communation. 2004. Kaiser Hospital, Honolulu,
Hawaii.
Pharmacortherapy of acute coronary syndrome. Cardiology Grand Rounds. St Joseph Hospital,
Orange County, January 5, 2005.
Management of acute coronary syndrome. Grand rounds.
“Umbrellas, Pills or Sutures in the treatment of Cardioembolic stroke. Update. Neurology update.
San Diego 2/19/05.
“CoStar Paclitaxel eluting Stent” . Bench to Bedside. Invited lecture. Hyderabad. Feb 23, 2005
“Chairperson: Use of betablockers in acute myocardial infarction, 2nd World Congress of Interventional
Cardiology. Bombay, India. February 24, 2005.
“Chairperson: Costar 1 clinical results. 2nd World Congress of Interventional Cardiology. Bombay,
INDIA. February 25, 2005.
Medicine Grand Rounds: Etiology and management of Cardioembolic Stroke. Cedars Sinai Medical Center.
April 29, 2005.
Cardiology Grand Rounds: Chronic left atrial pressure monitoring for heart failure patients: concept to
reality. Epworth Hospital, Melbourne, July 13, 2005
International Pediatric Conference: Invited Speaker: Use of the Heart POD device in monitoring left atrial
pressure: First human experience. Pediatric Interventional Cardiac Symposium, Buenos Aires, Sept 18,
2005
Transcatheter Therapeutics: Invited Speaker: Normal and Abnormal responses of Drug Eluting Stents:
Insights from animal models and cadaveric studies, Morphological effects of drug eluting stents: insights
from animal and cadaver studies. October 19, 2005, Washington DC
Cardiology Grand Rounds: Update on the use of antithrombotics in Acute Coronary Syndrome Patients.
Division of Cardiology, Loma Linda Medical Center, CA, USA. Nov 2005.
Page 10 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Cardiology Grand Rounds: Percutaneous Mitral Valve Repair: Division of Cardiology, Cedars Sinai Medical
Center, Los Angeles, CA, January 25, 2006
SingaporeLIVE2006: Judge Best of Young Interventionalist Competition. Singapore. 27 February 2006
SingaporeLIVE 2006: Invited Speaker: Preclinical Safety of Biolimus A9 Delivered from a Bioresorbable
Polymer Coated Stent-Preclinical Data. 27 February 2006
SingaporeLIVE 2006: Moderator: Clinical Cases. Suntec, Singapore. 28 February 2006
SingaporeLIVE 2006: Panelist: Complex Coronary issues/complications. Suntec, Singapore. 28 February
2006
Cardiology Grand Rounds: Edge to Edge repair of Mitral Valve: A reality: Division of Cardiology, White
Memorial Hospital, March 23, 2006
ELA D&T Spring Meeting: Percutaneous Mitral Valve Repair vs Surgery for Mitral Regurgitation.
El Paso De Robles, California, April 8, 2006
Clinical Neurology and Neurosurgery Update: Advances in Cardioembolic Stroke: Role of Interventional
Cardiology versus Medical Treatment, Red Rock Casino Resort, Las Vegas, April 29, 2006
SingaporeLIVE 2006: Guest Lecture: Percutaneous Mitral Valve Repair with the MitraClip. Suntec,
Singapore. 28 February 2006
Oriental Endovascular Therapy (OET): Bioabsorbable Polymer Drug Eluting Stent (EXCEL): Results of
Animal Study(Invited Lecture): June 10, 2006
Oriental Endovascular Therapy (OET): Percutaneous Mitral Valve Repair Using the Edge to Edge
Technique: A Concept to Reality (Invited Lecture): June 10, 2006
Cardiology Grand Rounds: Division of Cardiology, Scripps Green Hospital, San Diego:
Percutaneous Mitral Valve Repair using the Edge to Edge Technique. September 6, 2006
Stroke and Rehabilitation Conference, Los Angeles. La Meridian Hotel, Los Angeles.
Umbrella, Pills Sutures for the treatment of Cardioembolic Stroke. September 9, 2006
Medicine Grand Rounds: Dept of Medicine. Cedars Sinai Medical Center, Los Angeles.
Percutaneous Mitral Valve Repair: Concept to Reality. September 15, 2006
Scientific Symposium: 25th Anniversary of Epworth Hospital Cardiac Center. Current Status on
Percutaneous Mitral Valve Repair. Melbourne, Australia, October 6, 2006
Research in Progress Rounds: Overview of Interventions for Structural heart Disease. Methodist Hospital,
Houston, Texas, October 16, 2006
Transcatheter Therapeutics: Invited Speaker: Case Study: Structural Heart Disease Symposium,TCT,
Washington DC, October 22, 2006
Transcatheter Therapeutics: Moderator during a Live Case Session: Case: Structural Heart Disease TCT,
Washington DC, October 23, 2006
Kardioloski Dnevi: 14th Scientific Meeting of the Slovenian Society of Cardiology with Interventional
Participation. Invited Speaker: Umbrellas, Pills, and Sutures for the Treatment of Cardioembolic Stroke.
Portoroz, Slovenia, October 25th, 2006
Page 11 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Kardioloski Dnevi: 14th Scientific Meeting of the Slovenian Society of Cardiology with Interventional
Participation. Invited Speaker: Morphological effects of drug eluting stents-lessons learnt from preclinical
and human pathology studies. Portoroz, Slovenia, October 28th, 2006
Kardioloski Dnevi: 14th Scientific Meeting of the Slovenian Society of Cardiology with Interventional
Participation. Invited Speaker: Percutaneous Mitral Valve Repair using the Edge to Edge Technique.
Portoroz, Slovenia, October 28th, 2006
Update on Electrophysiology; Symposium: Percutaneous Closure of Left Atrial Appendage of Atrial
fibrillation. W Hotel, San Diego, CA. October 4, 2006
Medicine Grand Rounds: Endovascular Repair of Cardiac Defects: Update. Cedars Sinai Medical Center,
Los Angeles, CA, US November 10th, 2006
Medicine Noon Conference: Management of Acute Coronary Syndromes: Cedars Sinai Medical Center,
Los Angeles, CA October 2006
Vascular Interventions 2006. Preclinical Development of the CoStar Stent: results and the glimpse into the
future. Istanbul, Turkey, November 23rd 2006
Cardiology Noon Conference. Percutaneous Mitral Valve Repair. Dept of Cardiology, St Lukes Hospital,
Milwakee. December 6, 2006
Invited Speaker: International Conference: Percutaneous Mitral Valve Repair using the MitraClip (Evalve
Inc). 3-C Con 2007, Ahmedabad, India, January 26, 2007
Invited Speaker: International Conference: Closure of Patent Foramen Ovale for Stroke, Where are we in
2007. 3-C Con 2007, Ahmedabad, India, January 26, 2007
Invited Speaker: Topic: How to do a Coronary Reactivity Study Conference: Women and Ischemic Heart
Disease (offered in cooperation with the California Chapter of the American College of Cardiology). Cedars
Sinai Medical Center, Los Angeles, CA, US. April 28, 2007
Invited Speaker: Topic: Mitral Clip Procedure.
Conference: Congenital and Structural Heart & Interventions (CSI) Frankfurt 2007. June 8, 2007
Invited Speaker: Topic: Current Status of the Edge to Edge Mitral Valve Repair
Conference: Congenital and Structural Heart & Interventions (CSI) Frankfurt 2007, June 8, 2007
Invited Faculty: Panelist: Transcatheter Mitral Valve Repair
Conference: Congenital and Structural Heart & Interventions (CSI) Frankfurt 2007, June 8, 2007
Invited Speaker: Topic: Chronic Left Atrial Pressure Monitoring for Patients with Heart failure: The
Homeostasis Study. Conference: Congenital and Structural Heart & Interventions (CSI) Frankfurt 2007.
June 9, 2007
Invited Speaker: Topic: Percutaneous Mitral Valve Repair (25 minutes)
Annual Conference of the Cardiac Society of Australia & New Zealand (CSANZ 2007)
August 11, 2007
Invited Speaker: Topic: Left Atrial Appendage devices: the death knell for warfarin? (20 min) – “James Hay
Theatre”. Annual Conference of the Cardiac Society of Australia & New Zealand (CSANZ 2007)
August 12, 2007
Invited Speaker: Topic: Transcatheter Repair of Mitral Valve. 19th Annual Meeting of the Mediterranean
Association of Cardiology and Cardiac Surgery, in Opatija, Croatia, Hotel Ambassador, 27-30 September
Page 12 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
2007
Invited Speaker: Topic: Advances in prevention of Cardioembolic Stroke: Role of a newer Interventional
Techniques. Noon Conference, Dept of Cardiology, Tarzana Hospital. June 19th 2007
Invited Speaker:Topic. New Therapeutic Interventions for LV dysfunction. Mid year Update on Cardiac
Rhythm Management. Viceroy Santa Monica. July 7, 2007
Cardiology Grand Rounds: Update on Percutaneous Mitral Valve Repair using the MitraClip Dept of
Cardiology, Cedars Sinai Medical Center. July 24th, 2007
Noon Cardiology Grand RoundsConference: Valvuloplasty: An Update. Division of Cardiology, Fountain
Valley Regional Hospital, Foutain Valley, CA. August 6, 2007
Core Lecture for Fellows: History of Cardiac Catheterization. Division of Cardiology, Cedars Sinai Medical
Center, Los Angeles, CA. July 23, 2007
Medicine Grand Rounds. Umbrellas and Plugs for the prevention of Cardioembolic Stroke: Is it a Death
Knell for Coumadin? Dept of Medicine, Cedars Sinai Medical Center, Los Angeles, CA. September 7, 2007
Invited Speaker and Faculty: Topic: Cross fire Debate: Percutaeous Mitral Valve Repair. Controversies and
Advances in the Treatment of Cardiovascular Disease. The Seventh in the Series. Oct 4 -5, 2007
Cath Grand Rounds: UCLA. Percutaneous Mitral Valve Repair: concept to reality. W Hotel, Westwood,
Los Angeles, CA. Nov 15, 2007
Evalve Investigators Meeting for the EVEREST II clinical trial. MitraClip procedure.
Sheraton Hotel, San Francisco, January 10th, 2008
Evalve Investigators Meeting for the EVEREST II clinical trial. Recruitment for patients for the EVEREST II
clinical trial. Sheraton Hotel, San Franciso, Jan 10th, 2008.
Invited Speaker. Advances in Interventional Cardiology: Is Cardiac Surgery Obsolete.
Annual meeting in the West LA VA Hospital, Jan 25, 2008
Invited Lecture: The role of the HeartPOD device in heart failure patients. 4th Asian Pacific Heart Congress
of Heart Failure. Melbourne, Australia. February 1, 2008
Invited Speaker. Percutaneous Mitral Valve Repair. Conference: Heart Failure An Update of Therapy 2008.
Millennium Biltmore Hotel, Los Angeles, Feb 2, 2008
Invited Speaker/Faculty: Percutaneous Mitral Valve Repair: Using the MitraClip. The second Live
Demonstration Course in Basic & Advanced Interventional Cardiology, Dubai, UAE. March 26th, 2008
Invited Faculty: CoModerator: Live Case Transmission The second Live Demonstration Course in Basic &
Advanced Interventional Cardiology, Dubai, UAE. March 25,26, 2008.
Invited Speaker/Faculty: Percutaneous Mitral Valve Repair.
Invited Lecture. American College of Cardiology/Interventional 2 Summit. Mitral Edge to Edge Repair.
Chicago, March 31, 2008
Invited Faculty: Panelist: Understanding Mitral Regurgitation: Insights into interventional therapy for
structural and functional MR. March 31, 2008
Invited Speaker: Catheter Based treatment of mitral valve disease. Los Robles Conference at the
Sherwood Club, Westlake Village, CA April 12, 2008
Page 13 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Percutaneous repair/replacement of cardiac Valves. Annula Meeting of the National
Interventional Council of India, Kolkata, India. April 19, 2008
Invited Speaker. Medtronic Endeavor Program. Bistro, Bakersfield, CA. April 24, 2008
Invited Lecture: Percutaneous Valve Repair/replacement: Updatedd, Cardiovascular Conference St Judes
Medical Center, Fullerton, CA. May 8, 2008
Invited Lecture: Case example of Percutaneous Mitral Valve Repair: Catheter based therapy for Structural
Heart Disease symposium: American Association of Thoracic Surgeons annual Meeting. May 10, 2008,
San Diego
Invited Lecture: Catheter Based treatment of ASD, PFO, VSD.:at Symposium on Catheter based
approaches for Structural Heart disease. American Association of Thoracic Surgeons annual Meeting. May
10, 2008. San Diego
Invited Lecture.:Representative Clinical examples of PMR with the MitraClip Device/
symposium on mitral valve repair. EuroPCR., Barcelona, Spain, May 14, 2008
Invited Speaker/Facutly: 2nd Annual Women and Ischemic Heart Disease Symposium: Unique Challenges
and Case Review. Gender-specific Invasive Coronary Reactivity Testing. Cedars Sinai Medical Center,
Los Angeles, CA. May 28, 2008
Invited Speaker; Drug-Eluting Stent Update. 1st Annual State of the Art Nevada Cardiovascular
Symposium. Mesquite, Nevada, US. May 31, 2008
Invited Speaker; Drug-Eluting Stent Update. 1st Annual State of the Art Nevada Cardiovascular
Symposium. Mesquite, Nevada, US. May 31, 2008
Invited Speaker/Faculty: Taped Case demonstration using the MitraClip Valve repair system. Transcatheter
Valve therapies. Seattle, Washington. June 6, 2008
Invited Faculty: Evalve Mitral Valve system: Pt screening, selection, and procedural details. Transcatheter
Valve Therapies, Seattle, Washington, June 6, 2008
Invited Speaker/Faculty: Transcatheter Mitral Valve Repair-Edge to Edge Repair Works!. Conference:
Congenital and Structural Heart & Interventions(CSI) Frankfurt 2007.Frankfurt, June 27, 2008
Invited Speaker/Faculty: Mitral Valve Edge to Edge Repair-Problems and Complications. Conference:
Congenital and Structural Heart & Interventions(CSI) Frankfurt 2008.Frankfurt, June 27, 2008
Invited Speaker/Faculty: Monitoring of Left Atrial Pressure for management of Heart failure. Congenital and
Structural Heart & Interventions(CSI) Frankfurt 2008, June 28, 2008
Invited Speaker/Faculty: Update on the Endeavor Stent Platform. Cardiology Consultants of Bozeman,
Bozeman, Montana July 10, 2008
Invited Speaker: The Endeavor Stent Platform. Great Fall Cardiac Group, Benefis East Hospital, Great
Falls, Montana, July 11, 2008
Invited Speaker: Clinical Studies on the Endeavor Stent Platform. Montana Heart Center, Montana. July 11,
2008
Invited Speaker/Faculty: Percutaneous Monitoring of Left Atrial Pressure Monitoring Pediatric and Adult
Intervention Cardiac Symposium(PICS-AICS 2008). Las Vegas, July 22, 2008
Invited Speaker/Faculty: Current and Future Approach to the Treatment of Mitral Valve Regurgitation:
Page 14 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Percutaneous Edge to Edge Repair. Controversies & Advances in the Treatment of Cardiovascular
Disease-8th Series (Beverly Hills Hotel), September 4, 2008
Invited Speaker/Faculty: Chairperson : Debate: PFO closure for stroke : Clinical trials are required, versus
standard of care. Controversies & Advances in the Treatment of Cardiovascular Disease-8th Series
(Beverly Hills Hotel), September 5, 2008
Invited Lecture: Percutaneous mitral valve therapy: the edge to edge repair. Scripps Clinic 19th Annual
Conference, Coronary Interventions, Hilton La Jolla Torrey Pines in San Diego, September 18, 2008
Invited Speaker: Percutaneous Mitral Valve Repair: Cardiovascular Disease Between Intervention and
Surgery German Heart Center, Munich, Nov 6, 2008
Invited Speaker: Percutaneous Mitral Valve Repair. Interactive Forum for Interventions in Structural and
Congenital Heart Disease. Kochi, India Nov 8, 2008
Invited Speaker/Faculty: Judkins Imaging Symposium: Speaker and Chairman. SCAI 32nd Annuals
Scientific Sessions May 6-9, 2009, Caesars Palace, Las Vegas
Cardiology Grand Rounds. Advances in Interventions for Structural Heart disease: Percutaneous Mitral
Valve Repair and Left Atrial Appendage Occlusion for atrial fibrillation. Dept of Cardiology, Alfred Hospital,
November 11, 2008
Invited Speaker. Percutaneous repair of structural heart defects. Medicor Symposium, Portoroz, Slovenia
EU. December 6, 2008
Invited Speaker: Interventional Closure of PFOs: Indications and Techniques Symposium on
Neurovascular Disease 2009 (Sponsored by Dept of Neurosciences, Cedars Sinai Medical Center, CA.
Casa Del Mar Hotel, Los Angeles, CA, January 10, 2009
Invited Speaker. Update on EVEREST edge to edge repair trials. I2 Summit at American College of
Cardiology Meeting, Orlando, Florida, March 29, 2009
Invited Speaker. Shock and Aortic Stenosis in the Cath Lab. I2 Summit at the Annual American College of
Cardiology Meeting, Orlando, Florida, March 30, 2009
Invited Speaker. Percutaneous Treatment of Structural Heart Defects. Cardiology Grand Rounds. Sendai
Kosei Hospital, Sendai, Japan March 18. 2009
Invited Speaker: Update of Percutaneous treatment of structural heart defects. Interventional Cardiology
Fellows Forum. 8th meeting of acute coronary syndromes. Blyth, Slovenia. March 20, 2009
Invited Speaker: Percutaneous Aortic Valve Replacement and Mitral Valve Repair. Cardiology Grand
Rounds. Holly Cross Hospital
Invited Speaker: PFO and Strokes/Update: 3rd Annual Cardiovascular Symposium organized by Los
Robles Hospital. Sherwood Country Club, Thousand Oaks, CA. April 18, 2009
Invited Faculty: Moderator: Judkins Imaging Symposium: Echo in the Cath Lab. Annual Society of
Cardiovascular And Angiography Interventions. Caesars Palace, Las Vegas, May 6, 2009
Invited Speaker: Advanced transseptal challenges, special situations and procedure specific approaches.
Annual Society of Cardiovascular And Angiography Interventions. Symposium on working in the LA,
Caesars Palace, Las Vegas, May 9, 2009
Invited Speaker: Topic: Microvascular Angina Management: Case Review) 3rd Annual Women and
Ischemic Heart Disease Symposium, at Cedars-Sinai Medical Center in Los Angeles, May 13, 2009
Page 15 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Imaging Strategy for Edge to Edge Repair- in the plenary session of Mitral valve
incompetency: imaging and hemodynamics. EuroPCR, Barcelona. May 20th 2009
Invited Speaker:. Experience with the MitraClip therapy in the EVEREST II high risk. In the Symposium on
Mitra Clip Experience in Europe and North America. EuroPCR, Barcelona. May 20th 2009
Invited Speaker: MitraClip Technology: Symposium on ACCESS- Europe: May 19, 2009, Barcelona, Spain
Invited Speaker: Mitral Valve Regurgitation: Percutaneous Therapies- State of the Art Overview. Pediatric
and Adult Interventional Cardiac Symposium- in conjuction with the World Congress of Pediatric Cardiology.
Cains, Australia June 22, 2009
Invited Speaker: Structural Heart Disease Interventions: Heart Failure Monitoring Devices: Where are we?
Where are we heading ? Pediatric and Adult Interventional Cardiac Symposium- in conjuction with the
World Congress of Pediatric Cardiology. Cains, Australia June 22, 2009
Invited Speaker: Step-by-Step MitraClip for Mitral Valve Prolapse (Edited Taped Case) Transcatheter Valve
Therapies: June 25, Grand Hyatt, Seattle, WA
Invited Speaker: My Most memorable Transcatheter Mitral Valve Therapy Case(Success or Complication):
Transcatheter Valve Therapies, June 25th 2009, Grand Hyatt, Seattle, WA
Invited Faculty: Directors of the Session of the Transcatheter Evalve MitraClip Device. Transcatheter Valve
Therapies, June 26, 2009, Grand Hyatt, Seattle, WA
Invited Faculty: Advanced Imaging for Transcatheter Valve Therapies Transcatheter Valve Therapies,
June 26, 2009, Grand Hyatt, Seattle, WA
Invited Faculty: Leaflet Apposition- Concept and Techniques. Congenital & Structural Interventions,
Congress Center Messe Frankfurt Germany, July 11, 2009
Invited Speaker. Implantable Devices to Measure Cardiac Function in Chronic Heart Failure – HeartPOD.
Congenital & Structural Interventions, Congress Center Messe Frankfurt Germany, July 11, 2009
Invited Speaker: Hoag Endovascular Summit 2009: Nightmares and Dreamscapes Case presenter(2
cases) : He Blew I blew almost blew it too. Look Around. The Island Hotel, Newport Beach, CA
August 9, 2009-08-07
Invited Speaker: Endovascular Summit 2009: Nightmares and Dreamscapes Moderator.
The Island Hotel, Newport Beach, CA August 9, 2009-08-07
Invited Speaker: Percutaneous Mitral Valve Repair and Replacement. At the 20th Annual Conference of
Scripps Clinic on Coronary Interventions. Hilton La Jolla Torrey Pines, San Diego, October 30, 2009
Invited Speaker: Role: Discussant: Transcatheter Therapeutics Coronary Arteriovensous Malformation:
Case Presentations. Sept 21, 2009, San Francisco, CA
Invited Speaker: Transcatheter Therapeutics . Hemodynamic Assessment of Mitral Regurgitation (and
Percutaneous Mitral Valve Repair), and 3 Ways to be Fooled (with Case Presentations).
Sept 22, 2009, San Francisco, CA
Invited Speaker: Transcatheter TherapeuticsEchocardiographic Diagnosis of Hypertrophic ardiomyopathy
and Use During the Alcohol Septal Ablation. Sept 22, 2009
Invited Speaker: Transcatheter Therapeutics .A Step-by-Step Approach Using the Percutaneous Edge to
Edge Evalve MitraClip System.. Sept 22, 2009, San Francisco, CA
Page 16 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Transcatheter Therapeutics . Imaging Guidance of PFO and ASD Closure Sept 23, 2009,
San Francisco, CA
Invited Speaker: Transcatheter Therapeutics . The Coronary Sinus as a Mitral Valve Target: Insights From
Imaging Sept 25, 2009, San Francisco, CA
Invited Speaker: Moderator: Novel Transcatheter Valve Therapies Under Development.Session II. Miral
Valve Therapies Prior to and In Human Investigation Direct Annuloplasty Systems. Sept 25, 2009
Invited Speaker: Transcatheter Therapeutics . Image guidance of Evalve Clipping. Sept 24, 2009,
San Francisco, CA.
Invited Speaker: Transcatheter Mitral Valve Repair and Replacement. Scripps Clinic’s 20th Annual
Conference on Coronary Interventions, La Jolla, CA, October 30, 2009
Invited Speaker: Cardiology Grand Rounds: Monash Medical Center. Left Atrial Appendage Occlusion for
the prevention of cardioembolic stroke. November 25, 2009
Invited Speaker: Tips in the management of patients, Lessons learnt from the US experience. Key Opinion
Leader Meeting in Europe for MitraClip Therapy. Abbott Crossroads Center, Brussels, Dec 8, 2009
Core Curriculum Lecture for the EP Fellows in Cedars Sinai Medical Center. Intracardiac Echocardiography
for Septal and Left atrial interventions. Dec 10, 2009
Invited Speaker: 1st Annual Arrhythmia Symposium at Cedars Sinai Heart Institute: Atrial Appendage
Occluder for Stroke Prophylaxis: Just lock the appendage and throw away the key. Harvey Morse
Auditorium, Cedars Sinai Medical Center, Los Angeles, Dec 11, 2009
Invited Speaker: Topic: Potential future alternative therapeutic options for patients with functional mitral
regurgitation. Breakfast Symposium on the Pathophysiology and treatment consideration for patients with
functional mitral Regurgitation. Annual Society of Thoracic Surgeons Meeting. Fort Lauderdale, Florida
January 25, 2010
Invited Speaker: Erodable Polymer and Polymer Free Stents: BioMatrix and Biofreedom etc, India Live
2010, New Delhi, February
Invited Faculty: Moderator of Live Session, India Live 2010
Invited Speaker ; Visionary Interventional Procedures to treat Common Disorders: Heart Failure, Systemic
Hypertension and Beyond. i2 Summit of the Annual Meeting of the American College Cardiology, Atlanta,
March 14, 2010
Invited Speaker; Clinical Experience with the Percutaneous Edge to Edge Repair.. i2 Summit of the Annual
Meeting of the American College Cardiology, Atlanta, March 14, 2010
Invited Speaker; Evaluation and Management of Unstable Angina/Non ST elevation myocardial
infarction. .Annual Meeting of the American College Cardiology, Atlanta, March 15, 2010
Invited Faculty; Co-Chairperson: Core-Curriculum series: Coronary Artery Disease. Annual Meeting of the
American College Cardiology, Atlanta, March 15, 2010
Invited Speaker; Technique of left atrial appendage occlusion. . i2 Summit of the Annual Meeting of the
American College Cardiology, Atlanta, March 15, 2010
Invited Speaker/Faculty: Update on Percutaneous Pulmonary Valve Replacement. Concepts in
Contemporary Cardiovascular Medicine(CCC 2010) Houston April 8, 2010
Invited Faculty: Panelist for the live case demonstrations from Memorial Hermann Heart & Vascular
Page 17 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Institute. Houston April 8, 2010
Invited Faculty: Congenital Heart Disease and Pulmonary Hypertension. At Pulmonary hypertension in all
its Diversity: 2010 State of the Art for the Clinician. At Cedars Sinai Medical Center, April 10, 2010
Invited Faculty: Percutaneous Valve Surgery. 7th Annual Cardiology Symposium – Menifee Valley Medical
Center, Sun City, CA. April 10, 2010
Invited Speaker: Devices for Stroke Prevention: Left Atrial Appendage Occluders and PFO closure Devices
11th Annual Monterey Bay Regional Heart Symposium. The Clement Monterey Hotel, Monterey, CA, April
30, 2010.
Invited Speaker: Percutaneous Mitral Valve Repair 11th Annual Monterey Bay Regional Heart Symposium.
The Clement Monterey Hotel, Monterey, CA, April 30, 2010.
Invited Speaker: Percutaneous Aortic Valve Replacement. 11th Annual Monterey Bay Regional Heart
Symposium. The Clement Monterey Hotel, Monterey, CA, April 30, 2010.
Invited Speaker:2010 Adult Cardiac Skills Course Annual American Thoracic Society Meeting, Metro
Toronto Convention Center, Toronto, Canada. May 1, 2010.
Invited Speaker:2010. EVEREST II Clinical trial.Annual American Thoracic Society Meeting, Metro Toronto
Convention Center, Toronto, Canada. May 1, 2010.
Invited Speaker/Faculty: Panelist: MitraClip Symposium. Sapphire A Room, in Hilton San Diego Bayfront.
33rd Annual Meeting of SCAI, San Diego, CA, May 6, 2010.
Invited Speaker. How to Maximise Enrollment in Clinical Trials: A Cardiologist’s perspective. 33rd Annual
Meeting of SCAI, San Diego, CA May 7, 2010.
Invited Speaker. Imaging in Structural Heart Disease Symposium. 33rd Annual Meeting of SCAI, San Diego,
CA May 7, 2010.
Invited Faculty: Case Reviews:Who should undergo invasive coronary reactivity testing ?
Women & Ischemic Heart Disease Symposium. Cedars Sinai Medical Center, CA. May 12, 2010.
Invited Speaker: Percutaneous Mitral Valve Repair. Los Robles Cardiovascular Symposium. Sherwood
Country Club, Thousand Oaks, CA. May 15, 2010.
Invited Speaker. Practical Use of Different Imaging Modalities( Pre, intra, and post procedure during Mitral
Valve interventions. 33rd Annual Meeting of SCAI, San Diego, CA May 7, 2010.
Invited Faculty/Speaker: Mitral valve repair: detailed review of the EVEREST II randomised study.
EuroPCR 2010. Paris, May 26, 2010
Invited Faculty/Speaker: MitraClip Procedure Overview. EuroPCR 2010. Paris, May 28, 2010.
Invited Faculty/Speaker: Provocative discussion: transcatheter mitral valve repair. EuroPCR 2010, Paris,
May 28, 2010.
Invited Speaker: Session: MitraClip Device: Device Description and the Step-by-Step Technique.
Transcatheter Valve Therapies 2010. June 7, 2010.
Invited Faculty Session II Live Case Demonstrations: Transcatheter Valve Therapies 2010. June 7, 2010.
Invited Speaker: Panel Discussant:The Present and Future of Edge-to-Edge Repair: Panel Discussion with
Audience Q&A. Transcatheter Valve Therapies 2010. June 7, 2010.
Invited Speaker:
Coronary Sinus Mitral Annuloplasty Essentials: Anatomy, Mechanism, and Device
Page 18 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Similarities and Differences. Transcatheter Valve Therapies 2010. June 7, 2010
Invited Faculty: Session IV: Coronary Sinus Mitral Annuloplasty:Will Coronary Sinus Annuloplasty
Succeed? Panel Discussion with Audience Q&A. Transcatheter Valve Therapies 2010. June 7, 2010.
Invited Faculty: Session VII: Percutaneous Mitral Valve Therapies: Controversial Issues. Transcatheter
Valve Therapies 2010. June 7, 2010.
Invited Speaker: Step-by-Step Closure of Paravalvular Mitral Leaks Transcatheter Valve Therapies 2010.
June 8, 2010
Invited Faculty: Session VII: Percutaneous Mitral Valve Therapies: Controversial Issues. Transcatheter
Valve Therapies 2010. June 7, 2010.
Invited Faculty: Paravalvular Leak: Diagnosis and Treatment Workshop Transcatheter Valve Therapies
2010. June 8, 2010.
Invited Faculty: Mitral Bioskills Sessions II. Transcatheter Valve Therapies 2010. June 8, 2010.
Invited Speaker: Percutaneous Mitral Therapy with the Double Orifice Leaflet Repair Technique. Case
Reviews. Transcatheter Valve Therapies 2010. June 8, 2010
Invited Speaker: Optimal Puncture Sites for LAA Occlusive Devices and Percutaneous Mitral Edge to Edge
Repair Transcatheter Valve Therapies 2010. June 9, 2010.
Invited Speaker/Faculty: Hands on Transseptal Lab - Step by Step Technique Transcatheter Valve
Therapies 2010. June 9, 2010
Invited Speaker: LAA and Transseptal Bioskills Session: Complex Case Presentations.
Transcatheter Valve Therapies 2010. June 9, 2010
Invited Speaker. Update on MitraClip Procedure. Case selection and procedure details. Auckland, New
Zealand, June 14, 2010
Invited Speaker: Percutaneous Mitral Valve Repair with MitraClip: Deivce Overview, EVEREST Ii and
High-Risk Registry Update. C3(Complex Cardiovascular Catheter Therapeutics) Advanced Endovascular
and coronary intervention global summit. Baltimore Marriot Waterfront/Baltimore, MD. June 21st , 2010.
Invited Speaker: Selection of Appropriate Techniques for Reduction of Mitral Regurgitation - Who is
Suitable for Leaflet Repair?. iCi- Imaging in Cardiovascular Interventions 2010. Frankfurt, Germany, July 7,
2010.
Invited Speaker:Suitability for Mitral Valve Repair.. iCi- Imaging in Cardiovascular Interventions 2010.
Frankfurt, Germany, July 7, 2010.
Invited Faculty; Chairman: Catheter Treatment of Mitral Regurgitation..iCi-Imaging in Cardiovascular
Interventions. Frankfurt, Germany.July 7, 2010.
Invited Facultyr:Chairperson: Session: Mitral Valvuloplasty and Mitral Valve Repair.. iCi- Imaging in
Cardiovascular Interventions 2010. Frankfurt, Germany, July 7, 2010.
Invited Speaker: How to Manage Difficult MitraClip Situation. CSI 2010-Congenital and Structural
Interventions. Frankfurt, Germany, July 8, 2010.
Invited Faculty: Chairperson: Session; Left Atrial Appendage. Frankfurt, Germany, July 8, 2010.
Invited Speaker: Watchman LAA Occluder Procedural Technique. Frankfurt, Germany, July 9, 2010
Page 19 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Update on PFO clinical trials. CSI 2010-Congenital and Structural Interventions. Frankfurt,
Germany, July 8, 2010
Invited Faculty: Chairperson in the Session: Mitral Regurgitation. CSI 2010-Congenital and Structural
Interventions. Frankfurt, Germany, July 10, 2010
Invited Speaker: State of Art-Catheter Based Double Orifice Repair. CSI 2010-Congenital and Structural
Interventions. Frankfurt, Germany, July 10, 2010
Invited Faculty: Chairperson: Devices for Heart Failure Management.CSI 2010-Congenital and Structural
Interventions. Frankfurt, Germany, July 10, 2010
Invited Speaker: Devices for Monitoring Heart Failure Treatment. CSI 2010-Congenital and Structural
Interventions. Frankfurt, Germany, July 10, 2010.
Invited Speaker: Guided Delivery System. Frankfurt, Germany, July 10, 2010
Invited Speaker: Intra-Procedural Monitoring of PFO Closure: PICS & AICS. Sheraton Hotel, Chicago. July
17th. 2010.
Invited Speaker/Faculty: Systemic & Pulmonary veins and paravalvular leaks: Aortic & Mitral Sessions. July
17th. 2010.
Invited Speaker/Faculty: Atrial Appendage closure and Atrial Fibrillation: An update. The Head to Toe
Meeting at the Meritage Hotel. NAPA, CA. July 16, 2010.
Invited Speaker/Faculty: Percutaneous Mitral Valve Repair: Tackling the Mitral Valve Leaflets. Head to Toe
Meeting, NAPA, CA. July 16, 2010.
Invited Speaker/Faculty: Panelist Live Cases. PICS & AICS. Sheraton Hotel, Chicago, July 20th. 2010.
Invited Speaker/Faculty: Trans-septal puncture: Technique, complications: prevention & management, July
20th. 2010.
Invited Speaker/Faculty: Interventional Options for the Mitral Valve: The Percutaneous MitraClip ? Rocky
Mountain Valve Symposium. July 22, 2010.
Invited Speaker/Faculty: Which Technology and Approach is Best? Are we abandoning Outcomes in
Favour of Invasiveness. Debate with Faculty. Rocky Mountain Valve Symposium. July 22, 2010.
Invited Speaker/Faculty: Case Presentaton for Percutaneous Mitral Valve Repair. Tips and Tricks in
Complex Interventional Cardiovascular Therapy(CICT). Fairmont Hotel, San Francisco. July 31, 2010.
Invited Speaker: Mitral Valve Therapies and EVEREST data" Asian Pacific Great Minds Symposium,
Singapore, August 21, 2010.
Invited Speaker: Left Atrial Appendage Occlusion for the prevention of stroke. CVIT2010( Japanese
Association of Cardiovascular Interventions and Therapeutics. Sendai. August 22, 2010
Invited Speaker;(Sateliite seminar); Percutaneous Mitral Valve Repair Using the Mitra Clip: An Alternative
for Open Heart Surgery. CVIT2010( Japanese Association of Cardiovascular Interventions and
Therapeutics. Sendai. August 23, 2010
Invited Faculty: Session: Innovations in Structural and Valvular Heart Disease( the hottest topic of the year):
Discussant. TCT2010(Transcatheter Therapeutics), September 21, 2010.
Invted Speaker: Trans-Septal Crossing: An overview of New Approaches to Transseptal
Catheterization(RF, Jugular Approaches, and More). TCT2010(Transcatheter Therapeutics), September
Page 20 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
21, 2010.
Invited Speaker. Emerging Directions: The Mitral Valve Clip. TCT2010(Transcatheter Therapeutics),
September 21, 2010.
Invited Faculty: Discussant, Session 3: The Mitral Valve: Registered Cardiovascular Invasive
Specialists(RCIS) Review Course. TCT2010(Transcatheter Therapeutics), September 21, 2010.
Invited Faculyt: Moderator:Left Atrial Appendage Closure: Indications, Devices, and Techniques. Options to
Exclude the Left Atrial Appendage. TCT2010(Transcatheter Therapeutics), September 22, 2010.
Invited Faculty: Discussant: Left Atrial Appendage Closure: Indications, Devices, and Techniques, The
Watchman. TCT2010(Transcatheter Therapeutics), September 22, 2010.
Invited Speaker: Interim results form CAP, and future regulatory studies. TCT2010(Transcatheter
Therapeutics), September 22, 2010.
Invited Faculty: Discussant: Left Atrial Appendage Closure: Indications, Devices, and Techniques,Session
IV: Technical considerations and new directions. TCT2010(Transcatheter Therapeutics), September 22,
2010.
Invited Faculty: Discussant: Left Atrial Appendage Closure: Indications, Devices, and Techniques, The
Watchman. TCT2010(Transcatheter Therapeutics), September 22, 2010.
Invited Speaker: Case Presenter Left Atrial Appendage Occlusion tips and tricks; how to avoid
complications ( case-based reviews ).. TCT2010(Transcatheter Therapeutics), September 22, 2010.
Invited Speaker: The MitraClip Option for Functional MR III: How Much Does MR Need to be Reduced for
Clinical Benefit? TCT2010(Transcatheter Therapeutics), September 22, 2010.
Invited Faculty: Live Case Co-Moderator: How to Treat Theater: Structural Heart Disease I. Live cases:
Transcatheter Valve Therapies I. TCT2010(Transcatheter Therapeutics), September 23, 2010.
Invited Faculty: Discussant: How ot Treat Theater: Structural Heart Disease I: Transcatheter Valve
Therapies II. TCT2010(Transcatheter Therapeutics), September 23, 2010.
Invited Speaker: Patient selection, Technique Evolution and Clinical Outcomes with Percutaneous Mitral
Valve Repair: New Insights from the EVEREST Registries and Randomized Trials. TCT2010(Transcatheter
Therapeutics), September 23, 2010.
Invited Faculty: Discussant. How to Treat Theater: Structural Heart Disease I: Transcatheter Valve
Therapies II TCT2010(Transcatheter Therapeutics), September 23, 2010.
Invited Faculty: Discussant: Emerging Late Breaking Data: the EVEREST II Trial. TCT2010(Transcatheter
Therapeutics), September 23, 2010.
Invited Speaker: Has EVEREST II Demonstrated 3—Day Safety for the MitraClip ?TCT2010(Transcatheter
Therapeutics), September 23, 2010.
Invited Faculty; Discussant: Mystifying Hemodynamics in Structural Heart Disease Interventions
TCT2010(Transcatheter Therapeutics), September 24, 2010.
Invited Speaker. Hemodynamics of Percutaneous Mitral Valve Interventions.TCT2010(Transcatheter
Therapeutics), September 24, 2010.
Invited Faculty:.Discussant: Imaging Guidance for Transcatheter Valve Interventions: Session III.
Transcatheter Mitral Repair I: The Mitral Clip. TCT2010(Transcatheter Therapeutics), September 24, 2010.
Page 21 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Imaging Guidance to Select the Appropriate
Repair.TCT2010(Transcatheter Therapeutics), September 24, 2010.
Patient
for
Mitral
Clip
Invited Speaker(Debate): Sponsored by the British Cardiovascular Intervention Society: This House
Believes: Percutaneous MV Repiar Can Achieve as Good or Better Clincal Outcomes Compared to
Surgical Repair !. TCT2010(Transcatheter Therapeutics), September 24, 2010.
Invited Speaker( Cardiology Grand Rounds) Percutaneous Mitral Valve Repair: Not just a dream but a
true reality. University of Chicago Medical Center, Chicago, October 1, 2010
Invited Faculty:
Invited Speaker: St Jude Medical Symposium: Transcatheter Aortic Valve Implantation: An Overview.
October 9, 2010
Invited Speaker: Mitral Valve Therapies: From EVOLUTION to EVEREST. VIVA 10, Las Vegas, October 18,
2010.
Invited Speaker: A Glimpse into the Future: Percutaneous Mitral and Aortic Devices on the Horizon. VIVA
10, Las Vegas, October 18, 2010.
Invited Speaker. Percutaneous Mitral Valve Repair, The Leaflet Approach. Endovascular & Coronary
Revascularization in Seoul (ENCORE SEOUL 2010). November 6, 2010, Seoul, Korea
Invited Speaker. Left Auricle Appendage Closure:Actual Status. Endovascular
Revascularization in Seoul (ENCORE SEOUL 2010). November 6, 2010, Seoul, Korea.
&
Coronary
Invited Faculty. Panelist: Lunch Symposium on Contrast Induced Nephropathy. Endovascular & Coronary
Revascularization in Seoul (ENCORE SEOUL 2010). November 5, 2010, Seoul, Korea.
Invited Faculty. Panelist: Live Session 3. Endovascular & Coronary Revascularization in Seoul (ENCORE
SEOUL 2010). November 5, 2010, Seoul, Korea
Invited Faculty. Panelist Session: Transcatheter Aortic Valve Implantation.. Endovascular & Coronary
Revascularization in Seoul (ENCORE SEOUL 2010). November 6, 2010, Seoul, Korea.
Invited Speaker: Cardiology Grand Rounds: Montreal Heart Institute. Percutaneous Mitral Valve Repair
using the MitraClip Device. November 11, 2010
Invited Speaker: Cardiology and Surgery discussion: Patient screening and steps of the MitraClip
Procedure. November 11, 2010
Invited Speaker. Cardiology and Cardiac Surgery Grand Rounds. Sunny Brook Health Medical Center,
Toronto. Percutaneous Mitral Valve Repair using the MitraClip: Clinical Update. November 12, 2010.
Invited Speaker: Percutaneous Mitral Valve Repair using the MitraClip: A true reality. AMI2010( Acute
myocardial infarxtion 2010): New Frontiers in Cardiology. November 13, 2010.
Invited Speaker: Percutaneous closure of the left atrial appendage: Procedural steps & Tips and Tricks to
avoid complications. PREVAIL Investigator Meeting. Hyatt Regency, Chicago, November 13, 2010
Invited Speaker: Strategies to recruit patients for the Study. PREVAIL Investigators Meeting, Hyatt
Regency, Chicago, November 13, 2010.
Invited Speaker: Elizabeth’s Choice: The MitraClip. Excellence in Interventional Cardiology meeting at
Fairmont Chateau, Whistler Resort. Whistler, Canada. Dec 4, 2010.
Page 22 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: The MitraClip, So easy Even a Surgeon Can Do it. Dallas Leipzig International Valve 2010.
Dallas, Texas, US, December 9, 2010.
Invited Speaker: Mitral Valve Case Studies: Dallas Leipzig International Valve 2010. Dallas, Texas, US,
December 9, 2010.
Invited Speaker: “EBM about Percutaneous mitral valve repair” CULT 2011(Cardiac interventions Under
the Leaning Tower around Percutaneous valve procedures). Stazione Leopolda, Pisa, Italy, January 27,
2011.
Invited Faculy: Chairperson in Live TAVI session. India Live 2011: A national course on Percutaneous
Cardio-Vascular Interventions. Hotel Taj Lands End, Bandra, Mumbai. February 18, 2011
Invited Speaker: Percutaneous Mitral Valve Interventions. India Live 2011: A national course on
Percutaneous Cardio-Vascular Interventions. Hotel Taj Lands End, Bandra, Mumbai. February 19, 2011
Invited Speaker. New Approaches to trans-septal catheterization. India Live 2011: A national course on
Percutaneous Cardio-Vascular Interventions. Hotel Taj Lands End, Bandra, Mumbai. February 19, 2011
Invited Faculy; Chairperson of the Session: Emerging Therapy Conclave:Mitral Valve. India Live 2011: A
national course on Percutaneous Cardio-Vascular Interventions. Hotel Taj Lands End, Bandra, Mumbai.
February 19, 2011
Invited Faculty: Chairperson; Structural Heart disease symposium. India Live 2011: A national course on
Percutaneous Cardio-Vascular Interventions. Hotel Taj Lands End, Bandra, Mumbai. February 19, 2011
Invited Faculty: Live case Operator.. China Interventional Therapeutics(CIT), China National Convention
Center, Beijing, China, March 17, 2011
Invited Faculty: Live Case discussant; Case session 8: LM bifurcation and TAVI role. China Interventional
Therapeutics(CIT), China National Convention Center, Beijing, China, March 17, 2011
Invited Speaker: Percutaneous Pulmonic Vlve Replacement: An Option for Filed Conduits to the Pulmonic
Artery. China Interventional Therapeutics(CIT), China National Convention Center, Beijing, China, March
18, 2011
Invited Faculty: Panel Discussant with audience on Structural Heart disease symposium part II. China
Interventional Therapeutics(CIT), China National Convention Center, Beijing, China, March 18, 2011
Invited Faculty: Moderator, Fires Report Investigations China Interventional Therapeutics(CIT), China
National Convention Center, Beijing, China, March 18, 2011
Invited Speaker: Edge to Edge Mitral Valve Repair: Current Status of the MitraClip Porcedure. China
Interventional Therapeutics(CIT), China National Convention Center, Beijing, China, March 17, 2011
Invited Speaker. MitraClip: Is It Possible? What Do Surgeons Think? Case Based Studies on Valvular Heart
Disease symposium sponsored by Mayo Clinic Cardiovascular Division. New Orleans Marriot at the
Convention Center. New Orleans, April 2, 2011.
Invited Speaker: Structural Heart Tools, Tips and Tricks. Access to Closure:Interventional Cardiology
Fellows Symposium. Royal Sonesta, New Orleans, April 2, 2011.
Invited Faculty: Co Chairman: ACC i2 Symposium;Session Title: the MV disease and transcatheter
interventions; case reviews. New Orleans, April 3, 2011.
Invited Speaker: Current Status of LAA Occlusion: ACC i2 Symposium. New Orleans, April 3, 2011.
Invited Faculty: Co Chair: ACC i2 Symposium: Session: Imaging Before, During and After Mitral Valve
Procedures. New Orleans, April 4, 2011.
Page 23 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Evaluation and Management of Unstable Angina/NSTEMI; ACC Core-curriculum Lecture.
New Orleans, April 5, 2011.
Invited Faculty: Co Chairperson of ACC core curriculum lecture: Session: Acute and Chronic Coronary
artery disease., ACC, New Orleans, April 5, 2011.
Invited Faculty: ACC Panelist: Meet the Experts entitled Optimum Reperfusion Approach to STEMI, New
Orleans, April 5, 2011.
Invited Speaker: Percutaneous Mitral Valve Repair: Indications and Technique. Global Summit on
Interventions and Innovations(GI2 summit) BRAZIL 2011. Sao Paulo, Brazil, April 13, 2011.
Invited Faculty: Live Case First Session. Global Summit on Interventions and Innovations(GI2 summit)
BRAZIL 2011. Sao Paulo, Brazil, April 14, 2011
Invited Speaker: Can Left Atrial Appendage Closure Become an Important Therapy for Atrial Fibrillation
Patients? Global Summit on Interventions and Innovations(GI2 summit) BRAZIL 2011. Sao Paulo, Brazil,
April 14, 2011
Invited Speaker: Optimal clinical applications for the MitraClip and Other Devices Global Summit on
Interventions and Innovations(GI2 summit) BRAZIL 2011. Sao Paulo, Brazil, April 14, 2011
Invited Speaker: Transcatheter Implantable Monitoring Devices for Heart Failure Global Summit on
Interventions and Innovations(GI2 summit) BRAZIL 2011. Sao Paulo, Brazil, April 15, 2011
Invited Speaker: Perspectives from PARTNER: Striking Observations and Implications
Global Summit on Interventions and Innovations(GI2 summit) BRAZIL 2011. Sao Paulo, Brazil, April 15,
2011Invited Panelist Live Session 3 Global Summit on Interventions and Innovations(GI2 summit) BRAZIL
2011. Sao Paulo, Brazil, April 15, 2011.
Invited Speaker: MitraClip Therapy: indications and results. Los Angeles Society of Echocardiography
meeting. Good Samaritan Hospital, April 16, 2011.
Invited Speaker: Patient Selection for Percutaneous Mitral Valve Repair: What is Possible. Annual
Concepts in Contemporary Medicine Symposium (CCC 2011), Hilton of Americas, Houston, Texas, April 28,
2011.
Invited Faculty: Panelist: Live case demonstration: structural heart disease intervention. Annual Concepts
in Contemporary Medicine Symposium (CCC 2011), Hilton of Americas, Houston, Texas, April 28, 2011.
Invited Speaker: Interventional Procedures in Women: Gender Differences. 5th Annual Women & Ischemic
Heart Disease Symposium. Cedars Sinai Medical Center. April 29, 2011.
Invited Speaker; Keynote Lecture: Structural Heart Interventions in the Cath Lab: The next frontier; RCIS
course at the annual Society of Coronary Angiography and Intervention meeting (SCAI). May 6, 2011.
Invited Speaker: Overview of the EVEREST II trial. Annual Society of Cardiac Angiography & Intervention
Meeting(SCAI), Baltimore, May 7, 2011
Invited Faculty. Co-chairperson. Mitral Valve Interventions session . Annual Society of Cardiac
Angiography & Intervention Meeting(SCAI), Baltimore, May 7, 2011
Invited Speaker: PFO and ASD closure : invited lecture in the structural heart disease primer. Annual
Society of Cardiac Angiography & Intervention Meeting(SCAI), Baltimore, May 7, 2011
Invited Speaker: Left Atrial Appendag Occlusion : invited lecture in the structural heart disease primer.
Annual Society of Cardiac Angiography & Intervention Meeting(SCAI), Baltimore, May 7, 2011
Page 24 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: The Challenge of Acquiring New Technical Skills After Fellowship at the Early Career
Interventionalist Symposium. Annual Society of Cardiac Angiography & Intervention Meeting(SCAI),
Baltimore, May 7, 2011
Invited Speaker: WATCHMAN LAA Closure: The Cedars Sinai Experience. Symposium sponsored by
Boston Scientific Symposium at Pavillion Ledoyen at Paris, May 17, 2011
Invited Faculty: Co-chairman: Session: Edge to edge mitral valve repair: clinical, hemodynamic and
echocardiographic evaluation. EUROPCR 2011 at Palais des congress Paris, May 17, 2011
Invited Faculty: Panelist on a Plenary session on Percutaneous intervention for mitral regurgitation.
EuroPCR 2011, Palais des congress, Paris May 18, 2011
Invited Faculty: Co-chairperson: Percutaneous mitral valve repair therapy: building a successful
programme. EuroPCR2011, Palais des congress, Paris May 18, 2011
Invited Speaker: Left atrial appendage closure and the PROTECT AF trial: results at 1500 patient-years of
follow up. EuroPCR 2011, Palais des congress, Paris, May 20, 2011.
Invited Speaker: Advances in Mitral Valve Disease. 2nd Annual Highlights in Cardiovascular Therapies: A
contemporary course for cardiac and vascular specialists. Grand Hyatt, Seattle. May 20, 2011.
Invited Speaker: Percutaneous Coronary Interventions for Heart failure, Stem cells and Valves, Optimal
Care and New Therapies for Advanced Heart Disease Symposium.Bakersfield, May 21, 2011.
Invited Speaker: Update on MitraClip Therapy. 5th Oriental Congress of Cardiology (OCC 2011) at
Shanghai International Convention Center, Shanghai, China, May 30, 2011.
Invited Speaker. Update on percutaneous cardiac interventions. Delco Symposium, Santa Barbara. CA
June 1, 2011.
Invited Speaker: Bioskills lab on Mitral Valve anatomy and interventions. Transcatheter Valve Therapies
Meeting(TVT 2011). Vancouver, June 5, 2011
Invited Speaker: Mitral Valve Sessions: Edited Taped Case.. Transcatheter Valve Therapies.Meeting(TVT
2011). Vancouver, June 6, 2011
Invited Speaker: Transseptal Workshop. Targeted Transseptal with TEE for Mitral Valve interventions.
Transcatheter Valve Therapies(TVT 2011). Vancouver, June 7, 2011
Invited Faculty: Assist in Live case using Pulmonic Valve. Transcatheter Valve Therapies(TVT 2011),
Vancouver, June 7, 2011.
Invited Speaker: Live Taped case of LAA occlusion using the Watchman Device. Transcatheter Valve
Therapies(TVT 2011). Vancouver, June 7, 2011.
Invited Speaker/Coarse Directors: Transseptal course. Lennox Hill Hospital, June 10-11, 2011.
Invited Speaker: Percutaneous Mitral Devices: Can we surgical outcomes. 2011 Live Symposium of
Complex Coronary and Vascular Cases, New York, June 16, 2011.
Invited Faculty: Panelist: Live Symposium of Complex Coronary and Vascular Cases. Mount Sinai Hospital,
New York, June 17, 2011.
Invited Faculty : Chairperson in the session:Imaging in mitral valve interventions. iCiFrankfurt 2011(Imaging
in Cardiovascular Interventions. June 22, 2011
Invited Faculty : Long-term Echocardiographic Follow-up After MitraClip. iCiFrankfurt 2011(Imaging in
Cardiovascular Interventions. June 22, 2011
Page 25 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Intraprocedural Guidance for the Watchman Device. iCi Frankfurt 2011(Imaging in
Cardiovascular Interventions), Frankfurt June 22, 2011
Invited Faculty: Chairperson: Session on Left atrial appendage iCi Frankfurt 2011(Imaging in
Cardiovascular Interventions), Frankfurt June 22, 2011
Invited Speaker ; The Circulite System-a Partial Circulatory Support Device.
2011(Congenital & Structural Interventions),Frankfurt, June 23, 2011
CSI Frankfurt
Invited Speaker ;Update on the Watchman Trials.. CSI Frankfurt 2011(Congenital & Structural
Interventions), Frankfurt, June 23, 2011
Invited Speaker ; How to manage difficult cases of left atrial appendage occlusion.. CSI Frankfurt
2011(Congenital & Structural Interventions), Frankfurt, June 24, 2011
Invited Speaker ; “Let the Battle Commence”, Low surgical risk – Catheter technology versus surgery_ In
favour of Catheter therapy.. CSI Frankfurt 2011(Congenital & Structural Interventions), Frankfurt, June 25,
2011.
Invited Speaker How to do Transseptal puncture- Alternate approaches.. CSI Frankfurt 2011(Congenital &
Structural Interventions), Frankfurt, June 25, 2011
Invited Faculty: Multidisciplinary Advisory Summit : MitraClip Therapy. Chicago. June 27, 2011.
Invited Speaker: Evolution of trans-catheter heart technology The 1st Manchester Adult Structural Heart
Intervention Meeting. June 28, 2011.
Invited Speaker: Case Examples: Scope of MitraClip. The 1st Manchester Adult Structural Heart
Intervention Meeting. June 28, 2011.
Invited Speaker: The Cedars Sinai LAA learning curve: lessons for SHD intervention.The 1st Manchester
Adult Structural Heart Intervention Meeting. June 28, 2011.
Invited Speaker: Cardiac surgery and interventional cardiology grand rounds: Percutaneous Mitral Valve
Repair with the MitraClip System. St Paul’s Hospital, Vancouver, Canada. June 30, 2011
Invited Speaker/Course Director Gore® Helex® Device: A Physician Perspective. Atrial Septal defect
Closure Course, Cedars Sinai Medical Center, Los Angeles, CA July 7, 2011
Invited Speaker/Course Director: Clinical Data Overview of the Helex Septal Occluder. Atrial Septal defect
Closure Course, Cedars Sinai Medical Center, Los Angeles, CA July 8, 2011
Invited Speaker/Course Director: Hemodynamics/Rim assessment/Imaging: Atrial Septal defect Closure
Course, Cedars Sinai Medical Center, Los Angeles, CA July 8, 2011
Invited Speaker. New Mitral Valve Techniques(30minutes). NMCSDs Integrative Imaging Symposium,
Naval Hospital, Camp Pendleton, San Diego, July 10, 2011.
Invited Speaker: Structural Heart Disease Imaging( 30 minutes). NMCSDs Integrative Imaging Symposium.
Naval Hospital, Camp Pendleton, San Diego, July 10, 2011.
Invited Speaker: CLOSURE I Results Overview. Pediatric and Adult Interventional Cardiac
Symposium( PICS-AICS 2011), Westin Boston Waterfront, Boston, July 23, 2011
Invited Speaker:LAA Closure: Pre-selection, Guidance of Procedure & Follow up(15 minutes). Pediatric
and Adult Interventional Cardiac Symposium (PICS -AICS 2011). Westin Boston Waterfront. July 24, 2011.
Page 26 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Update on Percutaneous Mitral Valve Repair. Pediatric and Adult Interventional Cardiac
Symposium( PICS-AICS 2011), Westin Boston Waterfront, Boston, July 25, 2011
Invited Speaker: Update on MitraClip . The 5th Qianjiang International Cardiovascular Congress, Hangzhou,
China, July 29, 2011
Invited Speaker: Nightmare in the cath lab-case presentation on percutaneous valve complications(20
minutes). Great minds symposium, Grand Hyatt, Hong Kong. July 30, 2011
Invited Speaker: Debate: Mitraclip versus Surgery-for the motion. Great Minds Symposium, Grand Hyatt,
Hong Kong, July 30, 2011.
Invited Speaker: Pathology of the Mitral Valve & Overview of the Transcatheter Mitral Valve Therapies.
China Heart Conference(CHC), Beijing, August 13, 2011.
Invited Speaker: Transcatheter Closure of PFO. China Heart Conference(CHC), Beijing, August 13, 2011.
Invtied Speaker: Percutaneous Treatment of Mitral Valve using the MitraClip. Innovation in Cardiology 2011,
Gurgeon, New Delhi, August 14, 2011
Invited Speaker Percutaneous Mitral Valve Therapy: Is Repair feasible or is Replacement the Best Option?.
ACVS Hyderabad, India August 19, 2011.
Invited Speaker: Left Atrial Appendage Closure: Review of the Evidence. ACVS, Hyderabad, India, August
20, 2011.
Invited Speaker: Epworth Health Care Cardiac Sciences Clinical Institute Symposium (30th year
anniversary). Percutaneous intervention for mitral regurgitation. Park Hyatt Melbourne, Melbourne Sept
10th 2011.
Invited Speaker: Epworth Health Care Cardiac Sciences Clinical Institute Symposium (30th year
anniversary). If there is hole just close it. Park Hyatt Melbourne, Melbourne Sept 10th 2011.
Invited Speaker. PCI in Heart Failure: Valves and Stem Cells. Optimal Care and New therapies for
Advanced Heart Disease. Hyatt Regency, Newport Beach, CA. Sept 17, 2011.
Invited Speaker: Transcatheter Mitral Valve Repair and Replacement. Scripps’ 22nd Annual Coronary
Interventions, Hilton La Jolla, La Jolla, California, Sept 22, 2011
Invited Speaker: Evening symposium for Alfred Hospital. Advances in structural heart disease interventions.
Melbourne. September 27, 2011
Invited Speaker: Cardiology Grand rounds: Percutaneous closure of the left atrial appendage as an
alternative to Coumadin for prevention of stroke. Epworth Hospital. Sept 28, 2011
Invited Speaker: MitraClip: Lesson learned from the EVEREST II Trial. Kuala Lumpur Valve Summit 2011.
Hilton Kuala Lumpur, Malaysia, October 6, 2011
Invited Speaker: Live in Box: MitraClip Implantation. Kuala Lumpur Valve Summitt 2011, Hilton Kuala
Lumpur, Malaysia, October 6, 2011.
Invited Speaker: :Lunch Symposium: The critical role of TEE for successful LAA closure. Kuala Lumpur
Valve Summitt 2011, Hilton Kuala Lumpur, Malaysia, October 7, 2011.
Invited Speaker: Lunch Symposium: New generation Direct Thrombin Inhibitors(Dabigatran)- Alternative to
LAA Occluders? Kuala Lumpur Valve Summitt 2011, Hilton Kuala Lumpur, Malaysia, October 7, 2011.
Invited Speaker: PCI for Heart Failure, Stem Cells and Valves. Optimal Care And New Therapies For
Advanced Heart Disease, Las Vegas, Nevada, October 22, 2011
Page 27 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: LAA Closure With the Watchman Device: Tips and Tricks. American Heart Association
Meeting. Orlando, Florida, November 15, 2011.
Invited Faculty: Moderator LAA closure: Step by Step. LAA workshop 2011 in Frankfurt, November
19,2011
Invited Speaker: 2D and 3D TEE Before, During and After LAA Closure . LAA workshop 2011, in Frankfurt,
November 19,2011
Invited Speaker: We now Have new Drugs – do we Still Need LAA Closure at all? LAA workshop 2011, in
Frankfurt, November 19,2011
Invited Faculty: Live case operator. LAA workshop 2011 in Frankfurt, November 19,2011
Invited Speaker: Coherex WaveCrest LAA Occluder: Step by step. LAA workshop in Frankfurt, November
19,2011
Invited Speaker: Case presentation; a difficult case of Watchman Device. LAA workshop 2011 in Frankfurt,
November 19, 2011
Invited Speaker, Update on TAVI and MitraClip. State of the Art Cardiovascular Medicine Conference. Hyatt
Regency Mission Bay, Organized by University of San Diego. December 2, 2011
Invited Speaker: Advances in percutaneous structural heart interventions. Medicor Cardiovascular disease
symposium. Izola December 3, 2011
Invited Speaker: : Intevencionismo en cardopatia estructural:Oclusionde la orejuela izquierda en Fibrilacion
Auricular. Annual Congress of Mexican Society of Interventional Cardiology (SOCIME), Puebla, Mexico,
December 10, 2011
Invited Speaker: INTERVENTIONAL TREATMENT OF MITRAL INSUFFICIENCY WITH MITRAL REPAIR
– MITRACLIP.Annual Congress of Mexican Society of Interventional Cardiology (SOCIME), Puebla,
Mexico, December 10, 2011
Invited Faculty: Panelist for Live case demonstration. Asia PCR Singapore Live. Singapore, Jan 13, 2012
Invited Faculty: Panelist : Mini debate: Perspectives on PCI in patients with high risk acute coronary
syndrome. Asia PCR Singapore Live. Singapore, Jan 13, 2012
Invited Faculty: Chairperson: Transcatheter Mitral Interventions. Asia PCR Singapore Live. Singapore, Jan
13, 2012
Invited Speaker. Technical challenges and complications of mitral clip procedures. Asia PCR Singapore
Live. Singapore, Jan 13, 2012
Invited Faculty: Chairperson; Left atrial appendage closure for atrial fibrillation patients. Asia PCR
Singapore Live. Singapore, Jan 13, 2012
Invited Speaker: Overview of LAA closure devices and outcomes. Asia PCR Singapore Live. Singapore,
Jan 13, 2012
Invited Faculty: Panelist: In session How to treat ? Asia PCR Singapore Live. Singapore, Jan 14, 2012
Invited Faculty: Panelist: Live case demonstration. Asia PCR Singapore Live. Singapore, Jan 14, 2012
Page 28 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Faculty: Panelist; My vision of the future of non coronary interventions. Asia PCR Singapore Live.
Singapore, Jan 13, 2012
Invited Speaker: Chairperson: Mitral Valve Symposium. Second National Heart Valve Summit, New Delhi
January 27, 2012
Invited Speaker: Percutaneous approach to MV repair- Edge to edge Mitral leaflet repair with
Mitraclip Technique. Second National Heart Valve Summit, New Delhi January 28, 2012
Invited Speaker: Direct annuloplasty devices : Mitralign Quantum Core etc.. IInd National Heart Valve
Summit, New Delhi January 28, 2012
Invited Speaker: LA appendage occlusion – Technique with case demonstration. IInd National Heart Valve
Summit, New Delhi January 28, 2012
Invited Speaker: WATCHMAN Trial & LIVE IN BOX LAA Closure,. IInd National Heart Valve Summit, New
Delhi January 27, 2012
Invited Speaker: Does M.V. clipping effect outcome for subsequent valve replacement?. IInd National Heart
Valve Summit, New Delhi January 27, 2012
Invited Speaker: LIVE/ LIVE INBOX MITRA- CLIP. IInd National Heart Valve Summit, New Delhi January
27, 2012
Invited Speaker: Transcatheter Pulmonic Valve Implantation: Indications, Treatment Options, and
Procedure, Scripps Clinic’s Structural Heart Intervention and Imaging conference. San Diego Marriot, La
Jolla, California. February 2, 2012
Invited Speaker:The MitraClip Procedure: How, in Whom, and Why Scripps Clinic’s Structural Heart
Intervention and Imaging conference. San Diego Marriot, La Jolla, California. February 3, 2012
Invited Speaker: Percutaneous Mitral Valve Repair and Replacement. Tremblant Interventional Cardiology
2012, Tremblant, Canada, February 4, 2012
Invited Speaker: PERCUTANEOUS APPROACH TO MITRAL VALVE REPAIR: EDGE-TO-EDGE MITRAL
LEAFLET REPAIR. CRT 2012, Omni Shoreham Hotel, Washington DC, February 5, 2012
Invited Faculty: Panelist:: IS Percutaneous Valve Repair Ready for Prime Time? For Whom?. CRT 2012,
Omni Shoreham Hotel, Washington DC, February 5, 2012,
Invited Speaker: Advances in percutaneous treatment of structural cardiac defects. Emergency department
grand rounds. Cedars Sinai Medical Center, Los Angeles, February 9, 2012
Invited Speaker: MitraClip Overview; EVEREST RCT and I High Risk Registry. Innovation in Mitral Valve
Interventions. Shangri La Hotel, Sydney, Australia, February 18, 2012
Invited Speaker: MitraClip Case Reviews. Innovation in Mitral Valve Interventions. Shangri La Hotel,
Sydney, Australia, February 18, 2012
Invited Speaker: Cardiology Grand rounds: Percutaneous Devices for the prevention of Cardioembolic
stroke: Clinical evidence versus common sense. Cedars Sinai Medical Center, February 21, 2012
Invited Speaker: Radial Vascular Access and Closure: Technique, Devices, and Complications.
FellowsCourse. INDIA LIVE 2012, Taj Palace Hotel, New Delhi, February 23, 2012
Invited Speaker: Radial Vascular Access and Closure: Technique, Devices, and Complications.
FellowsCourse. INDIA LIVE 2012, Taj Palace Hotel, New Delhi, February 23, 2012
Page 29 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: Stent Selection and Optimal Implantation Techniques with Case Reviews. Fellows Course.
INDIA LIVE 2012, Taj Palace Hotel, New Delhi, February 23, 2012.
Invited Faculty: Chairperson: Percutaneous Valve Therapies. INDIA LIVE 2012, Taj Palace,Hotel, New
Delhi, February 24, 2012
Invited Faculty: Chairperson: Innovative therapies status report.. INDIA LIVE 2012, Taj Palace,Hotel, New
Delhi, February 24, 2012
[nvited Speaker: Left Atrial Appendage Closure in the innovative therapies status report. INDIA LIVE2012,
Taj Palace Hotel, New Delhi, February 24, 2012
Invited Chairperson: Lunch Session - How to Reduce Stroke Risk in Patients Who Can’t Tolerate Blood
Thinners: 11th Dead Sea Symposium, Telaviv, Israel, February 29, 2012
Invited Speaker: A Case of LAA Occlusion, Demonstration and Comments: 11th Dead Sea Symposium,
Telaviv, Israel, February 29, 2012[[
Invited Speaker: Tips and Tricks in LAA Occlusion: 11th Dead Sea Symposium, Telaviv, Israel, February 29,
2012
Invited Speaker: Results of the Pertinent Studies and Registries: 11th Dead Sea Symposium, Telaviv,
Israel, February 29, 2012
Invited Speaker;.E-Clip for Ischemic Mitral Regurgitation. Meet the experts session at the Annual Meeting
of the American College Cardiology, Chicago, March 24, 2012
Invited Faculty; Poster Discussant. i2 Symposium at the Annual Meeting of the American
College ;lCardiology, Chicago, March 24, 2012.
Invited Speaker; Pros and Cons of Closure of a patent foramen ovale for the prevention of stroke. i2
symposium of the Annual Meeting of the American College Cardiology. Chicago. March 25, 2012.
Invited Speaker; Debate: Mitral E- clip is a reasonable option for the treatment of functional mitral
regurgitation. Annual Meeting of the American College Cardiology. Chicago. March 25, 2012
Invited Speaker. MitraClip, best, worst and other complications. i2 Imaging Symposium at the Annual
Meeting of the American College Cardiology, Chicago, March 25, 2012.
Invited Faculty: MitraClip case in the box. i2 Symposium at the Annual Meeting of the American College
Cardiology, Chicago, March 26, 2012.
Invited Speaker; Case presentation of Left atrial appendage closure. i2 Symposium at the Annual Meeting
of the American College Cardiology, Chicago, March 26, 2012.
Invited Faculty: Panelist in the session;Anatomy and Transcatheter Therapy for the Structural Heart
Interventionalist. i2 Symposium at the Annual Meeting of the American College Cardiology, Chicago,
March 26, 2012.
Invited Speaker: Left atrial appendage closure. Boot camp for fellows at the i2 Symposium at the Annual
Meeting of the American College Cardiology, Chicago, March 26, 2012
Invited Faculty: Discussant
Structural II in the SOLACI session on Coronary and Congenital
Interventions.GI² - Global Summit in Innovations in Interventions, São Paulo, Brazil. on April 11th 2012.
Invited Speaker: Panelist for the Live cases. GI² - Global Summit in Innovations in Interventions, São Paulo,
Brazil, April 12th 2012
Invited Speaker: Is Percutaneous Closure of the LAA Superior to Medical Treatment?GI² - Global Summit in
Page 30 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Innovations in Interventions, São Paulo, Brazil. April 11th 2012
Invited Speaker: The MitraClip and Other Devices for Mitral Regurgitation, Indications, Technique &
Outcomes. GI² - Global Summit in Innovations in Interventions, São Paulo, Brazil, April 12th 2012
Invited Speaker: New Devices for Heart Failure and Pulmonary Hypertension. GI² - Global Summit in
Innovations in Interventions, São Paulo, Brazil, April 12th 2012
Invited Speaker: : Complications of Percutaneous Procedures II -- Complications of trans-septal
approachesThe Big Apple meeting The Heart Valve Society of America. New York, April 13, 2012
Invited Speaker: : How to Implant a MitraClip.The Big Apple meeting The Heart Valve Society of America.
New York, April 13, 2012
Invited Speaker: : Complex cases in review -- Clipping Functional MR with LV dysfunctionThe Big Apple
meeting The Heart Valve Society of America. New York, April 13, 2012
Invited Speaker; Percutaneous Mitral Valve Repair – Patients to Avoid. PCIS-AICS (Pediatric & Adult
Interventional Cardiac Symposium). Chicago, April 17, 2012
Invited Speaker; Debate: Against: Percutaneous Mitral Valve Therapies Should Be Restricted to Patients
Not Suitable for Surgical Repair? PCIS-AICS (Pediatric & Adult Interventional Cardiac Symposium).
Chicago, April 17, 2012
Invited Speaker:: "Percutaneous Repair of Mitral Regurgitaton-Another Treatment Option in the Cath Lab".
Antelope Valley hospital Symposium. Hellenic Center, Lancaster, CA, April 21, 2012
Invited Speaker: Mitral Insufficiency Percutaneous Treatment. 61st International Congress of The
European Society for Cardiovascular & Endovascular Surgery. Dubrovnik, Croatia, April 27, 2012
Invited Speaker: Mitral Insufficiency Percutaneous Treatment. 61st International Congress of The
European Society for Cardiovascular & Endovascular Surgery. Dubrovnik, Croatia, April 27, 2012
Invited Speaker. Structural Heart Disease Interventions. Fellows Course in the 61st International Congress
of The European Society for Cardiovascular & Endovascular Surgery. Dubrovnik, Croatia, April 27, 2012
Invited Speaker: Debate:Surgery Will Always Be Preferred For Some Patients with Mitral Regurgitation.
American Association of Thoracic Surgery(AATS) Conference. San Francisco, CA, May 2, 2012
Invited Speaker; Transcatheter Treatment of Mitral Vavle Disease: New Devices and Concepts. American
Association of Thoracic Surgery(AATS) Conference. San Francisco, CA, May 2, 2012
Invited Speaker: MitraClip a Life Changing Experience. Abbott Vascular Headquarters, Santa Clara, CA,
May 3, 2012
;
Invited Faculty: Moderator of the Session entitled LAA closure Step by Step. CSI Focus Workshop LAA
Asia-Pacific Singapore, May 5, 201212
Invited Speaker. Which Device for which appendage. CSI Focus Workshop LAA Asia-Pacific Singapore,
May 5, 2012
Invited Speaker. Watchman Occluders in Patients with Contraindications for Anticoagulation. CSI Focus
Workshop LAA Asia-Pacific Singapore, May 5, 2012.
Invited Faculty: Moderator Mitral Valve Interventions. Society of Cardiac Angiography and Interventions
Page 31 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
(SCAI) 2012 Las Vegas. May 10, 2012
Invited Speaker. The Role of MitraClip in functional mitral regurgitation. Society of Cardiac Angiography and
Interventions(SCAI) 2012. Las Vegas. May 10, 2012.
Invited Speaker. The ideal patient for Mitraclip. Society of Cardiac Angiography and Interventions(SCAI)
2012. Las Vegas. May 10, 2012.
Invited Speaker. PCI for heart failure, valves and stem cells. Ventura, CA, May 12, 2012
Invited Speaker. Device therapy in atrial fibrillation , CRT, ablation and LAA closure in patients with
congestive heart failure. CATCH UP-2012 New York Heart failure. New York-Presbyterian
Hospital/Columbia University Med Ctr, New York, May 17, 2012
Invited Faculty: Discussant.Anatomical Dissection for structural heart disease therapy. Transcatheter Valve
Therapeutics 2012 Seattle, June 2, 2012
Invited Speaker: Case Study: Concomitant Aortic Stenosis and MR. Transcatheter Valve Therapeutics 2012
Seattle, June 3, 2012
Invited Faculty: Role: Moderator. Mitral Session I. Mitral Regurgitation (MR) 2012: Major Themes and
Intriguing Issues Stretching the (Anatomic) Reach of the MitraClip Transcatheter Valve Therapeutics 2012
Seattle, June 3, 2012
Invited Faculty: Discussant.Functional MR: Current and Future Therapies and an Update on the COAPT Trial
Transcatheter Valve Therapeutics 2012 Seattle, June 4, 2012
Invited Speaker: Moderator.Preparing for the Future: Left Atrial Appendage Closure Transcatheter Valve
Therapeutics 2012 Seattle, June 3, 2012
Invited Speaker: Forming the LAA Closure Multidisciplinary Team Transcatheter Valve Therapeutics 2012
Seattle, June 5, 2012
Invited Speaker: Targeted Transseptal with TEE: For the Mitral Valve Transcatheter Valve Therapeutics 2012
Seattle, June 5, 2012
Invited Faculty: Moderator. Mitral Session III. Failure of Surgical and Transcatheter Mitral Valve (MV)
Therapies: Lessons for the Future Session II. Why the MitraClip Fails. Transcatheter Valve Therapeutics 2012
Seattle, June 5, 2012
Invited Speaker: Case Study 2: A Case When Imaging Saved the Day Transcatheter Valve Therapeutics 2012
Seattle, June 5, 2012
Invited Faculty: Moderator: LAA Session: Left Atrial Appendage Closure: Emerging Evidence, Techniques,
and Devices Transcatheter Valve Therapeutics 2012 Seattle, June 5, 2012
Invited Speaker: The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and
Future Directions. Transcatheter Valve Therapeutics 2012 Seattle, June 5, 2012
Invited Speaker: Taped Case Study: The Watchman Procedure Case. Transcatheter Valve Therapeutics 2012
Seattle, June 5, 2012
Invited Speaker: Tips and Tricks of LAA Occlusion Using the Watchman Device Transcatheter Valve
Therapeutics 2012 Seattle, June 5, 2012
Invited Speaker: Tips and Tricks of LAA Occlusion Using the Amplatzer Cardiac Plug Transcatheter Valve
Therapeutics 2012 Seattle, June 5, 2012
Invited Speaker: Complications of LAA Occlusion Devices: Frequency, Root Cause Analysis, and Prevention
Through Device Design and Technique Transcatheter Valve Therapeutics 2012 Seattle, June 5, 2012
Page 32 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker: The MitraClip from EVEREST to clinical practice. 2012 Port Douglas Heart Meeting. June
8, 2012
Invited Speaker: Prediction regarding newer technologies, take-home messages and concluding remarks.
Mitral Valve symposium, at the 2012 Port Douglas Heart Meeting, June 8, 2012
Invited Faculty: Moderator: Mitral valve symposium. 2012 Port Douglas Heart Meeting, June 8, 2012
Invited Speaker. The Future of structural heart disease interventions. 2012 Port Douglas Heart Meeting,
June 9, 2012
Invited Speaker: MitraClip EVEREST to Real World. Brisbane Cardiac Imaging Meeting. Stanford Plaza
Hotel, Brisbane, June 12, 2012
Invited Faculty: Panelist. Live case presentation: left main and bifurcation lesions. Mount Sinai Hospital,
New York. June 15, 2012
Invited Faculty: Panelist. Live case presentations, chronic total occlusions. Mount Sinai Hospital, New York ,
June 15, 2012
Invited Speaker. Case presentation in the Mitral Valve session. Imaging in Cardiovascular Interventions (iCi
Frankfurt 2012). Frankfurt, June 27, 2012
Invited Faculty. Chairsperson in the Mitral and Tricuspid Session. Imaging in Cardiovascular Interventions
(iCi Frankfurt 2012). Frankfurt, June 27, 2012
Invited Speaker. The Watchman Device. Congenital and Structural Interventions (CSI Frankfurt 2012).
Frankfurt, June 28, 2012
Invited Faculty. Chairperson, Session: LAA closure with the Watchman Occluder. Congenital and Structural
Interventions (CSI Frankfurt 2012). Frankfurt, June 29, 2012
Invited Faculty. Chairperson. Session on Left Atrial Appendage Closure. Congenital and Structural
Interventions (CSI Frankfurt 2012). Frankfurt, June 29, 2012
Invited Speaker. Long term Outcome after the Watchman Device. Congenital and Structural Interventions
(CSI Frankfurt 2012). Frankfurt, June 29, 2012
Invited Speaker. Endocardial Solution is the way to go. Congenital and Structural Interventions (CSI
Frankfurt 2012). Frankfurt, June 29, 2012
Invited Speaker. The Mitral Valve Apparatus: Influence of Echocardiography on Perioperative Clinical
Decision Making: Degenerative Mitral Valve Disease. Pre-operative Considerations: When to Select a
Percutaneous Approach. Annual American Society of Echocardiography Meeting (ASE 2012). National
Harbor, Maryland. June 30, 2012
Invited Speaker. E-Valve Mitral Clip- Everest & Beyond. Rock Mountain Valve Symposium. Missoula,
Montana. July 20, 2012
Invited Speaker. Ventricular Remodeling after Mitral Valve Intervention.. Rock Mountain Valve Symposium.
Missoula, Montana. July 20, 2012
Invited Speaker. The Failed Clip: Hospice or Surgery. Rock Mountain Valve Symposium. Missoula,
Montana. July 20, 2012
Invited Speaker. MitraClip-Clinical Outcome data Update. CICT(Complex Interventional Cardiovascular
Therapy). Fairmont Hotel. San Franscisco. July 28, 2012.
Page 33 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker. Taped Case on a Percutaneous Mitral Valve Repair using the MitraClip. China Heart
Congress 2012, Beijing, China, August 11, 2012
Invited speaker. MitraClip results and procedure(overview). ACVS Hyderabad 2012. Hyderabad, INDIA.
August 3, 2012
Invited speaker. LAA occlusion (overview of procedure and devices). ACVS Hyderabad 2012. Hyderabad,
INDIA. August 3, 2012
Invited faculty. Live case guest operator using the Amplatzer cardiac plug device in Care hospital,
Hyderabad, INDIA. August 4, 2012.
Invited Speaker. Percutaneous Closure of Left Atrial Appendage: An Alternative to Long-term
Antithrombotic Therapy in Patients with Atrial Fibrillation. China Heart Congress 2012, Beijing, China
August 11, 2012
Invited Speaker. Percutaneous Mitral Valve Repair Using the MitraClip: From EVEREST to "Real World..
China Heart Congress 2012, Beijing, China August,11, 2012
Invited Speaker. Angiographic vs physiologic coronary assessment - the fame debate: Counter Point, The
Angiogram is the best.. ANZET 2012. Brisbane, Australia, August 15, 2012
Invited Speaker. My most interesting, instructive, imposing or impressive case. Presentation 1
ANZET 2012. Brisbane, Australia, August 15, 2012
Invited Speaker. Percutaneous mitral valve repair: Climbing Everest with mitraclip. ANZET 2012. Brisbane,
Australia, August 16, 2012
Invited Speaker. : LAA occlusion: Is it ready for prime time?. ANZET 2012. Brisbane, Australia, August 16,
2012
Invited Faculty:Panelist..for Live case for North Shore Hospital, Sydney. ANZET 2012. Brisbane, Australia,
August 15, 2012
Invited Faculty. Panelist. Live Case the National Taiwan University Hospital, Taipei. ANZET 2012, Brisbane,
Australia, August 15, 2012
Invited Faculty. Panelist. Live Case from the Prince
Charles Hospital, Brisbane. ANZET 2012, Brisbane, Australia, August 15, 2012
Invited Faculty. Chairperson: The Current state of percutaneous valve interventions. CZANZ 2012 Annual
Scientific Meeting, Brisbane, Australia. August 17, 2012
Invited Speaker. Mitral clip - A new therapy but who will benefit?. CZANZ Annual Scientific Meeting.
Brisbane, Australia. August 18, 2012.
Invited Speaker. MitraClip: Where does it Fit in the Mitral Paradigm of Care Saibal Kar .2012 AATS Mitral
Valve Onclave. Nagano, Japan, September 17, 2012
Invited Faculty: Panelist, Live coronary session. Endovascular & Coronary Revascularisation in Seoul
(ENCORE Seoul 20120, Seoul, Korea, September 20, 2012
Invited Speaker. Devices and Results; Watchman versus Amplatzer Cardiac Plug. Endovascular &
Coronary Revascularisation in Seoul (ENCORE Seoul 20120, Seoul, Korea, September 20, 2012
Invited Speaker: Percutaneous mitral valve repair is a viable option for patients who are at high risk for
surgery.. Endovascular & Coronary Revascularisation in Seoul (ENCORE Seoul 20120, Seoul, Korea,
September 20, 2012
Page 34 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Speaker. Does closure of patent foramen ovale prevent recurrent strokes.. Endovascular &
Coronary Revascularisation in Seoul (ENCORE Seoul 20120, Seoul, Korea, September 20, 2012
Invited Speaker. 10 important points for Watchman implantation. Endovascular & Coronary
Revascularisation in Seoul (ENCORE Seoul 20120, Seoul, Korea, September 20, 2012
Invited Faculty: Moderator of the session meet the experts on the Watchman device. Endovascular &
Coronary Revascularisation in Seoul (ENCORE Seoul 2012, Seoul, Korea, September 20, 2012
Invited Speaker. LAA occlusion; indications and clinical data. Endovascular & Coronary Revascularisation
in Seoul (ENCORE Seoul 20120, Seoul, Korea, September 21, 2012
Invited Faculty: Live case operator (LAA closure) from Severance Hospital. Endovascular & Coronary
Revascularisation in Seoul (ENCORE Seoul 20120, Seoul, Korea, September 21, 2012.
Invited Speaker: Mitral Regurgitation: Percutaneous versus Surgical Repair. 23rd Great Wall International
Congress of Cardiology Asia Pacific Heart Federation Scientific Congress. Beijing, China, October 13, 2012
Invited Faculty. Live case operator for a Watchman Case.3rd Asia Pacific Congenital & Structural Heart
Intervention Symposium 2012, Hongkong. October 19, 2012
Invited Speaker. Complications and Tips & Tricks of MitralClip/ Leading Devices for Treating Mitral Valve
Regurgitation. 3rd Asia Pacific Congenital & Structural Heart Intervention Symposium 2012, Hongkong.
October 20, 2012
Invited Speaker. Why You Need a Multidisciplinary Heart Team: Case Scenario 2: Transcatheter Mitral
Valve Repair. Annual meeting of Transcatheter Therapeutics (TCT 2012). October 22, 2012
Invited Speaker. Prevail Study Design and Current Status. Transcatheter Therapeutics(TCT 2012),
October 23, 2012
Invited Speaker. WaveCrest (Coherex Medical): Device iteration, Human Outcomes, and Clinical Trial
Directions. Transcatheter Therapeutics (TCT 2012). Miami, October 23, 2012
Invited Speaker. Optimal Transseptal Puncture for the MitraClip. Transcatheter Therapeutics (TCT 2012).
Miami, October 24, 2012
Invited Faculty. Panelist. Live case presentation. Transcatheter Therapeutics (TCT 2012), October 25,
2012
Invited Speaker. The Expert MitraClip Procedure: From Transseptal Puncture to Echocardiographic
Guidance and Procedural Tips and Tricks. Transcatheter Therapeutics(TCT 2012), Miami, October 26,
2012.
Invited Speaker. Mitral valve repair, transcatheter approaches. Scientific sesson of the American Heart
Association. Los Angeles, CA, USA, November 5, 2012
Invited Faculty. Moderator for the session: case selection of TAVR. Annual scientific session of the
American Heart Association, Los Angeles, CA, USA, November 5, 2012
Invited Speaker. Transcatheter Mitral Valve Therapy. Annual scientific session of the American Heart
Association, Los Angeles, CA, USA, November 7, 2012
Invited Speaker. LAA Closure Without Anticoagulation: ASAP Results and Clinical Experience. LAA focus
workshop, Frankfurt, November 17, 2012
Invited Faculty. Chairperson of the session:Building a Program, Device Selection, Medical Management
and Special Considerations. LAA focus workshop, Frankfurt, November 17, 2012
Page 35 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Faculty. Chairperson of the session: The Evidence for LAA Closure and New Developments. LAA
focus workshop, Frankfurt, November 17, 2012.
Invited Speaker. Watchman: Long-Term Follow-up of PROTECT AF. LAA focus workshop, Frankfurt,
November 17, 2012
Invited Speaker. Coherex WaveCrest: Current Status and Future Directions. LAA focus workshop,
Frankfurt, November 17, 2012
Invited Speaker: Watchman Device: Mechanics, Technique & Follow up. Left Atrial Appendage Hands on
Animal Workshop 2012. Cardiovascular Preclinical Research Lab. Pyeongtaek, Korea, November 23, 2012
Invited Faculty: Hands on training using the Watchman Device. Left Atrial Appendage Hands on Animal
Workshop 2012. Cardiovascular Preclinical Research Lab. Pyeongtaek, Korea, November 23, 2012.
Invited Speaker. Endovascular approaches to LAA-Amplatzer Cardiac Plug II. Dallas-Leipzig Valve 2012
meeting, Dallas, December 5, 2012
Invited Faculty: Moderator: Session;State of The Art Imaging of Mitral Valve Disease. Dallas-Leipzig Valve
2012 meeting.Dallas, December 5, 2012
Invited Faculty: Moderator: Session; : Stroke Prevention: Drugs and Devices. Dallas-Leipzig Valve 2012
meeting. December 5, 2012
Invited Faculty. Moderator: Abstract session. Dallas-Leipzig Valve 2012, Dallas, December 6, 2012.
Invited Speaker. Challenging case. Dallas-Leipzig Valve 2012, Dallas, December 5, 2012.
Invited Speaker. The COAPT trial of the MitraClip Device. Dallas-Leipzig Valve 2012, Dallas, December 6,
2012.
Invited Speaker. Percutaneous Cardiac Procedures: Current and Future Possibilites. 10 th Annual
Emergency Medical Symposium. Los Angeles. December 7, 2012.
Invited Speaker. Medicor Cardiovascular symposium, Izola, Slovenia, December 15, 2012
Invited Speaker. Percutaneous Mitral Valve Repair and Replacement. CIMS-CON 2013. January 4, 2013,
Ahmedabad, INDIA
Invited Speaker. Coronary angiography is still the gold standard. CIMS-CON 2013. January 4, 2013,
Ahmedabad, INDIA
Invited Faculty. Panelist: Truth about TAVI/TAVR, What all physicians need to know. CIMS-CON 2013.
January 4, 2013, Ahmedabad, INDIA
Invited Speaker. Cardioembolic stroke: What all physicians need to know. CIMS-CON 2013. January 5,
2013, Ahmedabad, INDIA
Invited Speaker. Cardioembolic stroke. What all family physicians need to know. CIMS-CON 2013. January
6, 2013, Ahmedabad, INDIA
Invited Speaker. WATCHMAN – Where do we stand? PICS-AICS 2013( Pediatric and Adult
Cardiovascular Interventional Program). Miami, USA.January 20, 2013
Invited Speaker. LAA closure devices in development. PICS-AICS 2013( Pediatric and Adult
Cardiovascular Interventional Program). Miami, Florida, USA. January 20, 2013
Invited Faculty. Live Case Operator from Cedars Sinai Medical Center transmitting to PICS-AICS
2013.( Pediatric and Adult Cardiovascular Interventional Program). Miami, USA.January 20, 2013
Page 36 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited Faculty. Live case operator from National Heart Center transmitted to AsiaPCR/SingLive 2013,
Singapore, January 24, 2013
Invited Speaker: Transesophageal echocardiogram guided transseptal puncture for device
implantation(including MitraClip and LAA occlusion devices) AsiaPCR/SingLIVE 2013, Singapore, January
25, 2013
Invited Faculty:Panelist for session: Transseptal with imaging guidance. AsiaPCR/SingLIVE 2013,
Singapore, January 25, 2013
Invited speaker. Mitral valve repair and implantation in the cath lab; An overview of techniques and devices.
6th World Congress of Paediatric Cardiology and Cardiac Surgery. Cape Town, South Africa. February 19,
2013.
Invited faculty: Moderator of session: Catheter interventions from fetus to adults. 6th World Congress of
Paediatric Cardiology and Cardiac Surgery. Cape Town, South Africa. February 21, 2013
l
Invited speaker. Results of percutaneous repair of the mitral valve. 6th World Congress of Paediatric
Cardiology and Cardiac Surgery. Cape Town, South Africa. February 21, 2013
Invited speaker. MitraClip 2013. Asian Pacific Society of Cardiology 2013 Congress. Pataya, Thailand.
February 23, 2013.
Invited speaker. Tips for a Successful Mitral Clip Procedure. CRT 2013Washington DC. February 24, 2013.
Invited faculty: Panelist. Valve and structural heart disease revolution for surgeons I. CRt 2013. Washington
DC. February 24, 2013.
Invited speaker. Percutaneous Approach to Mitral Valve Repair: Edge-to-Edge Mitral Leaflet Repair with
the MitraClip--Technique Overview and a Taped Case. CRT 2013. Washington DC, February 24, 2013
Invited faculty. Panelist. Is Percutaneous Valve Repair Ready for Prime Time? For Whom?. CRT 2013,
Washington DC. February 24, 2013.
Invited speaker. Percutaneous mitral valve repair - Patient and device selection, Chennai, INDIA LIVE 2013.
March 1, 2013
Invited speaker. Mitral valve repair: overview and take home message. Chennai, INDIA LIVE 2013, March 1,
2013
Invited speaker: Tips and tricks to prevention complications during LAA closure. 1 st International
Symposium on Left Atrial Appendage, Kansas City, USA. March 2, 2013
Invited speaker:.ACP LAA Plug study. 1st International Symposium on Left Atrial Appendage. Kansas City,
USA. March 2, 2013
Invited Faculty. Chairperson. Imaging Transcatheter Mitral Valve Procedures: MitraClip and Beyond. ACC
i2 symposium, San Francisco, March 9, 2013
Invited Faculty. Chairperson. Understanding Mitral Valve Disease for the Interventionalist. TCT @
American College of Cardiology Scientific Meeting 2013, San Francisco, March 9, 2013
Invited speaker. Debate. All Moderate or Greater Residual Shunts after Device Closure Should be Closed.
American College of Cardiology Scientific Meeting 2013, San Francisco, March 11, 2013
Invited speaker. Imaging for MitraClip Procedure. The 77th Annual Scientific Meeting of the Japanese
Circulation Society(JCS 2013). Yokohama, Japan. March 16, 2013
Page 37 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited faculty. Moderator of session of transcatheter mitral valve therapies. China Interventional
Therapeutics in partnership with TCT (CIT 2013), Beijing, China, March 22, 2013
Invited Speaker. Introduction to the MitraClip: Technical and Procedural Considerations, Case Selection
and Early Clinical Outcomes. China Interventional Therapeutics in partnership with TCT (CIT 2013), Beijing,
China, March 22, 2013
Invited speaker. Taped case on MitraClip. China Interventional Therapeutics in partnership with TCT (CIT
2013), Beijing, China, March 22, 2013
Invited faculty. Discussant, Live case session. China Interventional Therapeutics in partnership with TCT
(CIT 2013), Beijing, China, March 22, 2013
Invited speaker. EVEREST II to Real World. Structural heart disease technology forum. Perth, Australia.
March 27, 2013
Invited speaker. Watchman will Prevail. Structural heart disease technology forum. Perth, Australia. March
27, 2013
Invited speaker. EVEREST II to Real World. Structural heart disease technology forum. Fenix restaurant,
Melbourne. Australia, March 27, 2013
Invited speaker. Watchman will Prevail. Structural heart disease technology forum. Fenix restaurant,
Melbourne. Australia. March 27, 2013
Invited speaker. Percutaneous mitral valve repair: emerging options. Southwest Valve Summit, Austin,
Texas, April 13, 2013.
Invited speaker. Case: Mulivalve dysfunction. Southwest Valve Summit, Austin, Texas, April 13, 2013.
Invited faculty. Moderator.MR treatment strategy. Southwest Valve Summit, Austin, Texas, April 13, 2013
Invited speaker.Transcaether LAA Occlusion: Morethan Anticoagulation-Title: Time to Intervene
Transcatheter Therapeutics Asia Pacfic (TCT-AP2013), Seoul, Korea, April 24, 2013
Invited faculty. Panelist: Breakfast Meeting-Stroke Prevention Therapies: PFO, LAA, Transcatheter
Therapeutics Asia Pacfic (TCT-AP2013). Seou, Korea, April 24, 2013
Invited faculty: discussant: Structural Heart Disease: Controversy 1: PFO CLosure for Stroke Prevention.
Transcatheter Therapeutics Asia Pacfic (TCT-AP2013), Seoul, Korea, April 24, 2013.
Invited faculty. Discussant. –Controversy#22 TAVR in Severe Aortic Stenosis.Transcatheter Therapeutics
Asia Pacfic (TCT-AP2013). Seoul, Korea, April 24, 2013
Invited speaker. Watchman Luncheon Symposium-Latest Updated on LAAC and Its Clinical Evidence.
Transcatheter Therapeutics Asia Pacfic (TCT-AP2013). Seoul, Korea. April 24, 2013
Invited speaker. Watchman Luncheon Symposium-Latest Updated on LAAC and Its Clinical Evidence.
Transcatheter Therapeutics Asia Pacfic (TCT-AP2013). Seoul, Korea. April 24, 2013
Latest Update on LAAC and Its Clinical Evidence
Invited speaker. Latest Update on LAAC and Its Clinical Evidence. Transcatheter Therapeutics Asia Pacfic
(TCT-AP2013). Seoul, Korea. April 24, 2013
Invited speaker. Case Presentation: Best and Worst Cases of LAA Closure.Transcatheter Therapeutics
Asia Pacfic (TCT-AP2013). Seoul, Korea. April 25, 2013
Invited faculty. Live case operator. Left atrial appendage occlusion case. Transcatheter Therapeutics Asia
Page 38 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Pacfic (TCT-AP2013). Seoul, Korea. April 25[, 2013
Invited speaker. The Most Exciting New Technologies (Excluding Valves) in the Cath Lab and Their Impact
on the Future. TCT@AATS2013, Minneapolis, May 8, 2013
Invited speaker. MitraClip: Why Isn't it Taking Off?. TCT@AATS2013, Minneapolis, May 8, 2013
Invited speaker. Debate on clip versus surgery in FMR-Pro(debate0. Society for Cardiovascular
Angiography and Interventions 2013 scientific session. Orlando, Florida, US. May 9, 2013.
Invited speaker. Challenging Case Example LAA Occlusion –Watchman. Society for Cardiovascular
Angiography and Interventions 2013 scientific session. Orlando, Florida, US. May 10, 2013.
Invited faculty. Discussant. Indications, contradictions and complications for PFO, ASD, LAA Closure
Society for Cardiovascular Angiography and Interventions 2013 scientific session. Orlando, Florida May 10,
2013
Invited speaker. A Septal Occluder with Fully Biodegradable Frame. Society for Cardiovascular
Angiography and Interventions 2013 scientific session. Orlando, Florida May 10, 2013
Invited speaker. Medicine grand rounds. Pills, patches, and umbrellas for the prevention of cardioembolic
stroke. Cedars Sinai Medical center. May 17, 2013
Invited faculty. Transcatheter Valve therapeutics 2013. Live case operator for a MitraClip procedure at St
Paul’s Hospital, Vancouver, Canada.
Invited speaker. World experience using the MitraClip. Cardiac Sciences Clinical Institute Symposium.
Melbourne, Australia, October 19, 2013
Invited speaker: Latest insights on the clinical evidences: from PROTECT AF to PREVAIL. UK Heart
Rhythm Conference , Birmingham UK, October 21, 2013
Invited speaker. Biological response following Watchman and Amplatzer Cardiac Plug implant. UK Heart
Rhythm Conference , Birmingham UK, October 21, 2013
Invited speaker. Deep dive of the Watchman Data. Protect AF, CAP AND PREVAIL, Safety
Issues.Transcatheter Therapeutics(TCT 2013). San Francisco, US. October 27, 2013
Invited faculty. Discussant. Session; Session: The Evidence for LAA Closure: Current and Emerging
Indications. Transcatheter Therapeutics(TCT 2013). San Francisco, US. October 27, 2013
Invited faculty. Moderator. Session; The Technique of LAA Closure. Transcatheter Therapeutics(TCT
2013). San Francisco, US. October 27, 2013
Invited speaker. Watchman Device. Transcatheter Therapeutics(TCT 2013). San Francisco, US. October
27, 2013
Invited speaker. Data Presented to the FDA to Support a Degenerative MR Indication in Patients Too High
Risk for Surgery.Transcatheter Therapeutics(TCT 2013). San Francisco, US. October 28, 2013
Invited faculty. Discussant: The MitraClip in Degenerative MR. Transcatheter Therapeutics(TCT 2013). San
Francisco, US. October 28, 2013
Invited faculty. Moderator. Session; The MitraClip in Functional MR. Transcatheter Therapeutics(TCT
2013). San Francisco, US. October 28, 2013
nvited speaker. Debate; If I Had to Have Just One for Functional MR..Give me the MitraClip. Transcatheter
Therapeutics(TCT 2013). San Francisco, US. October 28, 2013
Page 39 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited faculty. Next generation Mitral Valve Therapies Part 1: Today’s Contenders. Transcatheter
Therapeutics(TCT 2013). San Francisco, US. October 28, 2013
Invited speaker. Are Novel LAA Closure Devices ( Beyond Watchman) needed in the USA.Transcatheter
Therapeutics(TCT 2013). San Francisco, US. October 28, 2013
Invited faculty. Discussant . Partnership Sesson: The Interventional Gap Between Europe and the United
States: Devices available in Germany but Not the United States, Session III LAA Closure Devices.
Transcatheter Therapeutics(TCT 2013). San Francisco, US. October 28, 2013
Invited faculty.MODERATOR-PHARMACOLOGICAL & INTERVENTIONAL OPTIONS FOR STROKE
PREVENTION IN ATRIAL FIB-Session V. Provocative Cases: the Good, the Bad and the Ugly
Transcatheter Therapeutics(TCT 2013). San Francisco, US. October 29, 2013
Invited speaker. Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term
Prevention of Stroke. Transcatheter Therapeutics(TCT 2013). San Francisco, US. October 29, 2013
Invited faculty:Discussant. Stroke in Atrial fibrillation: A Preventable Condition. Transcatheter
Therapeutics(TCT 2013). San Francisco, US. October 29, 2013
Invited speaker. The MitraClip for functional MR.Transcatheter Therapeutics(TCT 2013). San Francisco,
US. October 29, 2013
Invited faculty. Interventional, Surgical and Hybrid Procedures: Case Studies in Conflict and
Consensus( Co-sponsored by the American Association for Thoracic Surgery) Session IV. Mitral Valve
Disease..Transcatheter Therapeutics(TCT 2013). San Francisco, US. October 29, 2013
Invited faculty. Chairperson. Mitralign: Applications for Mitral and Tricuspid Diseases. .Transcatheter
Therapeutics(TCT 2013). San Francisco, US. October 30, 2013
Invited faculty. Live case operator: Left main stenting. .Transcatheter Therapeutics(TCT 2013). San
Francisco, US. October 30, 2013
Invited speaker. Transseptal puncture for functional MR, case presentation. .Transcatheter
Therapeutics(TCT 2013). San Francisco, US. October 30, 2013
Invited speaker. Transseptal puncture for Mobile Interatrial Septum Therapeutics(TCT 2013). San
Francisco, US. October 30, 2013
Invited speaker. The MitraClip Procedure: Getting in and out of trouble..Transcatheter Therapeutics(TCT
2013). San Francisco, US. October 30, 2013
Invited faculty. The MitraClip Porcedure Broken Down..Transcatheter Therapeutics(TCT 2013). San
Francisco, US. October 30, 2013
Invited faculty. Plenary Session XXVIII. Clinically Oriented Case-Based Tutorials II. Aortic and Mitral Valve
Disease. Transcatheter Therapeutics(TCT 2013). San Francisco, US. November 1k, 2013
Invited speaker. Current status of mitral valve interventions. 9th Asian Cardiovascular Therapeutics,
Bangkok, Thailand, November 14, 2013
Invited faculty. Live case demonstration of Left atrial appendage occlude. 9 th Asian Cardiovascular
Therapeutics, Bangkok, Thailand, November 15, 2013
Invited speaker. Patent Foramen Ovale and Stroke: To Close or Not to Close . 9th Asian Cardiovascular
Therapeutics, Bangkok, Thailand, November 15, 2013
Page 40 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Invited speaker. Advanced Support Systems during High Risk PCI . 9th Asian Cardiovascular Therapeutics,
Bangkok, Thailand, November 15, 2013
Invited speaker. Percutaneous Mitral Valve Repair an indication update. The 4 th Sendai/New Tokyo Live.
Sendai, Japan, November 30, 2013
Invited faculty. Panelist for Live ASD closure case. The 4th Sendai/New Tokyo Live. Sendai, Japan,
November 30, 2013
Invited Speaker. Structural Heart Disease Program in Medicor, Izola.Medicor Cardiovascular symposium,
Izola, Slovenia, December 14, 2012
Invited speaker. “MitraClip” Current status in United States. The 20th Kamakura Live Demonstration Course.
Yokohama, Kanagawa, Japan, December 20, 2013
Invited speaker. “Percutaneous Mitral Valve Repair: Adding Life to Years”. The Abbott Vascular
Symposium at the 20th Kamakura Live Demonstration Course, Yokohama, Kanagawa, Japan, December
21, 2013
Invited faculty. Live case commentator. The 20th Kamakura Live Demonstration Course, Yokohama,
Kanagawa, Japan. December 21, 2013.
Invited speaker. Status of closure of Patent Foramen Ovale and Left atrial closure for the prevention of
stroke. 6th annual symposium on Neurovascular disease 2014, Los Angeles, CA, USA, January 25, 2014.
Invited speaker. Percutaneous Mitral Valve Interventions; Edge to Edge repair to replacement. Innovative
Procedures, Devices,and State of the Art Care for Arrhythmias, Heart Failure and Structural Heart Disease.
Hilton Hawaiian Village, Honolulu, Hawaii, USA. February 1, 2014
Invited faculty. Discussant on Left atrial appendage closure. jInnovative Procedures, Devices,and State of
the Art Care for Arrhythmias, Heart Failure and Structural Heart Disease. Hilton Hawaiian Village, Honolulu,
Hawaii, USA. February 1, 2014
Invited speaker. Newer devices on Mitraclip. Abbott Training symposium. Los Angeles, CA, USA. February
7, 2014
VISITING PROFESSORSHIP
Visiting Professor MC Medcor, Izola, Slovenia, September 2007
Scripps Green Hospital, San Diego, CA. Complex structural heart disease interventions
UCI Medical Center, Irvine, CA. Help in performance of complex structural heart disease interventions
Visiting Faculty: Cath Lab. University of Hamburg, Eppendorf, Hamburg, Germany,
August 5, 2009
PUBLICATIONS/BIBLIOGRAPHY
A.
Research Papers - Peer reviewed
Maity AK, Chatterjee SS, Todi S, Kar S, Chakinpurty M, Ganguly K, Kar CC: Profile of Renal Artery Stenosis
with Reference to Aortoarteritis. Ind Heart J 1986 Nov; 38(6): 451-6
Ghosh Sukumar, Choudhury D, Chatterjee SS,Kar S,Maity AK, Kar CC: Role of Echocardiography in
Borderline Hypertension. Ind Heart J 1988 Nov: 40(6): 460-5
Sagar S, Kar S, Gupta A, Sharma BK: Ocular Changes in Takayasu's Arteritis in India. Jpn J Ophthalmol
1994; 38: 97-102
Sloman JG, Kar S: Cardiovascular Problems: Three cases requiring angioplasty. Current Therapeutics
Page 41 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
1996; Feb: 31 – 34
Saibal Kar, Raj Makkar: Case review: Percutaneous Transluminal Septal Myocardial Ablation: A Novel,
Nonsurgical Treatment for Hypertrophic Cardiomyopathy. Rev Cardiovasc Med 2001;2:97-102
6.
Saibal Kar, Prediman K Shah: Acute Coronary Dissection Caused by Coronary Artery
Dissection Mimicking Acute Plaque Rupture. Rev Cardiovasc Med 2001; 2(4):215-219
7.
Matetzky S, Noc M, Domingo M, Eigler N, Kar S, Shah PK, Cercek B. Primary angioplasty in
octogenarians. Am J Cardiol 2001; 88: 680-684
8.
Noc M. Matetzky S. Domingo M. Kar S. Makkar R. Cercek B. Litvack F. Frequency of incomplete
reperfusion in patients with acute myocardial infarction undergoing primary angioplasty. Am J of Cardiol
2002; 90(3):316-8
9.
Ariel Finkelstein MD; Dougal McClean MB ChB MD; Saibal Kar MD; Kaname Takizawa MD; Kiron
Vargeese MD; Kinam Park PhD; Michael C. Fishbein MD; Raj Makkar MD; Frank Litvack MD; Neal L. Eigler
MD.Local Drug Delivery via a Coronary Stent With Programmable Release Pharmacokinetics. Circulation
2003;107: 777-784
10.
Matetzky S. Domingo M. Kar S. Noc M. Shah PK. Kaul S. Daar E. Cercek B. Acute
myocardial infarction in human immunodeficiency virus-infected patients. Archives of Internal Medicine.
2003;163(4):457-60
11.
Rukshin V. Santos R. Gheorghiu M. Shah PK. Kar S. Padmanabhan S. Azarbal B. Tsang VT.
Makkar R. Samuels B. Lepor N. Geft I. Tabak S. Khorsandhi M. Buchbinder N. Eigler N. Cercek B. Hodgson
K. Kaul S. A prospective, nonrandomized, open-labeled pilot study investigating the use of magnesium in
patients undergoing nonacute Percutaneous coronary intervention with stent implantation. Journal of
Cardiovascular Pharmacology & Therapeutics 2003; 8(3):193-200
12.
Eberhard Grube; Shinjo Sonoda; Fumiaki Ikeno; Yasuhiro Honda; Saibal Kar; Charles Chan; Ulrich
Gerckens; Alexander J. Lansky; Peter Fitzgerald. Six- and Twelve-Month Results From First
Human Experience Everolimus-Eluting Stents With Bioabsorbable Polymer. Circulation
2004;109:2168-2171
13.
Shengmei Zhou, MD, Lan S. Chen, MD, Yasushi Miyauchi, MD, Mizuho Miyauchi, MD, Saibal Kar,
MD, Simon Kangavari, MD, Michael C. Fishbein, MD, Behrooz Sharifi, PhD, Peng-Sheng Chen, MD.
Mechanisms of Cardiac Nerve Sprouting After Myocardial Infarction in Dogs. Short title: Mechanisms
of Cardiac Nerve Sprouting. Circulation Research 2004;95:76-83
14.
Fatma Aboul-Enein, MD; Saibal Kar, MD; Sean W. Hayes, MD; Maria Sciammarella, MD; Aiden
Abidov, MD; Raj Makkar, MD; John D Friedman, MD; Neal Eigler, MD; Daniel S Berman, MD.
Influence of Angiographic collateral Circulation on Myocardial Perfusion in Patients with Chronic
Total Occlusion of a Single Coronary Artery and No Prior Myocardial Infarction. J Nucl Med
2004;45:950-955
15.
Okuyama Y, Pak H-N, Miyauchi Y, Liu Y-B, Chou C-C, Hayashi H, Fu KJ, Kerwin WF, Kar S,
Karagueuzian HS, Fishbein MC, Chen P-S, Chen LS: Sympathetic nerve sprouting induced by
radiofrequency catheter ablation in dogs. Heart Rhythm 2004;1:712-7
16.
Aragon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: “TandemHeart” for
high-risk coronary intervention. Catheter Cardiovasc Interv 2005;65:346-52
Page 42 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
17.
Lee MS, Shah AP, Jamali A, Kar S, Dohad S, Aragon J, Makkar RR. Drug-eluting stenting is superior
to bare-metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 2005 Dec;66(4):507-11
18.
Kobal SL, Trento L, Baharami S, Tolstrup K, Naqvi TZ, Cercek B, Neuman Y, Mirocha J, Kar S,
Forrester JS, Siegel RJ. Comparison of effectiveness of hand-carried ultrasound to bedside
cardiovascular physical examination. Am J Cardiol, 2005 Oct 1;96(7):1002-6
19.
Matthew J Price, Chung-Chuan Chou, Malka Frantzen, Takashi Miyamoto, Saibal Kar, Steve Lee,
Prediman K Shah, Bradley J Martin, Michael Lill, James S Forrester, Peng-Sheng Chen, Raj Makkar.
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction
improves left ventricular function and alters electrophysiological properties. Int J Cardiol. 2005: Oct
21
20.
Michael S Lee, Nikil Kapoor, Faizi Jamal, Lawrence Czer, Joseph Aragon, James Forrester, Saibal
Kar, Sohail Dohad, Robert Kass, Neal Eigler, Alfredo Trento, Prediman K Shah, Raj Makkar.
Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug
eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2006 Feb
21;47(4):864-70
21.
Makkar RR, Price MJ, Lill M, Frantzen M, Takizawa K, Kleisli T, Zheng J, Kar S, McClelan R,
Miyamota T, Bick-Forrester J, Fishbein MC, Shah PK, Forrester JS, Sharifi B, Chen PS, Qayyum M.
Intramyocardial injection of allogenic bone marrow-Derived mesenchymal stem cells without
immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J
Cardiovasc Pharmacol Ther. 2005 ;10(4):225-33
22.
J Aragon, S. Kar, F.Tio, B. Trauthen, A. Parisky, C. Watanabe, A. Jamali, N. Eigler, P.W.Serruys, F.
Litvack. The effect of variable release kinetics on Paclitaxel efficacy rom a drug eluting stent in a
porcine model . EuroIntervention, Issue 2, 2005
23.
Ritzema-Carter JL, Smyth D, Troughton RW, Crozier IG, Melton IC, Richards AM, Eigler N, Whiting J,
Kar S, Krum H, Abraham WTImages in cardiovascular medicine. Dynamic myocardial ischemia
caused by circumflex artery stenosis detected by a new Implantable Left Atrial Pressure Monitoring
Device. Circulation. 2006 Apr 18;113(15):e705-6
24.
Kangavari S, Yong Seog OH, Shengmei Z, Ho-Joong Y, Man-Young L,
Wook-Sung J, Tae-ho R, Soon-Jo H, Kar S, Kerwin WF, Swerdlow CD, Gang ES, Gallik DM,
Goodman JS, Chen YI, Chen PS. Radiofrequency Catheter Ablation and Nerve Growth Factor
Concentration in Humans. Heart Rhythm. 2006 Oct;3(10):1150-5. Epub 2006 Jul 8
25.
McClean D, Jamali A, Aragon J, Kar S, Whiting J, Ritzema-Carter J, Troughton R, Krum H, Doughty
R, Abraham W, Eigler N. Non-invasive calibration of cardiac pressure transducers in patients with
heart failure: An Aid to implantable hemodynamic monitoring and therapeutic guidance. J Card Fail.
2006 Sep;12(7):568-76
26.
Michael S Lee, Daniel Jurewitz, Joseph Aragon, James Forrester, Raj Makkar,
Page 43 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Saibal Kar. Stent Fracture Associated with Drug-Eluting Stents: Clinical Characteristics and
Implications. Catheter Cardiovasc Interv. 2007 Feb 15;69(3):387-94
27.
Jay Ritzema, Iain C Melton, Mark Richards, Ian G Crozier, Chris Frampton, Robert N Doughty,
James Whiting, Saibal Kar, Neal Eigler, Hernry Krum, William Abraham, Richard Troughton. Direct
Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients. Circulation 007;116:2952-2959
28.
Ryan Berg, Joseph Aragon, Vladimir Royter, John F Shanley, Greg Cogert,
Renu Vermani, Saibal Kar, Neal Eigler, Frank Litvack. Pimecrolimus and Dual
Pimecrolimus-Paclitaxel Eluting Stents Decrease Neointimal Proliferation in a Porcine Model.
Catheterization and Cardiovascular Interventions. 2007;70:871–879
29.
L. Iri Kupferwasser, MD, FESc, Allen M. Amorn, MD, Nikhil Kapoor, MD,
Michael S. Lee, MD, Saibal Kar, MD, FACC, Bojan Cercek, MD, FACC,
Suhail Dohad, MD, James Mirocha, PhD, James S. Forrester, MD, FACC,
Prediman K. Shah, MD, FACC, and Raj R. Makkar,* MD
Comparison of Drug-Eluting Stents With Bare Metal Stents in Unselected Patients With Acute
Myocardial Infarction. Catheterization and Cardiovascular Interventions
2007; 70:1-8
30.
Ted Feldman, Saibal Kar. Percutaneous Mitral Valve Repair Technologies: Surgical Concepts
Adapted to Catheter-based Approaches. Indian Heart J 2008; 60:507-513 .
31.
Anthony J. White, MBBS, PHD,* Gautam Kedia, MD,* James M. Mirocha, MS,*
Michael S. Lee, MD,† James S. Forrester, MD,* Walter C. Morales, BS,*
Suhail Dohad, MD,*
Saibal Kar, MD,* Lawrence S. Czer, MD,* Gregory P. Fontana, MD,*
Alfredo Trento, MD,* Prediman K. Shah, MD,* Raj R. Makkar, MD* Comparison of Coronary Artery
Bypass Surgery and Percutaneous Drug-Eluting Stent Implantation for Treatment of Left
Mainoronary Artery Stenosis. J Am Coll Cardiol 2008;1:236-245.
31.
Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S, Hahn R, Rogers JH, Bommer WJ, Wang A,
Berke A, Lerakis S, Kramer P, Wong SC, Foster E, Glower D, Feldman T; EVEREST Investigators.
Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and
gradient.Eurointerventions 2009:4(4): 437-442.
32.
Takashi Akima, MD, Rajendra Makkar, MD, Toshihiko Nishioka, MD, Suhail Dohad, MD, Kiyoshi Iida,
MD, Sorel Goland, MD, Saibal Kar, MD, Huai Luo, MD, Robert J. Siegel, MD Impact of Nitroglycerin
and Verapamil on Coronary Arterial Distensibility as Assessed by Intravascular Ultrasound. J
Invasive Cardiol 2009;21:162–167
33.
Ted Feldman, MD, Saibal Kar, MD, Michael Rinaldi, MD,Peter Fail, MD, James Hermiller, MD,_
Richard Smalling, MD, PHD, Patrick L. Whitlow, MD,William Gray, MD, Reginald Low, MD, Howard C.
Herrmann, MD, Scott Lim, MD, Elyse Foster, MD,Donald Glower, MD, for the EVEREST
Investigators. Percutaneous Mitral Repair With the MitraClip System Safety and Midterm Durability
in the Initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) Cohort J. Am. Coll. Cardiol.
2009;54;686-694
34.
Wertman BM, Cheng VY, Kar S, Gransar H, Berg RA, Naik H, Makkar R, Friedman JD, Schapira
JN, Berman DS. Characterization of complex coronary artery stenosis morphology by coronary
computed tomography angiography. JACC Cardiovasc Imaging 2009;8:950-958
Page 44 of 65
Curriculum Vitae
35.
Saibal Kar, M.D, FAHA, FACC, FSCAI
Melmed G, Kar S, Geft I, Lo S. A new method for endoscopic closure of gastrocolonic fistula: novel
application of a cardiac septal defect closure device(video). Gastrointestinal Endoscopy 2009; 70:
542-545.
36 Asma Hussaini, Saibal Kar. Percutaneous Mitral Valve Repair: Potential in
Heart Failure Management. Curr Heart Fail Rep 2010;7:22-26.
37.
Norio Tada,; Renu Virmani, ; Gordon Grant, Lauren Bartlett, Alexander Black,; Claudia Clavijo,;
Uwe Christians, Ron Betts, Doug Savage, John Shulze ,Saibal Kar.
Polymer-Free Biolimus A9 Eluting Stent Demonstrates More Sustained Intimal
Inhibition, Improved Healing and Reduced Inflammation in Comparison to a
Polymer-Coated Sirolimus Eluting Cypher Stent in a Porcine Model.
Circ Cardiovasc Interv. 2010;3:174-183.
38.
Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S,
Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham
WT; Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients
(HOMEOSTASIS) Study Group.
Physician-directed patient self-management of left atrial
pressure in
advanced chronic heart failure. Circulation. 2010 ;121(9):1086-95.
39.
Biner S, Kar S, Siegel RJ, Rafique A, Shiota T. Value of color Doppler three-dimensional
transesophageal echocardiography in the percutaneous closure of mitral prosthesis
paravalvular leak. Am J Cardiol 2010;105(7): 984-989.
40.
Anthony J. Furlan MD*; Mark Reisman MD; Joseph Massaro PhD; Laura Mauri MD, MSc; Harold
Adams MD; Gregory W. Albers MD; Robert Felberg MD; Howard Herrmann MD; Saibal Kar MD;
Michael Landzberg MD; Albert Raizner MD; Lawrence Wechsler MD; for the CLOSURE I
Investigators. Study Design of the CLOSURE I Trial. A Prospective, Multicenter, Randomized,
Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System
Versus Best Medical Therapy in Patients With Stroke or Transient Ischemic Attack Due to
Presumed Paradoxical Embolism Through a Patent Foramen Ovale.
Stroke 2010; 41(12):2872-2883.
41. Siegel RJ, Biner S, Rafique AM, Rinaldi M, Lim S, Fail P, Hermiller J, Smalling R, Whitlow
PL, Herrmann HC, Foster E, Feldman T, Glower D, Kar S; EVEREST Investigators. The
acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 2011;57;1658-1665.
42.
Mehran Khorsandi, MD; Alex Abizaid,MD; Sameer Dani, MD; Henry Bourang, MD; Ricardo
Costa,
MD; Saibal Kar, MD; Raj Makkar, MD. Advanced Bifurcation Systems’ mother daughter platform.
Eurointerventions, 2010;6(Suppl J):J165-J168
43. Vivek Y. Reddy, David Holmes, Shepahl K. Doshi, Petr Neuzil, and Saibal Kar. Safety of
Percutaneous Left Atrial Appendage Closure: Results from the Watchman Left Atrial Appendage
System for Embolic Protection in Patients with AF (PROTECT AF) Clinical Trial and the Continued
Access Registry.
Circulation, 2011;123:417-424.
Page 45 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
44.
Ted Feldman, M.D., Elyse Foster, M.D., Donald G. Glower, M.D., Saibal Kar, M.D., Michael J.
Rinaldi, M.D., Peter S. Fail, M.D., Richard W. Smalling, M.D., Ph.D., Robert Siegel, M.D.,
Geoffrey A. Rose, M.D.,Eric Engeron, M.D., Catalin Loghin, M.D., Alfredo Trento, M.D., Eric R.
Skipper, M.D., Tommy Fudge, M.D.,George V. Letsou, M.D., Joseph M. Massaro, Ph.D., and
Laura Mauri, M.D., for the EVEREST II Investigators. Percutaneous Repair or Surgery for Mitral
Regurgitation.
N Engl J Med 2011; 364 :1395-1406.
45.
Hasan Jilaihawi, Saibal Kar. Left Atrial Appendage Occlusion:An Alternative to Long Term
Coumadin forPatients with Atrial Fibrillation. Revista Brasiliera de Cardiologia Invasiva
2011;19(1): 9-10.
46.
Damien Kenny , MD, Ziyad M. Hijazi 1, MD, MPH, Saibal Kar 2, MD, John Rhodes 3, MD,
Michael Mullen 4, MD, Raj Makkar 2, MD, Girish Shirali 5, MD, Mark Fogel 6, MD, John Fahey 7,
MD, Mary G Heitschmidt 1,RN, Christopher Cain. Percutaneous Implantation of the Edwards
SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position: Early Phase 1
Results from an International Mutlticenter Clinical Trial. J Am Coll of Cardiol 2011(in press)
47.
Jilaihawi H, Kar S, Doctor N, Fontana G, Makkar R. Contemporary application of
cardiovascular hemodynamics: transcatheter aortic valve interventions. Cardiol
Clin.2011;29:211-222.
48.
Jilaihawi H, Makkar R, Hussaini A, Trento A, Kar S. Contemporary application of cardiovascular
hemodynamics:transcatheter mitral valve interventions. Cardiol Clin.2011;29:201-209.
49.
Biner S, Perk G, Kar S, Rafique AM, Slater J, Shiota T, Hussaini A, Chou S, Kronzon I, Siegel
RJ.Utility of combined two-dimensional and three dimensional transesophageal imaging for
catheter-based mitral valve clip repair of mitral regurgitation. J Am Soc Echocardiogr. 2011
Jun;24:611-617.
50.
Azarbal B, Poommipanit P, Arbit B, Hage A, Patel J, Kittleson M, Kar S, Kaldas FM, Busuttil RW.
Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver
disease referred for liver transplantation. Liver Transpl.2011;17(7):809-813.
51.
Buch MH, Trento A, Kar S Is there a role for surgeons in transcatheter mitral valve procedures?
Curr Opin Cardiol. 2011;26(2):99-105.
52.
Thompson KA, Kar S, Makkar R, Victor RG.Drug-resistant hypertension: is renal sympathetic
denervation the answer? Curr Cardiol Rep. 2011;13(2):93-95.
53.
Chakravarty T, White AJ, Buch M, Naik H, Doctor N, Schapira J, Kar S, Forrester JS, Weiss RE,
Makkar R. Meta-analysis of incidence clinical characteristics and implications of stent fracture.
Am J Cardiol;106(8):1075-1080.
54.
Jilaihawi H, Hussaini A, Kar S. MitraClip: a novel percutaneous approach to mitral valve repair. J
Zhejiang Univ Sci B. 2011 Aug.;12(8):633-637.
55.
Perk G, Biner S, Kronzon I, Saric M, Chinitz L, Thompson K, Shiota T, Hussani A, Lang R, Siegel
R, Kar S. Catheter-based left atrial appendage occlusion procedure: role of
echocardiography.Eur J Echocardiogr. 2011 Sep 8.
Kulkarni M, Conte AH, Huang A, Lubin L, Shiota T, Kar S. Coronary artery disease, acute
myocardial infarction, and a newly developing ventricular septal defect: surgical repair or
percutaneous closure? J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1213-6.
56.
Page 46 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
57.
Nataša Černič Šuligoj, Metka Zorc, Anton Grad, Saibal Kar, Marko Noč. Percutaneous closure
of patent foramen ovale – experience with novel devices. Slov Kardiol 2011; 8: 15–19
58.
Whitow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Hermann
HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel, RJ, Foster E, Glower D, Mauri
L, Kar S; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral
valve leaflet repair: The EVEREST II(Endovascular Valve Edge-to-Edge Repair) high-risk study.
J Am Coll Cardiol 2012;59:130-139
58 Juan F. Viles-Gonzalez, , Saibal Kar, , Pamela Douglas, , Srinivas Dukkipati, , Ted Feldman, ,
Rodney Horton, ,David Holmes, , Vivek Y. Reddy, . The Clinical Impact of Incomplete Left Atrial
Appendage Closure With the Watchman Device in Patients With Atrial Fibrillation A PROTECT AF
(Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of
Stroke in Patients With Atrial Fibrillation) Substudy
J Am Coll Cardiol. 2012;59:923-929
59. Anthony J. Furlan, M.D., Mark Reisman, M.D., Joseph Massaro, Ph.D.,Laura Mauri, M.D., Harold
Adams, M.D., Gregory W. Albers, M.D.,Robert Felberg, M.D., Howard Herrmann, M.D., Saibal
Kar, M.D.,Michael Landzberg, M.D., Albert Raizner, M.D.,and Lawrence Wechsler, M.D., for the
CLOSURE I Investigators. N Engl J Med;2012:991-9.
60.
Saitoh T, Izumo M, Furugen A, Tanaka J, Miyata-Fukuoka Y, Gurudevan SV, Tolstrup K, Siegel RJ,
Kar S, Shiota T. Echocardiographic evaluation of iatrogenic atrial septal defect after
catheter-based mitral valve clip insertion.
Am J Cardiol. 2012;109(12):1787-91
61.
Kar S, Ibebuogu UN, Conte AH. Utilization of 3 amplatzer occluders for closure of post-myocardial
infarction ventricular septal defect.
J Invasive Cardiol. 2012 May;24(5):E101-3
62.
Biner S, Siegel RJ, Feldman T, Rafique AM, Trento A, Whitlow P, Rogers J, Moon M, Lindman B,
Zajarias A, Glower D, Kar S; EVEREST investigators. Acute effect of percutaneous MitraClip
therapy in patients with haemodynamic decompensation.
Eur J Heart Fail. 2012;14(8):939-45.
63.
Wei J, Mehta PK, Johnson BD, Samuels B, Kar S, Anderson RD, Azarbal B, Petersen J, Sharaf B,
Handberg E, Shufelt C, Kothawade K, Sopko G, Lerman A, Shaw L, Kelsey SF, Pepine CJ, Merz
CN. Safety of coronary reactivity testing in women with no obstructive coronary artery disease:
results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
JACC Cardiovasc Interv. 2012;5(6):646-53
64.
Ibebuogu UN, Cercek B, Makkar R, Dinh H, Kwarteng C, Mirocha J, Hussaini A, Singh S, Dohad S,
Shah PK, Khorsandi M, Kar S. Comparison between transradial and transfemoral percutaneous
coronary intervention in acute ST-elevation myocardial infarction.
Am J Cardiol. 2012 Nov 1;110(9):1262-5.
65.
Slipczuk L, Siegel RJ, Jilaihawi H, Hussaini A, Kar S. Optimizing procedural outcomes in
percutaneous mitral valve therapy using transesophageal imaging: a stepwise analysis.
Expert Rev Cardiovasc Ther. 2012 Jul;10(7):901-16.
66.
Matsumoto T, Yeow WL, Kar S. Percutaneous closure of iatrogenic ventricular septal defect
following surgical aortic valve replacement using two different approaches.
J Invasive Cardiol. 2013 Feb;25(2):E42-4.
Page 47 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
67.
Izumo M, Shiota M, Kar S, Gurudevan SV, Tolstrup K, Siegel RJ, Shiota T. Comparison of real-time
three-dimensional transesophageal echocardiography to two-dimensional transesophageal
echocardiography for quantification of mitral valve prolapse in patients with severe mitral
regurgitation.
Am J Cardiol. 2013 Feb 15;111(4):588-94
68.
Matsumoto T, Nakamura M, Yeow WL, Siegel RJ, Kar S. Transcatheter Left Atrial Appendage
Closure After Incomplete Surgical Ligation. JACC Cardiovasc Interv. 2013 Feb;6(2):e11-2.
69.
Chowdhury SM, Hijazi ZM, Rhodes J, Kar S, Makkar R, Mullen M, Cao QL, King L, Akin J, Shirali G.
Early Echocardiographic Changes After Percutaneous Implantation of the Edwards SAPIEN
Transcatheter Heart Valve in the Pulmonary Position. Echocardiography. 2013 Feb 22
70.
Alli O, Doshi S, Kar S, Reddy V, Sievert H, Mullin C, Swarup V, Whisenant B, Holmes D Jr. Quality
of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial
Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation)
Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation.
J Am Coll Cardiol 2013 Apr 30;61(17):1790-8
71.
Foster E, Kwan D, Feldman T, Weissman N, Grayburn P, Schwartz A, Rogers J, Kar S, Rinaldi M,
Fail P, Hermiller J, Whitlow PL, Herrmann HC, Lim S, Glower D. Percutaneous Mitral Valve Repair
in the Initial EVEREST Cohort: Evidence of Reverse Left Ventricular Remodeling.
Circ Cardiovasc Imaging. 2013 Apr 30.
72.
Yi GH, Cheng Y, Aboodi MS, Farnan R, Kar S, Burkhoff D, Farnan G, Granada JF. Safety and
feasibility of percutaneous delivery of a novel circulatory assist device (CircuLite® SYNERGY®) in
the swine model. EuroIntervention. 2013 Jun 22;9(2):259-68
73.
Chakravarty T, Jilaihawi H, Nakamura M, Kashif M, Kar S, Cheng W, Makkar R. Pre-emptive
positioning of a coronary stent in the left anterior descending artery for left main protection: A
prerequisite for transcatheter aortic valve-in-valve implantation for failing stentless bioprostheses?
Catheter Cardiovasc Interv. 2013 Jun 1. doi: 10.1002/ccd.25037.
74.
Matsumoto T, Yeow WL, Nakamura M, Siegel RJ, Kar S. Reply. JACC Cardiovasc Interv. 2013
Jul;6(7):762-3
75.
Kar, Saibal. Percutaneous transcatheter Mitral Valve Repair: Adding life to years. . J Am Coll
Cardiol 2013; 62:1063-1064.
76.
Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, Wang A, Whitlow PL, Gray WA, Grayburn
P, Mack MJ, Glower D. Improved Functional Status and Quality of Life in Prohibitive Surgical Risk
Patients With Degenerative Mitral Regurgitation Following Transcatheter Mitral Valve Repair with
the MitraClip® System. J Am Coll Cardiol. 2013 Oct 24. doi:pii: S0735-1097
D.
Research Papers(Non peer reviewed)
1.
Kar S, Grover A, Varma JS, Khattri HN, Bidwai PS: Permanent Pacing in Children Asia Pace News
1995; 10: 92
2.
Saibal Kar, Ted E. Feldman, Frederick St. Goar. Mitral Valve Repair Using the MitraClip: From
Concept to Reality. Cardiac Interventions Today. May/June 2008
Page 48 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
CHAPTERS
1.
Kar S, Litvack F: Excimer Laser Coronary Angioplasty in Practical Interventional Cardiology,2nd Ed
(Eds. Ever Grech and David Ramsdale)(Martin Dunitz, 2000)
2.
Saibal Kar, Prediman K Shah. Coronary Circulation. Colour Handbook of Ischemic Heart
Disease. 1st Ed(Editors. Erling Falk, Prediman K Shah) (in press)
3.
Saibal Kar, Prediman K Shah. Myocardium. Colour Handbook of Ischemic Heart Disease.
Ed(Editors: Erling Falk, Prediman K Shah)(in press)
4.
Ira Perry, Saibal Kar. Acute myocardial Infarction- complications Colour Handbook of Ischemic
Heart Disease. 1st Ed(Editors: Erling Falk, Prediman K Shah) (in press)
5.
Ira Perry, Saibal Kar. Acute myocardial Infarction- with normal coronary arteries Colour Handbook
of Ischemic Heart Disease. 1st Ed(Editors: Erling Falk, Prediman K Shah) (in press)
6.
Saibal Kar, Prediman K Shah. Impact of new percutaneous techniques of aortic valve replacement
on cardiology/CV surgery practice. Transcatheter valve repair. 1st Edition(Editors: Ted Feldman,
Ziyad Hijazi, (Martin Duntz 2005)
7.
Saibal Kar and Wen-Loong Yeow. “Chapter 14: Procedural tips and tricks”. Percutaneous Mitral
Leaflet Repair: MitraClip Therapy for Mitral Regurgitation. T. Feldman and F. St Goar, Eds. Informa
Healthcare, 2012, pp 102-109
8.
Mamoo Nakamura and Saibal Kar. “Transcatheter Occlusion of the Left Atrial Appendage”.
Congenital and Structural Heart Disease, An Issue of Interventional Cardiology Clinics (The Clinics:
Internal Medicine). K. Damien and ZM. Hijazi. Eds. Elsevier Health Sciences, 2013, pp 225-234.
LETTERS TO THE EDITOR
Reviews
1.
2.
Kar Saibal, Kar CC: Mitral valve Prolapse Syndrome. Ind Heart J 1989 Sept; 41(5): 278-9
Kar CC, Kar Saibal: Hypertrophic Cardiomyopathy - An Overview.
Ind Heart J 1988 March: 40(2): 72-5
ABSTRACTS
1.
Kar CC, Maity AK, Ganguly K, Todi S, Kar S: Profile of aortoarteritis in Eastern India.
World Congress of Cardiology, Sept 14-19, 1986, Washington D.C, USA.
2.
Kar CC, Maity AK, Choudhury D, Chatterjee SS, Kar S: Studies on Carotid Sinus
Hypersensitivity. The 9th Asian Pacific Congress of Cardiology, Feb 11-15, 1987,
Term Follow Up and Complications. Auckland, New Zealand.
3.
Maity AK, Kar S, Chatterjee SS, Choudhury D, Kar CC, Das MK: Carotid Sinus
Hypersensitivity: An increasing indication for Pacing. Asian Pacific Congress of Cardiac
Pacing, Aug 1989, Singapore
Page 49 of 65
Curriculum Vitae
4.
Saibal Kar, M.D, FAHA, FACC, FSCAI
Maity AK, Das MK, Chatterjee SS, Guha S, Kar S, Kar CC: Pacing in India today, Asian
Pacific Congress of Cardiac Pacing, August 1989, Singapore
5.
Kar CC, Maity AK, Chatterjee SS, Guha S, Kar S, Das MK: Pacemaker malfunction. Asian Pacific
Congress of Cardiac Pacing, August 1989, Singapore
6.
Kar S, Sharma BK, Gupta A, Sagar S: Ocular Changes in nonspecific aortoarteritis.
10th Asian Pacific Congress of Cardiology, October 1991, Seoul, Korea
7.
Kar S, Gupta A, Sharma BK, Sagar S: Ocular changes in Takayasu's Disease.
Golden Jubilee Conference of the All India Ophthalmological Society, Feb 2-6,1992,
New Delhi, INDIA
8.
Kar S, Maity AK, Kar CC: Carotid Sinus Hypersensitivity (CSH) an Important cause of Syncope and
Indication of Pacing in Elderly. 5th Asian Pacific Symposium on Cardiac Pacing and
ectrophysiology, August 1-4, 1993, Tokyo, Japan
9.
Kar S, Grover A, Varma JS, Khattria HN, Bidwai PS: Permane nt Pacing in Children: Long-Term
Follow Up and Complications. Ind Heart J 1993; Abstract Issue Abst No 111
10.
Dwivedi S, Varma JS, Khattri HN, Grover A, Kar S, Rao M, Sapru RP: Balloon Pulmonary
Valvotomy in Patients of Valvular Pulmonary Stenosis with Right Heart Failure. Ind Heart J 1993;
Abstract Issue Abst No 247
11.
Kapardy PLN, Bagrahtta R, Khattri HN, Kar S, Grover A, Varma JS, Rao M, Sapru RP: Coronary
Arteriographic Lesions in TMT Induced LV Dysfunction.
Ind Heart J 1993; Abstract Issue Abst No 284
12.
Kar S, Manolas E, Kumar P, Dick R, Lim Y, Rowe M: Direct coronary angioplasty for Acute
Myocardial Infarction. Australia and New Zealand J of Medicine 1996; 27 (1): 101
13.
Kar S, Manolas E, Kumar P, Dick R, Lim Y, Rowe M: Primary coronary angioplasty in Acute
Myocardial Infarction. Ind Heart J; 48(5): 537
14.
Kumar P, Kar S, Dick R, Manolas E, Rowe, Buxton B, Lim Y: Bailout surgery for failed PTCA.
Ind Heart J 1996; 48(5): 486
15.
Bhagaretta R, Kar S, Rowe M, Manolas E, Lim Y et al : Use of Abciximab(ReoproTM) in High-Risk
Angioplasty(PTCA): Initial In –hospital Experience. Ind Heart J 1996; 48(5): 514
16.
Kar S, Siegel R, , Eigler N, Robinson A, Goff B, Makkar R.
Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive
Cardiomyopathy (HOCM) using Myocardial Contrast Echocardiography (MCE). An Initial
experience: Early and Mid term results. Australian & New Zealand J of Med 1999;27:101(/Abstract)
17.
Takizawa K, Hausleiter J, Finkelstein A, Kar S, Eigler N, Makkar R: Cilostazol inhibits stent
thrombosis after oversized stenting in a porcine model. Am J Cardiol 2000;86(Suppl 8A) 120i
Page 50 of 65
Curriculum Vitae
18.
Saibal Kar, M.D, FAHA, FACC, FSCAI
Aboul-Enein FA, Kar S, Hayes S, Makkar R, Lewin HC, Friedman J, Berman D:
Influence of Angiographic Collaterals on Myocardial Perfusion in Patients With Chronic Total
Occlusion of a Single Coronary Artery and No History of Myocardial Infarction.
J Am Coll Cardiol 2001;37(Suppl A):1A-648A.
19.
S. Kar, R.J. Siegel, J. Bergman, H.G. Voorman, H. Luo, A. Robinson, K. Varghese, N.Eigler,
R. Makkar, Percutaneous transluminal septal myocardial ablation in hypertrophic Obstructive
cardimyopathy (hocm) using myocardial contrast Echocardiography (MCE): a single-center
experience. The J of Heart Dis 2 001;2 (Abstract issue): Abstr No 264.
20.
H Honda, S Kar, T Honda, K Takizawa, T Meguro, M Fishbein, R Makkar, N Eigler, F Litvack.
Everolimus Eluting Stents significantly inhibit neointimal hyperplasia in experimental pig coronary
model. Am J Cardiol 2002; 90(Suppl 6A): 73H
21.
T Honda, S. Kar, H. Honda, K. Takizawa, D. McClean, M. C. Fishbein, N. Eigler, F. Litvack.
Stent-Based Delivery of Everolimus Leads to Complete Vessel Wall Healing without Toxicity in a 90
Day Porcine Model. Am J Cardiol 2002; 90(Suppl 6A): 80H
22.
M J. Price , S Kar , D McClean , A. C. De Lara-Llarena, R Makkar.
Sixty-Minute Balloon Inflation Occlusion of the Left Anterior Deescending Artery: results in a
Predictable Porcine Model of Left Ventricular Dysfunction After Acute Myocardial Infarction.
Am J Cardiol 2002; 90(Suppl 6A): 187H
23.
D McClean, A Finkelstein, S Kar, K Takizawa, T Honda, N Baek, K Park, M C Fishbein, R Makkar,
F Litvack, N Eigler. Local Drug Delivery Using a Stent with Programmable Pharmacokinetics In
Vitro and in Porcine Coronary Arteries. Circ 2002; 106 (19):II-447.
24.
Makkar R, Price M, Lill M, Takizawa K, Frantzen M, Fishbein M, Kar S, Kleisli T, Zheng J,
Sharifi B, Qayyum M. Multilineage Differentiation of Transplanted Allogenic Mesenchymal Stem
Cells Injected in a Porcine Model of Recent Myocardial Infarction Improves Left Ventricular
Function. Circ 2002; 106 (19):II-34
25.
S Kar, T Honda, D McClean, M. C. Fishbein, H. Honda, K. Takizawa, N Eigler, F Litvack.Elution Of
Everolimus and Sirolimus From A Bio-Degradable Polymer Coated Stent Inhibits Neointimal
Hyperplasia Without Inflammation or Toxicity. J Am Coll Cardiol 2003;41(Suppl A): 6A
26.
Dougal McClean, Saibal Kar, Taku Honda, Michael C. Fishbein, Neal L. Eigler, Frank Litvack,
Cedars-Sinai Medical Center, Los Angeles, CA. Stent-Based Delivery of Programmable Erodable
Polymer Drug Release Systems are Nontoxic in Porcine Arteries.
J Am Coll Cardiol 2003;41(Suppl A): 57A
27.
S Zhou, Y Miyauchi, S Kangavari, M Miyauchi, S Kar, GM Suh, HS Karagueuzian, LS Chen,
P Chen: Increased Transcardiac Nerve Growth Factor Concentration During Acute Myocardial
Infarction in Dogs. PACE(Abstract)
28.
MJ Price, M Franzten, S Kar, D McClean, S Guo, PK Shah, M Lill, J Forrester, BJ Martin, R.Makkar,
Cedars Sinai Medical Center, Los Angeles, CA Usa Intravenous Mesenchymal Stem Cells
Page 51 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Attenuate Left Ventricular Remodeling In A Porcine Model Of Reperfused Acute Myocardial
Infarction. The J of Heart Disease (Abstract Issue)2003;3:2
29.
S. Kar, T. Naqvi, M. Price, J. Aragon, R. Makkar, N. Eigler. Use Of Intracardiac Echocardiography
For Guiding Device Closure Of Interatrial Communications.
The J of Heart Disease (Abstract Issue)2003;3:31
30.
S. Kar, D. McClean, J .Aragon, R. Makkar, F. Litvack, J. Whiting, N. Eigler.
Implantable Physiologic Optimized Dosimeter For Treating Advanced Congestive Heart Failure.
The J of Heart Disease (Abstract Issue)2003;3:45
31.
S.Kar, D.McClean, J.Aragon, R.Makkar, F.Litvack, J.Whiting, N. Eigler. Cedars Sinai Medical
Center. Implantable Left Atrial Physiologic Optimized Dosimeter for Treating Advanced Congestive
Heart Failure. Am J Cardiol 2003;92(Suppl A): 199L
32.
S Kar, MD, M Price MD, D. Mcclean MD, T. Naqvi MD, J. Aragon MD, H. Kotler RN, R. Makkar MD,
N. Eigler . The Use of Intracardiac Echocardiography in help guiding Closure of Interatrial
Communications. Am J Cardiol 2003;92(Suppl A):13L
33.
R Virmani, R.Jones, S. Kar, T. Honda, D. McClean, M. Fishbein, N. Eigler, J. Royal, L Coleman,
G. Cipolla. Everolimus and Sirolimus Drug-Eluting Stents Are Equally Effective at Reducing
Neointimal Proliferation in a 28-Day Porcine Coronary Model.
Am J Cardiol 2003;92(Suppl A): 178L
34.
Saibal Kar, Joseph Aragon, Dougal McClean, Aamer Jamali, James Whiting, Frank Litvack,
Neal Eigler. Chronic Implantation of Left Atrial Pressure Monitor Accurately easures Left Atrial
Pressure in Porcine Model. J Am Coll Cardiol 2004;43(Suppl A):208A
35.
Saibal Kar, Joseph Aragon, Alexander Paresky, Fermin Tio, John Shulze, Ronald Betts, Neal
Eigler, Frank Litvack. Biolimus A9: A New Generation Rapamycin Analogue Inhibits Intimal
Hyperplasia in a Porcine Model. J Am Coll Cardiol 2004;43(Suppl A):84A
36.
Joseph Aragon, Saibal Kar, Alexander Paresky, Colin Watanabe, Amar Jamali, Frank Litvack,
Neal Eigler. Optimization of Pharmacokinetic Vectors with a Programmable Paclitaxel Eluting
Stent. J Am Coll Cardiol 2004;43(Suppl A):83A
37.
Colin Watanabe, Joseph Aragon, Saibal Kar, Frank Litvack, Neal Eigler. Drug Eluting Stent with
Multidimensional Programmable Kinetics. J Am Coll Cardiol 2004;43(Suppl A):83A
38.
Richard E. Sinaiko, Mikele M. Bunce, Sepideh Farivar, Saibal Kar, Neal Eigler,
Emma C. Wollschlager. Drug Eluting Stent Use May Negatively Impact the Economic Growth of a
Hospital. A Single Center Case Study. J Am Coll Cardiol 2004;43(Suppl A):402A
39.
Matthew J. Price, Chung-Chuan Chou, Malka Frantzen, Takashi Miyamoto, Saibal Kar,
Dougal McClean, Suzhen Guo, Steve Lee, Prediman K. Shah, Bradley J. Martin, Michael Lill,
James S. Forrester, Peng-Sheng Chen, Raj R. Makkar. Intravenous Mesenchymal Stem Cell
Therapy Early After Reperfused Acute Myocardial Infarction Improves Left Ventricular Function
and Alters Ventricular Electrophysiological Properties. J Am Coll Cardiol 2004;43(Suppl A):63A
Page 52 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
40.
Shinjo Sonoda, Eberhard Grube, Yoshihisa Shimada, Ali H. M. Hassan, Yasuhiro Honda,
Charles Chan, Hidehiko Honda, Saibal Kar, Alexandra J. Lansky, Peter J. Fitzgerald. An
Intravascular Ultrasound Analysis From FUTURE I, the First Human Experience Using
Everolimus-Eluting Stents: Six- and Twelve-Month Results.
J Am Coll Cardiol 2004;43(Suppl A):85A
41.
Shinjo Sonoda, Eberhard Grube, Yoshihisa Shimada, Ali H. M. Hassan, Yasuhiro Honda,
Charles Chan, Hidehiko Honda, Saibal Kar, Alexandra J. Lansky, Peter J. Fitzgerald.
Effect of Everolimus-Eluting stents in preventing neointimal hyperplasia: An Intravascular
Ultrasound Analysis from the FUTURE II Trial. J Am Coll Cardiol 2004;43(Suppl A):66A.
42.
Sergio L. Kobal, Luca Trento, Simin Baharami, Kirsten Tolstrup, Tasneem Z. Naqvi,
Bojan Cercek, Yoram Neuman, James Mirocha, Saibal Kar, James S. Forrester, Robert J. Siegel.
J Am Coll Cardiol 2004;43(Suppl A):309A(abstract No. 1016-152)
43.
Aamer H. Jamali, MD; Jason S. Bradfield, MD; Robert Goldberg, MD; Rajendra Makkar,
Saibal Kar, MD. Drug Eluting Stent Use Is Associated With Increased Bare Metal Stent
Use—Implications for Cost Effectiveness Analysis.
Catheter Cardiovasc Interv 04;62:125 (abstract No D-3).
44.
Simon Kangavari, Shengmei Zhou, Su-Chao Ding, Saibal Kar, C. Thomas Peter, Walter F. Kerwin,
Charles D. Swerdlow, Eli Gang, Donna Gallik, Jeffrey S. Goodman, Yii-Der Ida Chen,
Peng-Sheng Chen. Radiofrequency Catheter Ablation of Supraventricular Arrhythmias Increases
Aortic and Cardiac Nerve Growth Factor Concentration in Humans. PACE 2004 (Abstract issue)
45.
S Kar, A Jamali, J Aragon, D McClean, F Litvack, B Mann, J Whiting, N. Eigler.
Chronic Left Atrial Pressure Monitoring in Pigs with HeartPOD™ Heart Failure Therapy System.
46.
S Kar, A Jamali, J Aragon, F Tio, M Fishbein, F Litvack, B Mann, J Whiting, N. Eigler. Implantable
HeartPOD™ System Allows Chronic Noninvasive Chronic Left Atrial Pressure Monitoring in a
Porcine Model. Accepted PICCS meeting September 2004
47.
Saibal Kar, Joseph Aragon, Fermin Tio, Ronald Betts, John Shulze, Sarah Reiver,
Douglas Savage, Gordon Grant, Eitan Kimchi, Neal Eigler, Frank Litvack. Biolimus A9: A New
Rapamycin Derivative Developed For Stent Applications Inhibits Intimal Proliferation In A Porcine
Model. Am J Cardiol 2004;94(Suppl A): 151E.
48.
Joseph Aragon, Dougal McClean, Saibal Kar, Aamer Jamali, Jon Bergman, James Whiting,
Frank Litvack, Neal L. Eigler Equilibration of Airway Pressure and Pulmonary Capillary Wedge
Pressure with Valsalva’s Maneuver During Right Heart Catheterization in Patients with
Congestive Heart Failure. Accepted Heart Failure Society of America Meeting 2004
49.
Joseph Aragon, Saibal Kar, Fermin Tio, Colin Watanabe, Aamer Jamali, Frank Litvack and
Neal Eigler. Evaluation of Overlapped Cobalt Chromium Paclitaxel Eluting Stents with
Programmable Release Kinetics. Am J Cardiol 2004;94(Suppl A); 28E
50.
Joseph Aragon, Saibal Kar, Fermin Tio, Brett Trauthen Colin Watanabe, Aamer Jamali,
Frank Litvack and Neal Eigler. Pre-clinical Analysis of PISCES Formulations: Histologic Results of
Page 53 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
a Paclitaxel Eluting Stent with Programmable Release Kinetics.
Am J Cardiol 2004;94(Suppl A): 28E
51.
S Lee, E Daniels, T.Z. Naqvi, P.K. Shah, A. Shah, S.Kar, J.K.Frazer, R.W. Maclellan,
M.Zhu, M.H. Hedrick, R. Makkar. Intracoronary Adipose Tissue-Derived Stem Cell Therapy
Preserves Left Ventricular Function in a Porcine Model. Am J Cardiol 2004;94(Suppl A): 188E.
52.
Saibal Kar, Taku Honda, Dougal McClean, Kaname Takizawa, Joseph Aragon,
Hidehiko Honda, Cedars Sinai Medical Center, Los Angeles, CA; Michael Fishbein, Litvack Frank,
Neal Eigler Everolimus And Sirolimus Are Identical At Preventing Intimal Thickening Over The
Range Of Vascular Injury. Circulation 2004; 110(Suppl III): III-380.
53.
S Kar, A Jamali, J Aragon, F Tio, M Fishbein, F Litvack, B Mann, J Whiting, N. Eigler.
Implantable HeartPOD™ System Allows Chronic Noninvasive Chronic Left Atrial Pressure
Monitoring in a Porcine Model. Accepted in Pediatric Interventional Cardiac Symposium, 2004.
54.
Saibal Kar, Simon Kangavari, Shengmei Zhou, Hongmei Li, Su-Chao Ding, C.Yii-Der Ida Chen,
Lan S. Chen, Peng-Sheng Chen. Elevation of Aortic and Coronary Artery Nerve Growth Factor
following Acute Myocardial Infarction in Humans. J Am Coll Cardiol 2005; 45(Supplement A):94A
56.
Joseph Aragon, Ryan Berg, Michael Lee, Eitan Kimchi, Kelley Davis, Honore Kotler, Raj Makkar,
Tasneem Naqvi, Robert Siegel, Saibal Kar. Neurological Outcomes Following Percutatneous
Closure of Inter-Atrial Communications. Catheterization and Cardiovascular Interventions
2005;65(1):93-94.
57.
Joseph Aragon, Michael Lee, Saibal Kar, Neal Eigler, Raj Makkar. High Risk Coronary
Intervention Using the Tandem Heart Percuataneous Left Ventricular Assist Device.
Catheterization and Cardiovascular Interventions 2005;65(1):113
58.
Michael Lee, Atman Shah, Joseph Aragon, Suhail Dohad, Saibal Kar, Raj Makkar.
Intermediate Outcomes in Patients Undergoing Multivessel Percuatneous Coronary Intervention
with Drug-Eluting Stents. Catheterization and Cardiovascular Interventions 2005; 65(1): 118.
59.
Joseph Aragon, Saibal Kar, Ryan Berg, Eitian Kimchi, Alexander Parisky, Samantha Chaikin,
Colin Watanabe, Aamer Jamali, Fermin Tio, Frank Litvack, Neal Eigler. Thin Walled Cobalt
Chromium Paclitaxwl Eluting Stents Have No Restenosis Advangtage Over Stainless Steel
Paclitaxel Eluitng Stents In A Porcine Model.Catheterization and Cardiovascular Interventions
2005;65(1):129.
60.
Saibal Kar, Aamer Jamli, Joseph Aragon, Fermin Tio, Michael Fishbein, Frank Litvack,
Brian Mann, James Whiting, Neal Eigler. Successful Direct Left ATrial Pressure Monitoring Via An
Implantable Heartpod Device In Animal Models: A Potential Adjunct to Rhythm Management For
Heart Failure Patients. Catheterization and Cardiovascular Interventions 2005; 65(1):130.
61.
Lee MS, Shah AP, Jamali A, Kar S, Dohad S, Aragon J, Makkar RR. Drug-eluting stenting is
superior to bare-metal stenting in saphenous vein grafts (abstract). TCT Asia Pacific 2005.
Am J Cardiol 2005;95(Suppl A):3A.
Page 54 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
62.
Lee MS, Shah AP, Friedman J, Dang N, Bobo D, Fariabi S, Kar S, Aragon J, Caraang C,
Berman D, Makkar RR. Characterization of the coronary venous system with contrast-enhanced
electron beam computed tomography (abstract). TCT Asia Pacific 2005.
Am J Cardiol 2005;95(Suppl A): 18A.
63.
Lee MS, Shah AP, Friedman J, Dang N, Bobo D, Fariabi S, Kar S, Aragon J, Caraang C,
Berman D, Makkar RR. Contrast-Enhanced Electron Beam Computed Tomography Provides
Detailed Characterization of the Coronary Venous System (abstract). Catheterization and
Cardiovascular Interventions 2005; 65(1)
64.
Saibal Kar, Ryan Berg, Gordon Grant, Vladimir Royter, Joseph Aragon, John Shulze,Ronald Betts,
Michael C Fishbein. Safety of Biolimus A9 Delivered from a Bioresorbable Polymer Coated Stent
in a 90 Day Porcine Model. Am J Cardiol 2005;96(Suppl 7A):212H
65.
Joseph Aragon, Ryan Berg, Saibal Kar, Vladimir Royter, Renu Vermani, Neil Eigler, Frank Litvack.
Pimecrolimus Eluting Cobalt Chromium Stent Decreases Inflammation and Neointimal Proliferation
in a Porcine Model. Am J Cardiol 2005;96(Suppl 7A):23H
66.
Joseph Aragon, Ryan Berg, Saibal Kar, Vladimir Royter, Renu Vermani, Neil Eigler, Frank Litvack
A Pimecrolimus and Paclitaxel Dual Drug-Eluting Stent: A Synergistic Response From Drugs With
Different Mechanisms and Different Release Kinetics From the COSTAR Stent Platform.
Am J Cardiol 2005; 96(Suppl 7A):8H
67.
Michael S Lee, Nikil Kapoor, Faizi Jamal, Lawrence Czer, Joseph Aragon, James Forrester,
Saibal Kar, Sohail Dohad, Robert Kass, Neal Eigler, Alfredo Trento, Prediman K Shah,
Raj Makkar. Comparison of coronary artery bypass surgery with percutaneous coronary
intervention with drug eluting stents for unprotected left main coronary artery disease.
Am J Cardiol 2005;96(Suppl 7A):201H
68.
David Smyth, Jay LT Ritzema-Carter, Richard W Troughton, Iain C Melton, Ian Crozier,
Saibal Kar, James Whiting, Neal Eigler. Dynamic Myocardial Ischemia Secondary to Left
Circumflex Artery Stenosis Documented by a Novel Permanent Implantable Left Atrial Pressure
Sensing Device. Am J Cardiol 2005;96(Suppl 7A): 192H
70.
Saibal Kar, Aamer Jamali, Roderick Tung, Jeffrey Levisman, Fermin Tio, Michael C Fishbein,
James Whiting, Neal Eigler. Successful Direct Left Atrial Pressure Monitoring And Fossal Pacing
Via Implantable HEARTPOD Device In Animal Models. J Am Coll Cardiol 2006;47(Suppl A): 78A.
71.
Jay L Ritzema-Carter, Iain C Melton, Ian G Crozier, Saibal Kar, Neal Eigler, James Whiting,
Henry Krum, William T Abraham, Richard W Troughton. First Human Experience With A New Left
Atrial Pressure Monitoring Device: Validation With Simultaneous Pulmonary Artery Occlusion
Pressure In Subjects With Heart Failure. J Am Coll Cardiol 2006;47(Suppl A): 78A
72.
Saibal Kar, Aamer Jamali, Werner Haffelfinger, Brian Mann, James Whiting, Neal Eigler. A New
Flexible Transeptal Catheter System Allows Access Into The Left Atrium From The Femoral Or
Jugular Venous Approach. 55th ACC I2(Abstract)
Page 55 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
73.
Kupferwasser LI, Amorn AM, Lee MS, Kar S, Cercek B, Dohad S, Kapoor N, Makkar R.
Comparison of sirolimus- and paclitaxel-eluting versus bare metal stenting in an unselected patient
population with acute myocardial infarction. 55th Annual Scientific Session of the American
College of Cardiology, Atlanta, 2006, abstract 2912-77
74.
Saibal Kar, Vladimir Royter, Gordon Grant, John Shulze, Douglas Savage, Michael C Fishbein.
Non Polymer Elution Of Biolimus From A Stent Inhibits Intimal Hyperplasia in A Porcine Model.
J Am Coll Cardiol 2007;49(9)Suppl B: 28B.
75.
Melissa Slivka, Bina Ahmed, Ryan Berg, Donna M. Polk, Saibal Kar, Maura Paul-Labrador,
Raj Makkar, Leslee J. Shaw, Margo B. Minissian, Noel Bairey Merz Myocardial Ischemia and Open
Coronary Arteries in Women: Etiological Mechanisms. J Am Coll Cardiol 2007; 49(9)Suppl A
78.
James Hermiller, Saibal Kar, Michael Rinaldi, Howard Herrmann, Peter Fail, Patrick L Whitlow,
Eric Horlick, Elyse Foster, Don Glower, Ted Feldman on behalf of the EVEREST Investigators.
Percutaneous Mitral Repair with the MitraClip™ Device for Functional Mitral Regurgitation: Acute
Success and 12-Month Durability. Am J of Cardiol 2007; Suppl 8A:216L(TCT -559)
79.
Michael Rinaldi, Saibal Kar, James Hermiller, Richard W Smalling, Bill Gray, John Carroll,
Andrew Wang, Elyse Foster, Don Glower, Ted Feldman. Significant Reverse Remodeling of the
Left Ventricle One Year After Percutaneous Mitral Repair with the MitraClip™ Device.
Am J of Cardiol 2007;100 Suppl 8A: 57L (TCT -123)
80.
Anthony J White, Gautam Kedia, James Mirocha, Michael S Lee, Gregory Fontana, Alfredo Trento,
Saibal Kar, Suhail Dohad, Prediman K Shah, Raj Makkar. Comparison of Coronary Artery Bypass
Surgery and Percutaneous Drug-eluting Stent Implantation for Treatment of Left Main Coronary
Artery Stenosis: Analysis by Propensity Score Adjustment and by Surgical Risk.
Am J of Cardiol 2007;100 Suppl 8A: 97L (TCT -233)
81.
Blasé A Carabello, Saibal Kar, Michael Rinaldi, James Hermiller, Vishwajeth Bhoopalam,
Azam Anwar, Tanvir Bajwa, Mike O’Donnell, Don Glowere, Ted Feldman. Significant Reverse
Remodeling of the Left Ventricle One Year After Percutaneous Mitral Valve Repair with the
MitraClip Device in Patients with Pre-existing Systolic LV function.
Circulation 2007; Suppl II Vol 116: II-357 (abstract No. 1698)
82.
Shufelt CL, Kar S, Slivka M, Thomson L, Yang Y, Berman D, Polk D, Tolstrup K,
Bairey Merz CN. Cardiac magnetic resonance imaging and coronary reactivity testing:
A useful noninvasive tool. Poster, Tuesday April 1, 2008, 11-12 noon presentation, Hall A,
McCormick Place, Session #1031
83.
Polk D, Shufelt C, Yang Y, Kirschner J, Paul-Labrador M, Williams, Kar S, Tolstrup K,
Bairey Merz CN. Angina, open arteries and endothelial dysfunction in women With suspected
ischemia. Poster, Monday March 31, 2008, 10-11 am presentation, McCormick Place, South Hall
84.
Slivka M, Shufelt C, Yang Y, Thomson L, Kar S, Shaw L, Berman D, Ahmed B, Tolstrup K,
Page 56 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Bairey Merz CN. Is cardiac magnetic resonance imaging a useful tool in the diagnosis of women
with microvascular angina. Poster, Tuesday April 1, 2008, 11-12 noon presentation, Hall A,
McCormick Place, Session #1031
85.
James Hermiller, MD; Saibal Kar, MD; Peter Fail, MD; Tanvir Bajwa, MD; Richard Smalling, MD;
John Lasala, MD; Scott Lim, MD; Robert Kipperman, MD; Howard Herrmann, MD;
Patrick L Whitlow, MD; Elyse Foster, MD; Don Glower, MD; and Ted Feldman, MD.
Percutaneous Mitral Repair with the MitraClip® Device for Functional Mitral Regurgitation: Acute
Success and One-Year Durability in the Initial EVEREST Cohort. Accepted ACC March 2008.
Late Breaking clinical trials
86.
Howard C Hermann, Saibal Kar, Peter Flail, Jason Rogers, Andrew Wang, Andrew Berke,
Paul Kramer, S Chiu Wong, Scott Lim, Elyse Foster, Don Glower, Ted Feldman on behalf of the
EVEREST investigators. Stability of Mitral Valve Area and Gradient Following Percutaneous
Repair of Mitral Regurgitation with MitraClip Device.excc . J Am Coll Cardiol 2008;51(10)(Suppl B):
B79
87.
Hursh Naik, Robert Weiss, Tarun Chakravarty, Anthony J White, James Forrester, Saibal Kar, and
Raj Makkar Abstract 2522: A Meta-analysis Of 2587 Patients Treated With Percutaneous Coronary
Intervention Or Coronary Artery Bypass Grafting For Unprotected Left Main Coronary Artery
Stenosis. Circulation, Oct 2008; 118: S_737
88.
Norio Tada, MD; Gordon Grant; Alexander Black, MB,BS; Renu Virmani, MD; Saibal Kar,
MD Polymer-Free Biolimus A9 Eluting Stent Demonstrates More Sustained Intimal Inhibition,
Improved Healing and Reduced Inflammation in Comparison to a Polymer-Coated Sirolimus
Eluting Cypher Stent in a Porcine Model. J Am Coll Cardiol 2009; Abstract Issue
89.
Norio Tada, Gordon Grant, John Shulze, Renu Virmani, Saibal Kar. Short and Long Term
Evaluation of Polymer Free Biolimus A9 Eluting Stent Compared to Sirolimus Eluting Stent in
Porcine Model. 73rd Annual Meeting of Japanese Circulation Society; Osaka, March 2009 . Circ J
2009;73(Suppl. I):433
90.
Norio Tada, Saibal Kar. Twelve Months Following Percutaneous Mitral Valve Repair Using the
Edge-to-Edge Repair with the MitraClip TM Device. 73rd Annual Meeting of the Japanese
Circulation Society, Osaka, March 2009.(Circ J 2009:73(Suppl.I): 344 abstract)
91.
Janet Wei, Louise Thomson, Chrisandra Shufelt, YuChing Yang, Edward Gill, Margo Minissian,
Saibal Kar, Daniel Berman, C. Noel Bairey Merz.Diastolic Dysfunction by Cardiac Magnetic
Resonance Imaging in Women With Open Coronary Arteries and Microvascular Dysfunction.
Annual Meeting of the American College of Cardiology: March, 2009.
92.
Anita Phan, Supurna Chowdhury, Margo Minissian, Chrisandra Shufelt, Saibal Kar, Doris Taylor,
Vera Regitz-Zagrosek, Noel Bairey Merz, Eduardo Marban Circulating Endothelial Progenitor Cells
in Women with Microvascular Dysfunction. Arteriosclerosis, Thrombosis and Vascular Biology
Annual Conference 2009.
Page 57 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
93.
Saibal Kar, Patrick Whitlow, Wesley Pedersen, Scott Lim, Robert Kipperman, Richard Smalling,
Tanvir Bajwa, Howard Hermann, John Lazala, Paul Kramer, James T Maddux, Ted Feldman,
Don Glower, Blaise A Carabello, Elyse Foster. Successful Percutaneous MitraClip® Therapy
Results in Favorable Septo-Lateral Mitral Annular Diameter and Left Ventricular Remodeling in
High Risk Surgical Patients with Functional Mitral Regurgitation.
American J of Cardiol 2009: 104(Suppl 6A): 33D.
94.
Scott Lim, Blasé A Carabello, Saibal Kar, Allan Schwartz, Richard Smalling, Catalin Loghin,
Jason Rogers, Damon Kwon, David Warth, Paul Grayburn, Stam Lerakis, Steven Bailey,
Donald Glower, Ted Feldman, Elyse Foster. Significant Reverse Left Ventricular Remodelling One
Year After Successful MitraClip® Therapy. American J of Cardiol 2009: 104(Suppl 6A): 34D.
95.
Brett M Wertmann, Mamta H Buch, Raj Makkar, Nicola D’Attellis, Saibal Kar, Acute Hypoxemia
Secondary to Right-to-Left Shunting Across the Interatrial Septum Following Deployment of an LA
Appendage Closure Device. ACC i2 Summit 2010.
96.
Robert J Siegel, Gila Perk, Takahiro Shiota, Itzhak Kronzon, James Slater, Saibal Kar, Asma
Hussaini, Simon Biner. Catheter-Based, Percutaneous Mitral Valve Clipping-The Added Value of
Real-Time Transesophageal Echocardiography.
J Am Coll Cardiol 2010;55(issue 10, suppl 1)A64.E607
97.
Saibal Kar; Patrick Whitlow; Wes Pedersen; Scott Lim; Robert Kipperman; Richard
Smalling; Tanvir Bajwa; Howard Herrmann; John Lasala; Paul Kramer; James
Maddux; Ted Feldman; Don Glower; Blase Carabello; Elyse Foster, on behalf of the
EVEREST investigators Successful MitraClip® Therapy Results in Favorable
Septo-Lateral Mitral Annular Diameter and Left Ventricular Remodeling in High Risk
Surgical Patients with Functional Mitral Regurgitation.
Cath Cardiol Interventions 2010;75(suppl):S147
98.
Saibal Kar et al on behalf of EVEREST II trial. High Risk Registry EVEREST II
Trial:One year results. SCAI Meeting. San Diego, 2010.
99.
Ted Feldman, Laura Mauri, Saibal Kar, Michael Rinaldi, Peter Fail, James Hermiller, Richard
Smalling, William Gray, Andrew Wang, Howard Hermann, Jason Rogers, John Lasala, Tanvir
Bajwa, Paul Greyburn, Wesley Pedersen, Elyse Foster, Alfredo Trento, Donald Glower.
EVEREST II Randomized Clinical Trial: A Critical Assessment of the Safety Data in Patients
treated with the MitraClip.
J Am Coll Cardiol.2010;56(13)(Suppl B): Abstract No 99.
100. Scott Lim, Ted Feldman, Saibal Kar, Michael Rinaldi, Peter Fail, James Hermiller, Richard Smalling,
William Gray, Andrew Wang, Howard Hermann, Jason Rogers, John Lasala, Tanvir Bajwa, Paul
Greyburn, Wesley Pedersen, Brian Whisenant, Andrew Burke, Michael O’Donnell, Patrick Whitlow,
Robert Siegel, Alfredo Trento, Donald Glower, Elyse Foster on behalf of the EVEREST II
Investigators.
EVEREST II Randomized Clinical Trial: Significant Reverse Left Ventricular Remodelling One Year
Following MV Surgery and MitraClip Therapy.
J Am Coll Cardiol.2010;56(13)(Suppl B): Abstract No 101
101. James Hermiller, Saibal Kar, Michael Rinaldi, Scott Lim, Richard Smalling, William Gray, Andew
Page 58 of 65
Curriculum Vitae
.
Saibal Kar, M.D, FAHA, FACC, FSCAI
Wang, Howard Herrmann, Jason Rogers, John Lasala, Tanvir Bajwa, Paul Greyburn, Wesley
Pedersen, Brian Whisenant, Andrew Burke, Michael O’Donnell, Patrick Whitlow, Robert Siegel,
Alfredo Trento, Donald Glower, Ted Feldman, Elyse Foster.
EVEREST II Randomized Clinical Trial: Clinical Benefti by MR Grade in Patients One Year
following Successful MitraClip Therapy.
J Am Coll Cardiol.2010;56(13)(Suppl B): Abstract No 107.
102.
Mehran Khorsandi, Henry Bourang, Michael Shenoda, Sepehr Fariabi, Rajendra Makkar, Saibal
Kar. Coronary Bifurcation Lesions Treated with the Novel Advanced Bifurcation Systems TM
Dedicated Stent: Animal Experience.
J Am Coll Cardiol.2010;56(13)(Suppl B): Abstract No 134.
103.
Mehran Khorsandi, Alex Abizaid, Sameer Dani, Michael Shenoda, Henry Bourang, Ricardo Costa,
Saibal Kar, Rajendra Makkar. Coronary Bifurcation Lesions Treated with the Novel Advanced
Bifurcation-SystemTM Dedicated Stent: Preliminary Results of the Prospective Multicenter First in
Man Experience.
J Am Coll Cardiol.2010;56(13)(Suppl B): Abstract No 142.
104.
Saibal Kar, David Holmes, Shephal K Doshi, Petr Neuzil, Vivek Y Reddy. The Safety of
Percutaneous Left Atrial Appendage Closure in Stroke Prevention in Atrial Fibrillation Patients: Is
there Evidence for a Learning Curve.
J Am Coll Cardiol.2010;56(13)(Suppl B): Abstract No 472.
105.
106
TCT 2010
Saibal Kar on behalf of the EVEREST II investigators. MitraClip Therapy Demonstrates Continued
Clinical Benefit and Favorable Left Ventricular Remodeling at Two Years in High Risk Surgical
Patients with Significant Mitral Regurgitation: Analysis of the EVEREST II High Risk Registry. J Am
Coll Cardiol 2011;57(issue 14 suppl 1): E1308
106.
Saibal Kar, Mamta Buch, Brett Wertmann, Asma Hussaini, Rajendra Makkar, Robert Siegel. The
Safety and Efficacy of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial
Fibrillation Patients. The Experience of a Large Volume Single Center in the PROTECT AF study.
ACC Poster Session, New Orleans, April 5, 2011.
107.
David Holmes Jr, Saibal Kar, Shephal Doshi, Petr Neuzil, Vivek Reddy.The Safety of
Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation(AF)
Patients: Is there Evidence for a Learning Curve.
J Am Coll Cardiol 2011;57(use 14, Suppl 1): E1682.
108.
Mehran Khorsandi, Alex Abizaid, Sameer Dani, Sepher Fariabi, Henry Bourang, Ricardo Costa,
Saibal Kar, Raj Makkar. Advanced Bifurcation Systems™ Novel Modular Platform in Treatment of
Coronary Bifurcation Disease,Initial Resuls of the Multicenter, First-in-Human Feasibility Trial.
J Am Coll Cardiol 2011;57(issue 14, suppl 1):E1995.
107.
Saibal Kar, Michael Rinaldi, Scott Lim, Ted Feldman. EVEREST II Realism: A Continued Access
Study to Evaluate the Safety and Effectiveness of the MitraClip Device: Demographics and
Procedural Outcomes. Catheterization and Cardiovascular Interventions 2011;77:abstract E34
108.
Rinaldi M, Kar S, Lim S, Feldman T. EVEREST II Realism: A Continued Access Study ot Evaluate
the Safty and Effectiveness of the MitraClip Device: Analysis of a 6 MonthPatient Cohort.
Page 59 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Catheterization and Cardiovascular Interventions 2011;77:S134. SCAI 2011
109.
Ibebuogu U, Makkar R, Harrison D, Kwarteng C, Mirocha J, Hussaini A, Singh S, Dohad S, Cercek
B, Khorsandi M, Kar S. Comparison Between Transradial and Transfemoral Percutaneous
Coronary Intervention in Acute ST-elevation Myocardial Infarction. Catheterization and
Cardiovascular Interventions 2011;77:S27. Saibal Kar, Radial artery study. SCAI 2011.
110.
Khorsandi M, Abizaid A, Dani S, Bourang H, Costa R, Kar S, Makkar R. Advanced bifurcation
systems mother-daughter platform, a novel system in treatment of coronary bifurcation
lesions:preliminary results of the prospective, multicenter first-in-man experience.
Eurointerventions 2011;(Vol 7 Suppl M):M127
111.
Kar S, Holmes D, Doshi S, Neuzil P, Reddy V. The safety of percutaneous left atrial appendage
closure for stroke prevention in atrial fibrillation patients: is there evidence for a learning curve?
Eurointerventions 2011;(Vol 7, Suppl M): M231
112.
Kar S, Reddy V, Turi Z, Doshi S, Sieveret H, Buchbinder M, Holmes D. Left atrial appendage
closure and the Protect AF trial: results at 1500 patient-years of follow-up. Eurointerventions
2011;(Vol 7 Suppl M):M232.
113.
Mehran J Khorsandi, Alex Abizaid, Sameer Dani, Henry Bourang, Ricardo Costa, Saibal Kar, Raj
Makkar. Advanced Bifurcation Systems Mother-Daughter Platform in Treatment of Complex
Coronary Bifurcations: Prospective Mutlicenter First-in-Man Feasibility Experience.
J Am Coll Cardiol 2012; 59(Suppl A):A20 (abstract No 2524.
114.
Shahryar Chowdhury, Girish Shirali, Ziyad Hijazi, Saibal Kar, Raj Makkar, John Rhodes, Michael
Mullen, Qi-Ling Cao, Jodi Akin. Early Echocardiographic Changes after Percutaneous Implantation
of the Edwards SAPIEN Transcatheter Heart Valve in the Pulmonic Position.
J Am Coll Cardiol 2012;59(Suppl A);A197, abstract no 1136-134.
115,
Takeji Saito, Masaki Izumo, Yoko Fukuoka, Azusa Furugen, JUN TANAKA, Kenji Harada,
Swaminatha Gurudevan, Kirsten Tolstrup, Robert Siegel, Saibal Kar, Takahiro Shiota.
The Evaluation of Iatrogenic Atrial Septal Defect After Catheter-based Mitral Valve Clip
Repair:Two-and Three-dimensional Echocardiographic Study.
J Am Coll Cardiol 2012;59(Suppl A);A271(abstract no 1091-16
116.
R David Anderson, Puja Mehta, Janet Wei, Delia Johnson, John Petersen, Eileen Handberg,
Chrisandra Shufelt, Saibal Kar, Bruce Samuels, Babak Azarbal, Kamlesh Kowthawade, Sheryl
Kelsey, Barry Sharaf, Leslie Shaw, Carl Pepine, C Noel Bairey Merz.
J m Coll Cardiol 2012;59(Suppl A):A365( Abstract No 1200-138
117.
Saibal Kar, Shephal Doshi, David Holmes, Sven Mobius-Winkler, Vivek Reddy, Gerhard Schuler,
Peter Sick, Horst Sievert. Watchman Left Atrial Appendage Closure in atrial fibrillation
Patients 75 years or greater: a Sub-Analysis of the PROTECT AF Study.
J Am Coll Cardiol. 2012;60(17_S): B 26
118.
Anita Asgar, Paul Khairy, Raoul Bonan, Anique Ducharme, Saibal Kar. Safety and Efficacy of the
MitraClip For The Treatment of Patients With A Dilated Left Ventricle And Functional Mitral
Regurgitation.
J Am Coll Cardiol.2012;60(17_S): B27-B28
119.
Asma Hussaini, Wen Loong Yeow, Takashi Matsumoto, Mamoo Nakamura, Hassan Jlaihawi, Raj
Page 60 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Makkar, Saibal Kar. Large 22 to 24 Fr femoral vein hemostasis with a subcutaneous stitch or a
double Perclose closure is effective and safe.
J Am Coll Cardiol.2012;60(17_S): B 120
120.
D Scott Lim, Saibal Kar, Patrick Whitlow, Michael Argenziano, Alfredo Trento, Gorav Ailawadi,
Donald Glower, Ted Feldman.Effectiveness of Transcatheter Mitral Valve Repair in Degenerative
Mitral Regurgitation in High Surgical Risk Patients.
J Am Coll Cardiol.2012;60(17_S):B 229
121.
Takashi Matsumoto, Wen Loong Yeow, Asma Hussaini, Mamoo Nakamura, Moody Makar,
Swaminatha V. Gurudevan, Robert Siegel, Saibal Kar. Procedural success is improved with a 2nd
MitraClip placement without additional complications.
J Am Coll Cardiol.2012;60(17_S): B 231-B232
122.
Wen Loong Yeow, Mamoo Nakamura, Takashi Matsumoto, Hassan Jlaihawi, Asma Hussaini,
Moody Makar, Swaminath V. Gurudevan, Robert Siegel, Saibal Kar.The MitraClip Procedure For
Functional Mitral Regurgitation Results in A Significant Change In Procedural Hemodynamics.
J Am Coll Cardiol.2012;60(17_S): B 231-B232
123.
Jun Tanaka, Takashi Matsumoto, Wen Loong Yeoew, Kenji Harada, Javier Berdejo, Kentaro,
Shibayama, Kazumasa Harada, Saibal Kar, Takahiro Shiota. Evaluation of Mitral Valve Area after
MitraClip Procedure: A Real-Time 3D Transesophageal Echocardiographic Study. J Am Coll
Cardiol 2013;61(10 Suppl A):A217
124.
Puja Mehta, Tara Sedlak, Tanya Kenkre, B Delia Johnson, Chrisandra Shufelt, John Petersen,
Babak Azarbal, Bruce Samuels, R. Anderson, Leslee Shaw, Saibal Kar, Eileen Handberg, Sheryl
Kelsey, Carl Pepine, C. Noel Bairey Merz. Angina and Anti-anginal Therapy in Women with Signs,
and Symptoms of Ischemia and No Obstructive Coronary Artery Disease.J Am Coll Cardiol
2013;61(10 Suppl A):A366 Abstract No 1115-98
125.
Takashi Matsumoto, Wen-Loong Yeow, Asma Hussaini, Mane Arabyan, Amin Manuchehry,
Mamoo Nakamura, Moody Makar, Swaminatha Gurudevan, Takahiro Shiota, Alfredo Trento,
Saibal Kar. Preoperative Pulmonary Hypertension Has an Adverse Effect in Patients with
Functional Mitral Regurgitation Undergoing the MitraClip Procedure. J Am Coll Cardiol 2013;61(10
Suppl A):A473; Abstract No 2114-248B
126.
Mane Arabyan, Wen-Loong Yeow, Takashi Matsumoto, Asma Hussaini, Takahiro Shiota,
Swaminatha Gurudevan, Vinny Ram, Rehan Kanji, Alfredo Trento, Saibal Kar. High Mortality in
Screened Patients with Functional Mitral Regurgitation Awaiting MitraClip Procedure.J Am Coll
Cardiol 2013;61(10 Suppl A):A481. Abstract No 1111-77
127.
Wen-Loong Yeow, Takashi Matsumoto, Robert Siegel, Asma Hussaini, Mamoo Nakamura, Moody
Makar, Amin Manuchehry, Rehan Kanji, Alfredo Trento, Saibal Kar. Acute Changes in Cardiac
Output following MitraClip Procedure Are a Powerful Predictor of Clinical Outcomes. J Am Coll
Cardiol 2013;61(10 Suppl A):A481. Abstract No 1111-78
128.
Scott Lim, Saibal Kar, Peter Fail, Brian Whisenant, William Gray, Tanvir Bajwa, Michael Rinaldi,
Robert Kipperman, John Williams, Richard Smalling, James Hermiller, Paul Grayburn, Gorav
Allawadi, Neil Weissman, Elyse Foster, Donald Glower, Ted Felman. The EVEREST II High
Surgical Risk Cohort: Effectiveness of Transcatheter Reduction of Significant Mitral Regurgitation
in High Surgical Risk Patients. J Am Coll Cardiol 2013;61(10 Suppl A):A489. Abstract No. 922-5
129.
Saibal Kar, D Lim, Richard Smalling, Brian Whisenant, Chidambaram Rammohan, Peter Fail,
Michael Rinaldi, James Hermiller, Howard Herrmann, Robert Kipperman, John Williams, Carlos
Ruiz, William Gray, James Slater, Neil Weisman, Elyse Foster, Ted Feldman.J Am Coll Cardiol
2013;61(10 Suppl A):A489. Abstract No.922-6
Page 61 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
127.
Kar S, Hou D, Russ J, Werner D, Swanson L, Tischler B, Huibregtse B, Virmani R.Biology
response following watchman and Amplatzer cardiac plug implantation in a canine let
atrialappendage model. EuroPCR2013, Paris, May 24, 2013.
128.
Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Kar S, Halperin J, Whisenant B,
Swarup V, Holmes D. Long Term Results of PROTECT AF:The Mortality Effects of Left Atrial
Appendage Closure versus Warfarin For Stroke Prophylaxis in AF. Heart Rhythm Society Meeting,
Denver, Colorado, US, May 9, 2013
129
Saibal Kar, MD, Shephal Doshi, Vijay Swarup, Kenneth Tucker, Brian Whisenant, Rodney Horton,
Vivek Reddy, Maurice Buchbinder, Horst Sievert, David Holmes. Long Term Efficacy
of Left Atrial Appendage Closure with WATCHMAN® Device. European Society of Cardiology,
Amsterdam, Sept 1, 2013
130.
Alfredo Trento, Wen Loong Yeow, Takashi Matsumoto, Asma Hussaini, Swaminatha V.
Gurudevan,Takahiro Shiota, Saibal Kar. Outcomes of surgery are preserved following the MitraClip
Procedure. Transcatheter Therapeutics, San Francisco, October 29, 2013. J Am Coll Cardiol.
2013;62(18_S):B28-B29.
131.
Saibal Kar, Shephal Doshi, Vjendra Swarup, K. Tucker, Brian Whisenant, Rodney Horton, Vivek
Reddy, Maurice Buchbinder, David Holmes Jr. Long Term Event Rates of Left Atrial Appendage
Closure with WATCHMAN Device Stratified by CHADS2 Score. Transcatheter Therapeutics, Sanf
Francisco, Oct 2013. J Am Coll Cardiol 2013;62(18_S):B31
132
Wen Loong Yeow, Takashi Matsumoto, Asma Hussaini, Robert Siegel, Pooja Khanolkar, Alfredo
Trento, Swaminatha V. Gurudevan, Moody Makar, Saibal Kar. Tethering Area is an Important
Predictor of Recurrent Mitral Regurgitation Following the MitraClip Procedure. Transcatheter
Therapeutics, San Francisco, October 2013. J Am Coll Cardiol. 2013;62(18_S):B215
133.
Takashi Matsumoto, Jun Tanaka, Wen Loong Yeow, Asma Hussaini, Mamoo Nakamura, Moody
Makar, Alfredo Trento, Takahiro Shiota, Saibal Kar. Three-dimensional color Doppler
transesophageal echocardiography is helpful in determining the number of MitraClip devices.
Transcatheter Therapeutics, San Francisco, Oct 2013. J Am Coll Cardiol 2013;62(18_1):B214
134.
Saibal Kar, Scott Lim, Vivek Rajagopal, Tanvir Bajwa, Ramon Quesada, John Carroll, Elyse Foster,
Neil Weissman, Alfredo Trento, Michael Mack, Donald Glower, Ted Feldman. Percutaneous
Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II
Randomized, Continued Access, and High Risk Clinical Programs. Transcatheter Therapeutics,
San Francisco, Oct 2013. J Am Coll Cardiol 2013;62(18_S):B29.
135.
Michael Rinaldi, Saibal Kar, D. Scott Lim, James Hermiller Jr, Richard Smalling, James Slater,
Elyse Foster, Ted Feldman. Percutaneous Reduction of Severe Mitral Regurgitation in Elderly High
Surgical Risk Patients. J Am Coll Cardiol 2013;62(18_S):B30.
136.
Dongming Hou, Saibal Kar, Russell M. Jones, Dennis Werner, Lynne Swanson, Brian Tischler,
Barbara A. Huibregtse, Renu Virmani. Anatomical Effect on Left Atrial After Transcatheter Left
Atrial Appendage Devices: Watchman and Amplatzer Cardiac Plug in a Canine Model. J Am Coll
Cardiol 2013;62(18_S):B242.
OTHER ACTIVITIES
Performed Interventional procedures on children
In Ciudad Obregon, Mexico as a part of charity.
April 2-4, 2005
Page 62 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
The devices were donated by AGA Co. The other sponsors were Liga’s Children Heart Program
And Rotary Club.( I went as a team of 3 doctors, Myself, Dr Siegel, and Dr Watanabe,) Our work was
mentioned in the local media, and we are trying to make this mission and annual event
Performed Interventional procedures on children
December 9-11, 2005
In Ciudad Obregon, Mexico as a part of charity.
The devices were donated by AGA Co.
The other sponsors were Liga’s Children Heart Program
And Rotary Club.( I went as a team of 3 doctors, Myself, Dr Siegel, and Dr Wong, and Dr Ryan Berg,) Our
work was mentioned in the local media, and we are trying to make this mission and annual event
Performed Interventional procedures on 4 children
December 9-11, 2006
In Ciudad Obregon, Mexico as a part of charity.
The devices were donated by AGA Co. The other sponsors were Liga’s Children Heart Program
And Rotary Club.( I went as a team of 3 doctors, Myself, Dr Siegel, and Dr Fernando Mendoza, Dr ). This is
an inspiring experience. We also taught the physicians to do the procedures.
Faculty Controversies in the Treatment of Cardiovascular Disease, October 6th to 7th, 2005. Los Angeles,
CA
PROCTORSHIP
1.
Savacor/St Jude Medical
Dr Iain Melton, Christchurch Hospital, March 2005, May 2006
Dr Stewart, Greenlane Hospital, Auckland, New Zealand, November 2005, May 2006
Dr Anthony Walton, Alfred Hospital, July 15, 2005, November 2005, May 2006
Dr Charles Love, Dept of Cardiology, OSU, Columbus, Ohio, November 7, 2005
Dr Paul Terstein, and Dr Johnson, Scripps Green Hospital, San Diego, CA
2.
NMT Medical
Dr Paul Ho, Kaiser Hospital, Honolulu, Hawaii, Sept 2005
Dr. Richard Heuser, Phoenix, Arizona
Dr. Sanjiv Goyal, Las Robles Hospital, Thousand Oaks, CA
Dr Vishwa Dev, Las Robles Hospital, Thousand Oaks, CA
Dr Neal Klein, Phoenix, Arizona
Dr Joseph Ruggio
Dr John Badado, Sunrise Hospital, Las Vegas, Nevada
Dr Steve Bailey, San Antonio Hospital, Texas
Dr Geoffrey Kuntz, Alberquque, New Mexico.
Dr Marko Noc, December 6-8, Medicor, Izola, Slovenia, -EU.
3.
AGA Medical
Dr Arthur Lussararian
Dr Aijaz Hashmi, Loma Linda University.
Dr Asan Chowdhury, Las Vegas.
Dr Ulrich Luft and Dr Molly Szerlip…..University of Tuscon, Arizona : Atrial Septal Defect Closure. January
23, 2010.
Dr Jim Joy, El Camino Hospital, CA. Post MI Ventricular Septal defect closure
Dr Marko Noc, Medicor, Izola, Slovenia, EU. 4 complex Atrial Septal Defect closures. May
14, 2011
Page 63 of 65
Curriculum Vitae
4.
Saibal Kar, M.D, FAHA, FACC, FSCAI
Percutaneous Mitral Valve Repair (evalve Inc)
Ziyad Hijazi, Sept 2, 2009.
Dr Michael Mack, (one case)October 28, 2009, October 14, 2010.
Dr Darren Walters (2 cases)
Dr David Muller (1 case)
Dr David Muller, (1 case), St Vincent Hospital, Sydney, Australia, August 13, 2012
Prof Teguh Santoso (4 cases). Medistra Hospital, Jakarta, Indonesia. February 23, 24, 2013
Dr Ravinay Bhindi and Dr Peter Jensen(3 cases), Northshore Private Hospital, Sydney, Australia, March
28,2013
Prof Teguh Santoso(2 cases), Medistra Hospital, Jakarta, Indonesia, April 21, 2013
Dr Ravinay Bhindi and Dr Peter Jensen(1case), Northshore Private Hospital, Sydney, Australia, October
17,2013
Dr Anthony Walton, Dr Stephen Duffy (2 cases), Alfred Hospital, Melbourne, Australia, October 18, 2013
Prof Teguh Santoso (3 cases). Medistra Hospital, Jakarta, Indonesia, November 16, 2013
5.
Atrial appendage occlusion ( Watchman Device))
Prof Gerhard Schuller, ( 4 cases)Liepzig Heart Center, Liepzig, Germany, Aug 4, 2009
Dr Jeffrey Allison, (3 cases) Monash Medical Center, Melbourne, Australia, Nov 24, 2009
Dr Karen Phillips, (3 cases), Greenslopes Hospital, Brisbane, Australia, Nov 25, 2009.
Dr Paul Sparks, (3 cases), Royal Melbourne Hospital, Melbourne, Australia, Nov 27, 2009.
Dr Halkin Amir, Dr Raphael Rosso, Dr Itzhak Herz,(2 cases) Ichilov Medical Center, Tel-Aviv, Israel, May 30,
2010.
Prof Michael Glikson, Dr Victor Guetta, Sheba Medical Center, Tel Hashomer, Israel. June 1, 2010 (3
cases)
Dr Pak, Severence Hospital, Seoul, Korea( 2 cases)
Dr Young-Keun On, Samsung Medical Center, Seoul, Korea (one case) .
Dr Young Hoon Kim, Korea University Medical Center, Seoul, Korea (one case)
Dr Matthew Price and Dr Gibson, Scripps Green Hospital, La Jolla, CA ( two cases), April
2011
Dr James Stewart, Mercy Hospital, Auckland, New Zealand (2 cases) Sept 7, 2011
Dr Teguh Santoso, Jakarta, Indonesia, (9 cases), January 14, 15th, 2012
Dr Alexander Black, Geelong Hospital (2 cases), Australia February 16, 2012
Dr Darren Walters, Prince Charles Hospital (3 cases), Brisbane, Australia, February 17,
2012
Prof Teguh Santoso, Medistra HospitalJakarta, Indonesia (5 cases), February 26, 2012
Dr. Gi-Byung Nam, Dr Won-Jang Kim (2 cases), ASAN Medical Center, Seoul, Korea,
September 18, 2012
Dr Cheol-Woong Yu, Dr Rakyung Choy, Dr Sangwon Park, (2 cases), Sejong General
Hospital, Seoul, Korea
Dr Gabriel Yip, and Dr Yat Yin Lam. Grantham Hospital, Hongkong, (2 cases), October, 19,
2012 St Mary Hospital, Seoul, Korea, November 22, 2012
Dr Jason Chan, Dr Michael Lee Queen Elizabeth Hospital, Hongkong ( 2 cases). February 25, 2013
Dr Michael Neuyen, and Dr Andrew Liu, (3 cases), Fremantle Hospital, Western Australia, March 26, 2013
Dr Gregory Szto(2 cases). Peninsula Private Hospital, Frankston, Australia, March 27, 2013.
Dr Rodney Teperman (2 cases), Peninsula Private Hospital, Frankston, Victoria, Australia. March 27, 2013
Dr ……………….. (2 cases), Hospital, Kuala Lumpur, Malaysia, November 12. 2013
Dr
(2 cases), Hospital, Bangkok, Thailand, November 13, 2013.
Dr
(2 cases) Police Hospital, Bangkok, Thailand, November 13, 2013
Dr
(1 case), Hospital, Bangkok, Thailand, November 15, 2013
6.
Coherex PFO closure device
Dr Marko Noc, Medicor, Izola, Slovenia.(4 cases) Dec 5, 6, 2009 and Sept 12, 2010 (5 cases)
7.
Coherex WaveCrest Left Atrial Appendage Occluder
Page 64 of 65
Curriculum Vitae
Saibal Kar, M.D, FAHA, FACC, FSCAI
Dr Karen Phillips, Dr Julie Humphries (2 cases), Greenslopes Hospital, Brisbance,
Australia, Sept 26, 2011.
Dr Ian Meredith, Dr Jeffrey Allison, Dr Richard Harper (2 cases), Monash Medical Center,
Melbourne, Australia, Sept 28, 2011
Dr Marko Noc,(3 cases). Medicor, Izola, Slovenia
Dr David Muller (1 case), St Vincent Hosptial, Sydney, Australia. August 14, 2012
Dr Marko Noc (2 cases), Medicor, Izola, Slovenia, September 30, 2012
L Dr Marko Noc (1 case), Medicor, Izola, Slovenia, December 15, 2012
8.
Percutaneous Mitral Valvuloplasty
Dr Hirsh Naik, West Valley Hospital, Phoenix, One case, January 6, 2012
Course Directors
1.
2.
Atrial Septal Defect Closure Course, July 7-8, 2011, Cedars Sinai Medical Center, Los Angeles,
CA.
1st International Symposium on Left Atrial Appendage. Kansas City. US., March 1-2, 2013
Page 65 of 65